The University of Chicago Header Logo

David Rubin

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Professor of Pathology, Chief of the Section of Gastroenterology, Hepatology & Nutrition and Director of the Inflammatory Bowel Disease Center at the University of Chicago Medicine. He earned a medical degree with honors at The University of Chicago Pritzker School of Medicine where he also completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics. He is associate faculty member at the MacLean Center for Clinical Medical Ethics, associate investigator at the University of Chicago Comprehensive Cancer Center and a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He is the immediate past Chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation and current Chair of the International Organization for the Study of IBD.

    Dr. Rubin’s research is focused on disease modification in IBD including clinical trial designs, novel measures of inflammation and prevention of adverse outcomes, and quality of life in IBD. He has twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), and in 2020, Dr. Rubin received the Sherman Prize for Excellence in Crohn’s and Colitis and in 2023, the UChicago Michael Reese Lectureship Award for outstanding faculty who have developed novel teaching and clinical research that advances healthcare, and separately, the distinguished UChicago Arthur H. Rubenstein Mentorship in Academic Medicine Award. He is Editor-in-Chief of the ACG On-Line Education Universe. Dr. Rubin is an editor of Curbside Consultation in IBD (3rd ed), senior editor of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (12th ed), and an author on >600 articles on management of IBD, including the 2019 and 2025 ACG Practice Guidelines for ulcerative colitis.

    Collapse Biography 
    Collapse education and training
    University of Chicago Pritzker School of Medicine, ChicagoFellowship06/2001Gastroenterology
    University of Chicago Pritzker School of Medicine, ChicagoResidency06/1997Internal Medicine
    University of Chicago Pritzker School of Medicine, ChicagoMD06/1994
    University of Illinois, Urbana-ChampaignBS06/1990Honors Biology

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Moghe R, Mathew AJ, Choi D, Rubin DT. Guselkumab as a Treatment Adjunct for Pyoderma Gangrenosum While Maintaining Clinical Remission of Ulcerative Colitis. ACG Case Rep J. 2026 Sep; 13(9):e02290. PMID: 42746618; PMCID: PMC13577436.
      Citations:    
    2. Afzali A, Danese S, Panaccione R, Rubin DT, Sands BE, Reinisch W, Panés J, Van Rampelbergh R, Terry NA, Salese L, Vetter ML, Yee J, Corbett C, van Duijnhoven W, Hisamatsu T, Andrews JM, D'Haens GR, GALAXI 1 investigators . Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial. Inflamm Bowel Dis. 2026 Sep 01; 32(9):1669-1682. PMID: 42065683; PMCID: PMC13533210.
      Citations:    Fields:    
    3. St-Pierre J, Delisle M, Miyatani Y, Falloon K, Ernest-Suarez K, Pabla B, Huynh H, Maracle B, Kung JY, Cleveland N, Rubin DT, Dolinger M, Novak K, Damas O, Melmed GY, Lu C, Kellar A. Ultrasound criteria for transmural healing and response in Crohn's disease: a systematic review of definitions and thresholds. Inflamm Bowel Dis. 2026 Sep 01; 32(9):1707-1721. PMID: 42222916; PMCID: PMC13533201.
      Citations:    Fields:    
    4. Shahub S, Lin KC, Choi NK, Garcia NM, Muthukumar S, Rubin DT, Prasad S. Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease. Inflamm Bowel Dis. 2026 Aug 28. PMID: 42665275.
      Citations:    
    5. Rochlin DH, Boe L, Snow D, Dimaano M, Rubin D, Mehrara BJ, Matros E, Xiao F. Negotiated Prices for Reconstructive Surgery Converge without Reduction in Overall Price Level after Federal Price Transparency Regulations. J Am Coll Surg. 2026 Aug 25. PMID: 42640626.
      Citations:    
    6. Rubin DT, Yarur A, Wood R, Chen BP, Young LE, Gower M, Yajnik V. Advancing Equity and Patient Partnership in Clinical Trials for Inflammatory Bowel Disease: A Model for Inclusive Trial Design. Clin Exp Gastroenterol. 2026; 19:603005. PMID: 42657205; PMCID: PMC13508045.
      Citations:    
    7. Dubinsky M, Moses R, Peyrin-Biroulet L, Travis S, Rubin DT, Walsh A, Bleakman AP, Owen C, Camilleri M. Assessment of Bowel Urgency in Ulcerative Colitis: Current Measures and Future Directions. Gastro Hep Adv. 2026; 5(11):101086. PMID: 42740948; PMCID: PMC13572057.
      Citations:    
    8. Rubin DT, Panés J, Torres J, Kobayashi T, Su C, Lawendy N, Modesto I, Segovia M, Gardiner S, Wang W, Vermeire S. Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial. Crohns Colitis 360. 2026 Jul; 8(3):otag093. PMID: 42669025; PMCID: PMC13525840.
      Citations:    
    9. Lombard R, Wang W, Chervonsky A, Dalal S, Cohen RD, Sakuraba A, Rubin DT, Weber CR, Pekow J. FUT2 non-secretor status is not associated with disease phenotype or outcomes in patients with Crohn's disease. Crohns Colitis 360. 2026 Jul; 8(3):otag094. PMID: 42662997; PMCID: PMC13521598.
      Citations:    
    10. Dotan I, Dubinsky MC, Siegel CA, Lindsay J, McGovern D, Allez M, Myrelid P, Lewis J, Sands BE, Peyrin-Biroulet L, Danese S, Ahuja V, Kaplan GG, Konings M, Gearry R, Ng SC, Jairath V, Magro F, Silverberg MS, Turner D, Abreu MT, Hart A, Dignass A, Rubin DT, International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). IOIBD: the International Organization for the Study of Inflammatory Bowel Disease. Ther Adv Gastroenterol. 2026; 19:17562848261470923. PMID: 42553409; PMCID: PMC13434103.
      Citations:    
    11. Rubin DT, Schreiber S, Peyrin-Biroulet L, Danese S, Gianfrancesco MA, Soonasra A, Sidhu S, Vranic I, Shelbaya A, Gruben D, Wei Y, Winthrop KL, Curtis JR, Regueiro MD, Dubinsky MC. Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments. Inflamm Bowel Dis. 2026 Jul 28. PMID: 42520305.
      Citations:    Fields:    
    12. Rubin DT, Lees CW, Baert F, Kudela M, Bhattacharjee A, Lazin K, Goetsch M, Abbatemarco AM, Wosik K, Marshall JK. The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program. Ther Adv Gastroenterol. 2026; 19:17562848261470909. PMID: 42523912; PMCID: PMC13408076.
      Citations:    
    13. George AT, Gottlieb K, Colucci DR, Eastman WJ, Baxi S, Battioui C, Lehrer J, Yu E, Brodskiy P, Wang Y, Thomason D, Haft-Javaherian M, Rubin DT. Artificial intelligence assessment of endoscopic severity and extent: A machine learning approach to continuous evaluation of endoscopic inflammation in ulcerative colitis. Inflamm Bowel Dis. 2026 Jul 17. PMID: 42467467.
      Citations:    Fields:    
    14. Kuriakose Kuzhiyanjal AJ, Rhodes S, Sethi-Arora K, Hancock L, Selinger C, Lamb CA, Rubin DT, Limdi JK. Healthcare professionals' knowledge, attitudes, and practice with addressing sexual health among people living with inflammatory bowel disease: A UK cross-sectional survey. Inflamm Bowel Dis. 2026 Jul 10. PMID: 42430211.
      Citations:    Fields:    
    15. Peyrin-Biroulet L, Kubassova O, Himoff J, Weber CR, Adsul S, Freire M, Hussaini BE, Biedermann L, Koelzer VH, Bressler B, Xiong W, Niess JH, Matter MS, Kopylov U, Barshack I, Mayer C, Magro F, Carneiro F, Maharshak N, Greenberg A, Rubin DT. Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis. United European Gastroenterol J. 2026 Jul; 14(6):e70227. PMID: 42390952; PMCID: PMC13326826.
      Citations:    Translation:Humans
    16. Kinford CW, Tijerina M, Nordgren RK, Rubin DT, Hurst RD, Shogan BD, Shaffer VO, Olortegui KS. End-to-Side Ileocolonic Anastomosis After Ileocecectomy for Crohn's Disease Is a Safe Option With Low Recurrence. Dis Colon Rectum. 2026 Sep 01; 69(9):2283-2290. PMID: 42302313.
      Citations:    Fields:    
    17. Schreiber S, Wu J, Duan Y, Keohane A, Navabi S, Rubin DT. Combined bowel urgency, clinical outcomes, and quality of life improvement in mirikizumab-treated ulcerative colitis: a step toward comprehensive disease management. Crohns Colitis 360. 2026 Apr; 8(2):otag051. PMID: 42358866; PMCID: PMC13293077.
      Citations:    
    18. Choden T, Mathew AJ, Goffinet A, Scott A, Choi D, Cleveland NK, Dalal SR, McDonald BD, Pekow J, Cohen RD, Rubin DT. Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients With Baseline Cardiovascular Risk. Am J Gastroenterol. 2026 Jun 09. PMID: 42262536.
      Citations:    Fields:    
    19. Fear EN, McDonald BD, Kennedy MS, Mathew AJ, McMillan RH, Fine ZD, McDermott AR, Choi D, Kellar A, Rubin DT. Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn's disease. Crohns Colitis 360. 2026 Apr; 8(2):otag049. PMID: 42328295; PMCID: PMC13282075.
      Citations:    
    20. Natt N, Choi D, Shafrir A, Dalal SR, Krugliak Cleveland N, Cohen RD, Rubin DT. Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel Disease. Dig Dis Sci. 2026 Oct; 71(10):4831-4841. PMID: 42240958; PMCID: PMC13558318.
      Citations:    Fields:    
    21. Danese S, Goetsch M, Peyrin-Biroulet L, Yarur AJ, Dubinsky M, Rubin DT, Feagan BG, D'Haens G, Baert F, Lazin K, Gu G, Yu J, Lawendy N, Zang C, Wang W, Menon S, Law EH, Modesto I, Wosik K, Sidhu S, Niezychowski W, Vermeire S. The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results From the Phase II GLADIATOR Trial. Clin Gastroenterol Hepatol. 2026 Jun 04. PMID: 42248437.
      Citations:    Fields:    
    22. Faggiani I, Danese S, Biroulet LP, Jairath V, Rubin DT, Allocca M. Imaging endpoints in inflammatory bowel disease: current evidence and future directions for ultrasound and MRI. BMC Med. 2026 05 29; 24(1). PMID: 42216172; PMCID: PMC13440104.
      Citations:    Fields:    Translation:Humans
    23. Hanzel J, Yuan Y, Goodwin SW, Nardone OM, Roseira J, Solitano V, Vuyyuru SK, Leong RW, Sands BE, Turner D, Moum B, Long MD, Louis E, Reinisch W, Rubin DT, Danese S, Dignass A, Siegel CA, Panaccione R, Dubinsky MC, Peyrin-Biroulet L, Halfvarson J, Magro F, Hart A, Jairath V, ENDPOINT and PRO Clusters of the International Organization for the Study of Inflammatory Bowel Dise. Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2026 Oct; 24(10):2650-2670. PMID: 42214800.
      Citations:    Fields:    
    24. Wils P, Jairath V, Sands BE, Dignass A, Magro F, Rubin DT, Dotan I, Reinisch W, Dulai P, Gearry R, Ma C, Long M, Armuzzi A, Kobayashi T, Turner D, Vieujean S, Verstockt B, Hart A, Danese S, Peyrin-Biroulet L. Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus. J Crohns Colitis. 2026 May 08; 20(5). PMID: 42159038.
      Citations:    Fields:    Translation:Humans
    25. Danese S, Dignass A, Laharie D, Limdi JK, Kempinski R, Lewis JD, Younes Z, Cohen E, Alaka K, Eastman WJ, Tian T, Redondo I, Rubin DT, Dubinsky M. Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial. J Crohns Colitis. 2026 May 08; 20(5). PMID: 42112567; PMCID: PMC13158796.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    26. Lichtenstein GR, Allegretti JR, Rubin DT, Magro F, Bressler B, Panés J, Afif W, Samaan MA, Ye BD, Yarandi S, Germinaro M, Shipitofsky N, Miao Y, Zhang H, Dignass A, Sands BE, Hisamatsu T, Peyrin-Biroulet L. Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study. Am J Gastroenterol. 2026 May 01. PMID: 42065421.
      Citations:    Fields:    
    27. Rubin DT, Danese S, Nakase H, Ungaro RC, Wolf DC, Alekseeva O, Petersen A, Liu Z, Mehra D, Jain A, Osterman MT, Krakovich A, Riolo JV, DeBoer E, Appio J, Sinh P, Cree BAC, Cohen JA, Irving P. Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis. Inflamm Bowel Dis. 2026 May 01; 32(5):954-962. PMID: 41677183; PMCID: PMC13135834.
      Citations:    Fields:    Translation:Humans
    28. Miyatani Y, St-Pierre J, Klein J, Rubin DT, Krugliak Cleveland N. Intestinal ultrasound in acute severe ulcerative colitis treated with intravenous cyclosporine: case series. Crohns Colitis 360. 2026 Apr; 8(2):otag037. PMID: 42111047; PMCID: PMC13152635.
      Citations:    
    29. Su Q, Chen S, Lau LH, Lui RN, Wang Y, Xu Z, Cheung CP, Ching JYL, Shen X, Peng Y, Tun HM, Ianiro G, Rubin D, Chang EB, Chan FKL, Ng SC. Artificial intelligence-driven donor-recipient gut microbiome matching for optimized fecal microbiota transplantation. Cell Rep. 2026 May 26; 45(5):117301. PMID: 42061404.
      Citations:    Fields:    Translation:Humans
    30. Han J, Puangampai A, Man B, Kandah HM, Rubin DT, Choi DK. Evaluation of a pharmacist directed treat to target approach in patients with inflammatory bowel disease receiving upadacitinib or risankizumab. Crohns Colitis 360. 2026 Apr; 8(2):otag026. PMID: 42131776; PMCID: PMC13166866.
      Citations:    
    31. Dang CP, Chen-Liaw A, Xue M, Luchak A, Mu K, Li Q, Ren MY, Lee SH, Moayyedi P, Griffiths AM, Deslandres C, Murthy SK, Steinhart AH, Otley A, Dieleman LA, Jacobson K, Rubin DT, Panaccione R, Feagan BG, Streutker C, Mogno I, Britton GJ, Faith JJ, CCC GEM Project Research Consortium, Croitoru K, Turpin W. Pre-Crohn's Disease Stool From Discordant Siblings Promotes the Development of Colitis in Germ-Free Mice. Gastroenterology. 2026 Sep; 171(3):489-503. PMID: 42002154.
      Citations:    Fields:    
    32. Arzivian A, Rubin DT, Seow CH, Kerkham A, Tran Y, Leong RW. The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2026 Apr 01; 32(4):661-676. PMID: 41338243.
      Citations:    Fields:    Translation:Humans
    33. Hart A, Sridhar S, Venkat S, Lee T, Rusbuldt JJ, Richards D, Sisk C, Horowitz D, Tomsho L, Kannan AK, Ruane D, Van den Berge K, Rubin DT, Sands BE, De Hertogh G, Huang KG, Germinaro M, Cua D, Waterworth D, Freeman TC, Vetter ML, McRae B, Verstockt B, Branigan P. Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitis. BMJ Open Gastroenterol. 2026 Mar 23; 13(1). PMID: 41871904; PMCID: PMC13034392.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    34. Steinway C, Carbaugh L, Belton T, Teng O, Shults J, Bennett L, Griffis H, Aygun B, Appiah-Kubi A, Apollonsky N, Boruchov D, Niss O, Schwartz L, Crosby LE, Barakat L, Andemariam B, Rubin D, Smith-Whitley K, Jan S. Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study. Pediatr Blood Cancer. 2026 Jun; 73(6):e70252. PMID: 41846329.
      Citations:    Fields:    Translation:Humans
    35. Jairath V, Hunter Gibble T, Peyrin-Biroulet L, Sands BE, Hirai F, Hibi T, Loftus EV, Cross RK, Protic M, Chan LS, Morris N, Traxler K, Rubin DT. Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY study. Crohns Colitis 360. 2026 Jan; 8(1):otag018. PMID: 41908680; PMCID: PMC13017000.
      Citations:    
    36. Dignass A, Narula N, Pratap K, Danese S, Dotan I, Iacucci M, Jairath V, Loftus EV, Magro F, Mantzaris G, Peyrin-Biroulet L, Rubin DT, Sands BE, Turner D, Reinisch W, International Organization for the Study of IBD. IOlBD evidence-based consensus on the use of artificial intelligence for assessment of endoscopic and histologic endpoints in clinical trials of inflammatory bowel disease. J Crohns Colitis. 2026 Mar 10; 20(3). PMID: 41802119.
      Citations:    Fields:    Translation:Humans
    37. Faye AS, Rubin DT, Siegel CA, Long MD, Khan N, Danese S, Irving PM, Cross RK, Blumenstein I, Armuzzi A, Horst SN, Dignass A, Kobayashi T, Lawlor G, Krakovich A, Petersen A, Liu Z, Wang D, Jain A, Ananthakrishnan AN, Sabino J. Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age. Inflamm Bowel Dis. 2026 Mar 01; 32(3):512-525. PMID: 41274280; PMCID: PMC12794806.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    38. Kellar A, George T, Dolinger MT, Smyth M, Cleveland NK, Rubin DT, St-Pierre J. Reliability and Validity of Mesenteric Fat Assessment by Intestinal Ultrasound in Pediatric Crohn's Disease Using the Chicago Mesenteric Fat Index. Inflamm Bowel Dis. 2026 Mar 01; 32(3):444-451. PMID: 41206568.
      Citations:    Fields:    Translation:Humans
    39. St-Pierre J, Kellar A, George T, Miyatani Y, Krugliak Cleveland N, Choi NK, Liao C, Fear E, Fine Z, Picker E, Rubin DT. The Chicago Mesenteric Fat Index: A Novel Metric for Point-of-Care Intestinal Ultrasound Evaluation of Mesenteric Fat Wrapping in Crohn's Disease. Inflamm Bowel Dis. 2026 03 01; 32(3):452-460. PMID: 41441773.
      Citations:    Fields:    Translation:Humans
    40. Panaccione R, Panés J, Peyrin-Biroulet L, Colombel JF, Lindsay JO, Baert F, Atreya R, Vermeire S, Fujii T, Dubcenco E, Klaff J, Duncan B, Suravaram S, Fish I, Lacerda AP, Vladea R, Ford S, Shah S, Anyanwu SI, Rubin DT. Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies. Clin Gastroenterol Hepatol. 2026 Oct; 24(10):2783-2795. PMID: 41763462.
      Citations:    Fields:    
    41. Yanai H, Choi D, Ben-Horin S, Salomon N, Loebstein R, Leshno M, Rubin DT. Curcumin-QingDai Combination for Active Ulcerative Colitis: A Cost-Effectiveness Analysis. Value Health. 2026 Jul; 29(7):1162-1170. PMID: 41724213.
      Citations:    Fields:    Translation:Humans
    42. Jairath V, Vuyyuru SK, Zou G, Ma C, Neustifter B, Agboton C, Romo Bautista I, Allocca M, An YK, Begun J, Bryant RV, Danese S, Dubinsky M, Feagan BG, Freire M, Novak KL, Panaccione R, Pudipeddi A, Rubin DT, Sands BE, Sparrow MP, Taylor SA, Gecse KB, Wilkens R, Maaser C. Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trial. BMJ Open Gastroenterol. 2026 Feb 20; 13(1). PMID: 41720589; PMCID: PMC12927283.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    43. Miyatani Y, Choi NK, Krugliak Cleveland N, Rubin DT. Intestinal Ultrasound-Assisted Endoscopic Management of Acute Bowel Obstruction in a Patient With Crohn's Disease. ACG Case Rep J. 2026 Feb; 13(2):e01987. PMID: 41669274; PMCID: PMC12885663.
      Citations:    
    44. Yanofsky R, McDonald BD, Nikzad N, Choi D, Shea CR, Chadha AA, Rubin DT. Erratum to: New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors. Am J Gastroenterol. 2026 Feb 05. PMID: 41642655.
      Citations:    Fields:    
    45. Cohen-Mekelburg S, Hashash JG, Loftus EV, Rubin DT. AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review. Gastroenterology. 2026 02; 170(2):408-417. PMID: 41579011.
      Citations:    Fields:    Translation:Humans
    46. Bedell A, McDermott AR, Karpin JE, Rodriguez TG, Glick LR, Aeder CB, Rubin DT. Ethical and Practical Considerations for Mental Health Screening in Adult Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2026 Sep 01; 121(9):2288-2292. PMID: 41568822.
      Citations:    Fields:    
    47. Xiao F, Boe L, Snow D, Dimaano M, Rubin D, Nelson J, Mehrara BJ, Matros E, Rochlin DH. Transparency, Repricing, and Price Convergence in Cancer Care. Value Health. 2026 Jul; 29(7):1235-1244. PMID: 41577238.
      Citations:    Fields:    Translation:Humans
    48. Long M, Allegretti JR, Danese S, Germinaro M, Baker T, Alvarez Y, Kavalam M, Han C, Jörgens S, Jiang L, Zhang H, Hisamatsu T, Rubin DT, Peyrin-Biroulet L, ASTRO Study Group. Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2026 Apr; 11(4):284-298. PMID: 41544637.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    49. Ezenwanne C, Spicer S, Brancaccio H, Goodwin B, Rubin D, Carmichael T, Zou I, Mukhopadhyay S, Siu G. Thread carpal tunnel release vs. minimally invasive carpal tunnel release: a systematic review and meta-analysis. Pain Manag. 2026 Apr; 16(4):341-349. PMID: 41524415; PMCID: PMC13248507.
      Citations:    Fields:    Translation:Humans
    50. Cohen NA, Bettenworth D, Sror N, Khedraki R, Yang Q, Abreu MT, Atreya R, Al-Bawardy B, Connor SJ, D'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon IO, Hedin CRH, Hernandez-Rocha C, Kobayashi T, Leibovitzh H, Lu C, Maharshak N, Naseer M, Ollech J, Rubin DT, Sebastian S, Siegmund B, Silverberg MS, Steinwurz F, Torres J, Watermeyer G, Aswani Omprakash T, Frenkel L, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F, Study of Upper Gastrointestinal Manifestations and Management of Crohn's Disease (SUMM-CD) Group. Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study. Lancet Gastroenterol Hepatol. 2026 Mar; 11(3):243-255. PMID: 41520669.
      Citations:    Fields:    Translation:Humans
    51. Rubin DT, Reinisch W, Narula N, Colucci DR, Eastman W, Gottlieb K, Lacerda AP, Laroux FS, Modesto I, Navajas EE, Owen CC, Wang Y, Baxi S. Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review. Inflamm Bowel Dis. 2026 Jan 01; 32(1):159-168. PMID: 41206586.
      Citations:    Fields:    Translation:Humans
    52. Yarur A, Irving P, Siegmund B, Dubinsky MC, Ananthakrishnan AN, Regueiro M, Ungaro RC, Ritter T, Nakase H, Liu Z, Mehra D, Osterman MT, Jain A, Rubin DT, Hibi T. Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid. Inflamm Bowel Dis. 2026 Jan 01; 32(1):77-86. PMID: 41003640; PMCID: PMC12759051.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    53. Rubin DT, Natt NK. Is it Time to Treat to Histologic Remission Yet? Clin Gastroenterol Hepatol. 2026 May; 24(5):1234-1235. PMID: 41475529.
      Citations:    Fields:    
    54. Luan X, Fisher BT, Coffin SE, Rubin D, Matone M, Huang J. School masking and COVID-19 community transmission: a synthetic control study. Health Aff Sch. 2025 Dec; 3(12):qxaf233. PMID: 41445937; PMCID: PMC12723219.
      Citations:    
    55. Rubin DT, Ananthakrishnan AN, Siegel CA, Barnes EL, Long MD. Correction: ACG Clinical Guideline Ulcerative Colitis in Adults. Am J Gastroenterol. 2026 Mar 01; 121(3):809-810. PMID: 41384833.
      Citations: 1     Fields:    
    56. Nikzad N, Khadilkar S, Onajin Darkwa O, Mann Gradwohl K, Chadha AA, Pekow J, Rubin DT. Cutaneous and Genitalia Inflammation Treated With Guselkumab and Antimicrobial Therapy in a Patient with a History of Crohn's Disease. ACG Case Rep J. 2025 Dec; 12(12):e01936. PMID: 41415696; PMCID: PMC12711364.
      Citations:    
    57. Reddy N, Klein JA, Thomas N, Micic D, Deng Z, Rubin DT, Cohen RD, Dalal S, Christensen B, Haider HI, Valuckaite V, Meckel KR, Bissonnette M, Weber CR, Pekow J. Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease. Clin Transl Sci. 2025 12; 18(12):e70422. PMID: 41277578; PMCID: PMC12641277.
      Citations:    Fields:    Translation:Humans
    58. Rajagopal G, Paknikar R, Deng Z, Dwadasi S, V Goens D, Zafer M, Cohen RD, Sakuraba A, Rubin DT, Dalal S, Micic D, Pekow J. A positive Clostridioides difficile test does not impact outcomes in hospitalized patients with acute severe ulcerative colitis. Ther Adv Gastroenterol. 2025; 18:17562848251394957. PMID: 41283172; PMCID: PMC12639233.
      Citations:    
    59. Miyatani Y, Choi D, Aronsohn AI, Pillai A, Cohen RD, Rubin DT. Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case Series. Dig Dis Sci. 2026 May; 71(5):1711-1715. PMID: 41263898; PMCID: PMC13201271.
      Citations:    Fields:    Translation:Humans
    60. de Boer NK, Gearry RB, Bernstein CN, Banerjee R, Rubin DT, Kaplan GG, Globalization Cluster of the International Organization of IBD. The essential medicines list for inflammatory bowel disease: time to raise the standards of global care. Lancet Gastroenterol Hepatol. 2026 Jan; 11(1):7-9. PMID: 41265466.
      Citations:    Fields:    
    61. Jan S, Steinway C, Belton T, Shults J, Bennett L, Teng O, Griffis H, Aygun B, Appiah-Kubi A, Apollonsky N, Boruchov D, Niss O, Schwartz L, Crosby L, Barakat L, Andemariam B, Mulchan SS, Rubin D, Smith-Whitley K. Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA Netw Open. 2025 11 03; 8(11):e2543571. PMID: 41247734; PMCID: PMC12625686.
      Citations:    Fields:    Translation:Humans
    62. Ho AHY, Rubin DT. Reply. Clin Gastroenterol Hepatol. 2026 Aug; 24(8):2325. PMID: 41177325.
      Citations:    Fields:    
    63. Allocca M, Jairath V, Sands BE, Rubin DT, Caron B, Laurent V, Novak K, Panaccione R, Bossuyt P, Bruining DH, Dignass A, Dotan I, Fletcher J, Fumery M, Furfaro F, Halfvarson J, Hart A, Kobayashi T, Krugliak Cleveland N, Kucharzik T, Laghi A, Lakatos PL, Leong RW, Loftus EV, Louis E, Magro F, Olivera PA, Sebastian S, Siegmund B, Vavricka SR, Wilson SR, Stoker J, Rimola J, Peyrin-Biroulet L, Danese S. International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials. J Crohns Colitis. 2025 Sep 28; 19(9). PMID: 40973472.
      Citations: 2     Fields:    Translation:Humans
    64. Mojica JJ, Rubin D, Mastria M, Baratta JL. Updates on Multimodal Analgesia for Orthopedic Surgery. Anesthesiol Clin. 2025 Dec; 43(4):625-643. PMID: 41233099.
      Citations:    Fields:    Translation:Humans
    65. Caron B, Jairath V, Sands BE, Rubin DT, Allocca M, Laurent V, Novak K, Panaccione R, Bossuyt P, Bruining DH, Dignass A, Dotan I, Fletcher J, Fumery M, Furfaro F, Halfvarson J, Hart A, Kobayashi T, Cleveland NK, Kucharzik T, Laghi A, Lakatos PL, Leong RW, Loftus EV, Louis E, Magro F, Olivera PA, Shaji S, Siegmund B, Vavricka SR, Danese S, Stoker J, Peyrin-Biroulet L. International Magnetic Resonance Imaging Consensus for Use in Luminal Crohn's Disease Trials and Clinical Practice. Clin Gastroenterol Hepatol. 2026 Apr; 24(4):1130-1140. PMID: 40882718.
      Citations: 1     Fields:    Translation:Humans
    66. Yanofsky R, McDonald BD, Nikzad N, Choi D, Shea CR, Chadha AA, Rubin DT. New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors. Am J Gastroenterol. 2026 01 01; 121(1):268-273. PMID: 40844618.
      Citations:    Fields:    Translation:Humans
    67. Luan X, Fisher BT, Coffin SE, Rubin D, Matone M, Huang J. School masking and COVID-19 community transmission: a synthetic control study. medRxiv. 2025 Aug 13. PMID: 40832423; PMCID: PMC12363737.
      Citations:    
    68. Ho AHY, Choi D, Mathew AJ, McDermott A, Fine Z, Fear E, Choi NK, Cohen RD, Dalal SR, Pekow J, Krugliak Cleveland N, Rubin DT. Real-world Experience of Upadacitinib Reinduction and High-dose Maintenance Therapy in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2026 Mar; 24(3):763-771. PMID: 40782945.
      Citations:    Fields:    Translation:Humans
    69. DesRochers J, Chow A, Rubin D, Raja A. Effect of gait retraining in minimalist footwear or barefoot on running footstrike and cadence: a systematic review. Res Sports Med. 2026 Mar-Apr; 34(2):163-175. PMID: 40762620.
      Citations:    Fields:    Translation:Humans
    70. Rubin DT, Hart AL. A Guide to the Patient-Centric Use of Vedolizumab for Crohn's Disease. Inflamm Bowel Dis. 2025 Aug 01; 31(8):2269-2285. PMID: 40512051; PMCID: PMC12342800.
      Citations:    Fields:    Translation:Humans
    71. Choi D, Kellar A, Klein J, Choi NK, Garcia NM, Friedberg S, Rubin DT. Incidence and Risk Factors for Development of Acne (JAKne) in Patients with Inflammatory Bowel Disease Treated With Upadacitinib. Inflamm Bowel Dis. 2025 Aug 01; 31(8):2311-2314. PMID: 40411447.
      Citations: 1     Fields:    
    72. Krugliak Cleveland N, Bhondwe KS, Duty CM, Rubin DT. Intestinal Ultrasound Identified Crohn's Disease In Previously Undiagnosed Siblings. Inflamm Bowel Dis. 2025 Aug 01; 31(8):2315-2317. PMID: 39903445.
      Citations:    Fields:    
    73. Honap S, St-Pierre J, Colwill M, Patel K, Le Berre C, Caron B, Nogami A, Kobayashi T, Altwegg R, Laharie D, Hebuterne X, Nachury M, Roblin X, Uzzan M, Kotze PG, Lukáš M, Vieujean S, D'Amico F, Albshesh A, Guillo L, Fumery M, Nancey S, Ye BD, Bergemalm D, Halfvarson J, Buisson A, Karmiris K, Rubin DT, Vicaut E, Peyrin-Biroulet L, ATTRACT Study Group. Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2026 Mar; 24(3):784-793. PMID: 40721074.
      Citations: 3     Fields:    Translation:Humans
    74. Dubinsky MC, Potts Bleakman A, Schreiber S, Rubin DT, Panaccione R, Hibi T, Kayhan C, Gibble TH, Flynn EJ, Favia AD, Panni T, Atkinson C, Saxena S, Travis S. Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey. Curr Med Res Opin. 2025 Jun; 41(6):1017-1030. PMID: 40635574.
      Citations: 1     Fields:    Translation:Humans
    75. Panaccione R, Feagan BG, Afzali A, Rubin DT, Reinisch W, Panés J, Danese S, Hisamatsu T, Terry NA, Salese L, Van Rampelbergh R, Sahoo A, Vetter ML, Yee J, Han C, Frustaci ME, Wan KYY, Yang Z, Johanns J, Andrews JM, D'Haens GR, Sands BE, GALAXI 2 & 3 Study Group. Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials. Lancet. 2025 07 26; 406(10501):358-375. PMID: 40684778.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    76. Rubin DT, Bleakman AP, Travis S, Dubinsky M, Schreiber S, Panaccione R, Gibble TH, Kayhan C, Panni T, Flynn E, Favia AD, Atkinson C, Saxena S, Hibi T. Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn's Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey. Adv Ther. 2025 Sep; 42(9):4510-4526. PMID: 40643842; PMCID: PMC12394242.
      Citations: 1     Fields:    Translation:Humans
    77. Vieujean S, Sands BE, Panaccione R, Rubin DT, Jairath V, Danese S, Peyrin-Biroulet L, Schreiber S, Vermeire S, D'Haens G, Dignass A, Dulai PS, Narula N, Reinisch W. Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review. J Crohns Colitis. 2025 Jul 03; 19(7). PMID: 40692351; PMCID: PMC12280173.
      Citations:    Fields:    Translation:Humans
    78. Yanai H, Feakins R, Allocca M, Burisch J, Ellul P, Iacucci M, Maaser C, Zilli A, Zidar N, Wilkens R, Verstockt B, Vavricka S, Uzzan M, Stoker J, Scharitzer M, Rubin D, Rosini F, Rimola J, van Rheenen P, Borralho Nunes P, Novak K, Noor NM, Nardone OM, Lu C, Kopylov U, Katsanos K, de Kock I, Kellar A, Karmiris K, Maconi G, Furfaro F, Flanagan E, Driessen A, Chavannes M, Bettenworth D, Ben-Horin S, Bhatnagar G, Baldin P, Kucharzik T, Taylor S. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2. J Crohns Colitis. 2025 Jul 03; 19(7). PMID: 40742985.
      Citations: 11     Fields:    
    79. Kucharzik T, Taylor S, Allocca M, Burisch J, Ellul P, Iacucci M, Maaser C, Baldin P, Bhatnagar G, Ben-Horin S, Bettenworth D, Chavannes M, Driessen A, Flanagan E, Furfaro F, Maconi G, Karmiris K, Kellar A, De Kock I, Katsanos K, Kopylov U, Lu C, Nardone OM, Noor NM, Novak K, Borralho Nunes P, van Rheenen P, Rimola J, Rosini F, Rubin D, Scharitzer M, Stoker J, Uzzan M, Vavricka S, Verstockt B, Wilkens R, Zidar N, Zilli A, Yanai H, Feakins R. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1. J Crohns Colitis. 2025 Jul 03; 19(7). PMID: 40741688.
      Citations: 15     Fields:    Translation:Humans
    80. Feuerstein JD, Rubin DT, Aberra FN, Yarur AJ, Malter L. Appropriate Use and Complications of Corticosteroids in Inflammatory Bowel Disease: A Comprehensive Review. Clin Gastroenterol Hepatol. 2025 Nov; 23(12):2068-2082. PMID: 40588110.
      Citations: 1     Fields:    Translation:Humans
    81. Olivas AD, Mou Ngai PC, Schahrer E, Xing J, Ghadiri M, Olortegui KS, Cursio JF, Akiyama S, Chang EB, Shen L, Umanskiy K, Rubin DT, Zemmour D, Weber CR, Olivas AD, Mou Ngai PC, Schahrer E, Xing J, Ghadiri M, Olortegui KS, Cursio JF, Chang EB, Shen L, Umanskiy K, Rubin DT, Zemmour D, Weber CR. Histopathologic Evaluation and Single-cell Spatial Transcriptomics of the Colon Reveal Cellular and Molecular Abnormalities Linked to J-Pouch Failure in Patients With Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2025; 19(10):101563. PMID: 40571096; PMCID: PMC12362706.
      Citations:    Fields:    Translation:HumansCells
    82. Rubin DT, Kubassova O, Weber CR, Adsul S, Freire M, Biedermann L, Koelzer VH, Bressler B, Xiong W, Niess JH, Matter MS, Kopylov U, Barshack I, Mayer C, Magro F, Maharshak N, Greenberg A, Hart S, Dehmeshki J, Carneiro F, Peyrin-Biroulet L. Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis. Inflamm Bowel Dis. 2025 Jun 13; 31(6):1630-1636. PMID: 39284932; PMCID: PMC12166296.
      Citations: 6     Fields:    Translation:Humans
    83. Armuzzi A, Rubin DT, Schreiber S, Panés J, Fellmann M, Bartolome L, Gruben D, Goetsch M, Bhattacharjee A, Chaparro M, Dubinsky MC. Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12. Inflamm Bowel Dis. 2025 Jun 13; 31(6):1583-1594. PMID: 39326009; PMCID: PMC12166301.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    84. Ma C, Khanna R, Maguire BR, Zou G, Bressler B, Hindryckx P, Mosli M, Sparrow MP, Hart AL, Leong RW, Rubin DT, Rémillard J, Shackelton LM, D'Haens GR, Danese S, Peyrin-Biroulet L, Sands BE, Panaccione R, Feagan BG, Jairath V. Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials. Lancet Gastroenterol Hepatol. 2025 08; 10(8):746-756. PMID: 40505666.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    85. DeLeon O, Mocanu M, Tan A, Sidebottom AM, Koval J, Ceccato HD, Kralicek S, Colgan JJ, St George MM, Lake JM, Cooper M, Xu J, Moore J, Su Q, Xu Z, Ng SC, Chan FKL, Tun HM, Cham CM, Liu CY, Rubin DT, Martinez-Guryn K, Chang EB. Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects. Cell. 2025 Jul 24; 188(15):3927-3941.e13. PMID: 40482640; PMCID: PMC12330209.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    86. Danese S, Kobayashi T, D'Haens G, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S. Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis. J Crohns Colitis. 2025 Jun 04; 19(6). PMID: 40355364; PMCID: PMC12137900.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    87. Rubin DT, Ananthakrishnan AN, Siegel CA, Barnes EL, Long MD. ACG Clinical Guideline Update: Ulcerative Colitis in Adults. Am J Gastroenterol. 2025 Jun 03; 120(6):1187-1224. PMID: 40701556.
      Citations: 42     Fields:    Translation:Humans
    88. Hanžel J, Solitano V, Vuyyuru SK, Panaccione R, Sands BE, Peyrin-Biroulet L, Danese S, D'Haens GR, Atreya R, Allez M, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen BL, Colombel JF, D'Amico F, Dignass A, Dubinsky M, Fleshner P, Gearry RB, Hanauer SB, Hart AL, Kayal M, Kucharzik T, Lakatos PL, Louis E, Magro F, Narula N, Leong RW, Panés J, Raine T, Ran Z, Regueiro MD, Reinisch W, Singh S, Steinhart AH, Travis S, Ungaro RC, Janneke van der Woude C, Yamamoto T, Ahuja V, Rubin DT, Dulai PS, Cornfield LJ, Hogan M, Sandborn WJ, Feagan BG, Jairath V, Ma C, Hanžel J, Solitano V, Vuyyuru SK, Panaccione R, Sands BE, Peyrin-Biroulet L, Danese S, D'Haens GR, Allez M, Bernstein CN, Bressler B, Cohen BL, Colombel JF, Dubinsky M, Fleshner P, Hanauer SB, Hart AL, Kayal M, Lakatos PL, Magro F, Narula N, Raine T, Regueiro MD, Singh S, Steinhart AH, Travis S, Ungaro RC, van der Woude CJ, Rubin DT, Dulai PS, Cornfield LJ, Hogan M, Sandborn WJ, Feagan BG, Jairath V, Ma C. An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Gastroenterology. 2025 11; 169(6):1282-1293. PMID: 40446946; PMCID: PMC12354294.
      Citations: 2     Fields:    Translation:Humans
    89. Shi J, Morris JS, Rubin D, Huang J. Development of an Early-Phase Local Model for Pandemics Using Public Health Data: Application to the COVID-19 Pandemic. AMIA Annu Symp Proc. 2024; 2024:1170-1179. PMID: 41726514; PMCID: PMC12919430.
      Citations:    Fields:    Translation:HumansPHPublic Health
    90. Cohen NA, Sror N, Naseer M, Bettenworth D, Lu C, Khedraki R, Abreu M, Atreya R, Al-Bawardy B, Connor SJ, d'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon IO, Hedin C, Kobayashi T, Leibovitzh H, Maharshak N, Ollech J, Sebastian S, Siegmund B, Rubin DT, Silverberg MS, Steinwurz F, Torres J, Watermeyer G, Hernandez-Rocha C, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F, Naseer M, Lu C, Khedraki R, Abreu MT, Al-Bawardy B, Connor SJ, d'Haens G, Feakins R, Gordon IO, Hedin C, Kobayashi T, Sebastian S, Siegmund B, Rubin DT, Torres J, Gurizzian P, Silfen A, Falloon K, Rieder F. Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2026 Apr; 24(4):932-948. PMID: 40378982; PMCID: PMC13504736.
      Citations: 4     Fields:    Translation:Humans
    91. Aboursheid T, Beran A, Hijazi M, Albuni MK, Sawaf B, Guardiola JJ, Abdeljawad K, McDonald BD, Rubin DT. Comparison Between Adalimumab and Infliximab in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis. Gastro Hep Adv. 2025; 4(8):100697. PMID: 40612626; PMCID: PMC12221630.
      Citations: 3     
    92. Feagan BG, Battat R, Kandi S, Lacerda AP, Levine P, Neimark E, Rubin DT, Ji QC, Chen X, Polakow SB. Association of bile acid diarrhea with symptoms and disease activity in Crohn's disease: post-hoc clinical trial analysis of serum 7a-hydroxy-4cholestern-3-one, C4, in patients with active Crohn's disease. J Crohns Colitis. 2025 May 08; 19(5). PMID: 40202488.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    93. Hracs L, Windsor JW, Gorospe J, Cummings M, Coward S, Buie MJ, Quan J, Goddard Q, Caplan L, Markovinovic A, Williamson T, Abbey Y, Abdullah M, Abreu MT, Ahuja V, Raja Ali RA, Altuwaijri M, Balderramo D, Banerjee R, Benchimol EI, Bernstein CN, Brunet-Mas E, Burisch J, Chong VH, Dotan I, Dutta U, El Ouali S, Forbes A, Forss A, Gearry R, Dao VH, Hartono JL, Hilmi I, Hodges P, Jones GR, Juliao-Baños F, Kaibullayeva J, Kelly P, Kobayashi T, Kotze PG, Lakatos PL, Lees CW, Limsrivilai J, Lo B, Loftus EV, Ludvigsson JF, Mak JWY, Miao Y, Ng KK, Okabayashi S, Olén O, Panaccione R, Paudel MS, Quaresma AB, Rubin DT, Simadibrata M, Sun Y, Suzuki H, Toro M, Turner D, Iade B, Wei SC, Yamamoto-Furusho JK, Yang SK, Ng SC, Kaplan GG, Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature. 2025 06; 642(8067):458-466. PMID: 40307548; PMCID: PMC12158780.
      Citations: 88     Fields:    Translation:Humans
    94. Solitano V, Bernstein CN, Dotan I, Dignass A, Domilici R, Dubinsky MC, Gearry RB, Hart A, Kaplan GG, Ma C, Magro F, Mak JWY, Ng SC, Panaccione R, Raja S, Rubin DT, Siegel CA, Jairath V, Peyrin-Biroulet L, Danese S. Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response. Nat Rev Gastroenterol Hepatol. 2025 Jun; 22(6):438-452. PMID: 40263433.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    95. Jairath V, Rubin DT, Verstockt B, Çekin AH, Abreu MT, Lees CW, Fellmann M, Woolcott JC, Crosby C, Wu J, Bhattacharjee A, Herman D, Gu G, Siegmund B. The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program. Inflamm Bowel Dis. 2025 04 10; 31(4):923-934. PMID: 38899786; PMCID: PMC11985396.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    96. Reinisch W, Loftus EV, Schreiber S, Rubin DT, Louis E, Hecht PM, Barrachina EM, Kalabic J, Vladea R, Sharma D, Duan WR, Zhang Y, Panaccione R. Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis. J Crohns Colitis. 2025 Apr 04; 19(4). PMID: 40168091; PMCID: PMC11976722.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    97. Honap S, Agrinier N, Torres J, Croitoru K, Lee SH, Turpin W, Ungaro RC, Agrawal M, Peter I, Turner D, Dotan I, Hart AL, Netter P, D'Haens G, Rubin DT, Ng SC, Gearry R, Jairath V, Ananthakrishnan AN, Danese S, Colombel JF, Peyrin-Biroulet L. Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design. Lancet Gastroenterol Hepatol. 2025 06; 10(6):593-604. PMID: 40187359.
      Citations: 2     Fields:    Translation:Humans
    98. Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar MC, Rubin DT, Hashash JG, Metwally M, Ali T, Ma C, Hoentjen F, Narula N, Bessissow T, Rosenfeld G, McCurdy JD, Ananthakrishnan AN, Cross RK, Rodriguez Gaytan JR, Gurrola ES, Patel S, Siegel CA, Melmed GY, Weaver SA, Power S, Zou G, Jairath V, Hou JK. Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1). PMID: 40164445; PMCID: PMC11962770.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    99. Yanofsky R, Stein SL, Rubin DT, Kellar A. Hermansky-Pudlak Syndrome Complicated by Crohn's Disease and Hidradenitis Suppurativa: A Case of Multisystem Immune Dysregulation. ACG Case Rep J. 2025 Apr; 12(4):e01647. PMID: 40165941; PMCID: PMC11957655.
      Citations: 1     
    100. Goodwin B, Khan D, Mehta A, Brancaccio H, Goud M, Rubin D, Eltman N, Davuluri S, Lo D, King A. Exercise Therapies for Fibromyalgia Pain Catastrophizing: A Systematic Review and Comparative Analysis. Prim Care Companion CNS Disord. 2025 Mar 27; 27(2). PMID: 40163350.
      Citations:    Fields:    Translation:Humans
    101. Mcdonald BD, Choi NK, Klein JA, St-Pierre J, Fine ZD, Rubin DT. Clinical Trials for Perianal Crohn's Disease: A Call for a Revised Approach. Gastroenterology. 2025 Aug; 169(2):183-187.e1. PMID: 40120773.
      Citations:    Fields:    
    102. Panaccione R, Bleakman AP, Schreiber S, Travis S, Dubinsky M, Hibi T, Gibble TH, Panni T, Kayhan C, Flynn EJ, Favia AD, Atkinson C, Rubin DT. US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey. Crohns Colitis 360. 2025 Apr; 7(2):otaf011. PMID: 40364800; PMCID: PMC12070485.
      Citations: 2     
    103. St-Pierre J, Choi D, Fear E, Choi NK, Mathew AJ, Cohen RD, Dalal SR, Pekow J, Krugliak Cleveland N, Rubin DT. Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center. Dig Dis Sci. 2025 May; 70(5):1864-1872. PMID: 40048134.
      Citations: 7     Fields:    Translation:Humans
    104. Sands BE, Rubin DT, Gecse KB, Goetsch M, Schreiber S, Leung Y, Panés J, Wang W, Woolcott JC, Smith CC, Wosik K. Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program. J Crohns Colitis. 2025 Mar 05; 19(3). PMID: 39306680; PMCID: PMC11945297.
      Citations: 3     Fields:    Translation:Humans
    105. Falloon K, Dossaji Z, Mude P, Abushamma S, Ananthakrishnan A, Barnes EL, Bhalla J, Bhattacharya A, Cheemalavagu S, Colombel JF, Cross RK, Ermann J, Ha C, Herfarth H, Horst S, Hou J, Husni ME, Kuhn KA, Long MD, Loftus EV, Lukin DJ, Patel A, Rubin DT, Scherl EJ, Shah SA, Siaton BC, Sleiman J, Qazi T, Weisman MH, Cohen BL, Feagan BG, Rieder F, Kline TM. Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review. Inflamm Bowel Dis. 2025 03 03; 31(3):812-842. PMID: 38836521.
      Citations: 4     Fields:    Translation:Humans
    106. Shahub S, Kumar RM, Lin KC, Banga I, Choi NK, Garcia NM, Muthukumar S, Rubin DT, Prasad S. Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device. Inflamm Bowel Dis. 2025 03 03; 31(3):647-654. PMID: 38520737.
      Citations: 7     Fields:    Translation:Humans
    107. Malter L, Hong SJ, Lopatin S, Murphy M, Hudesman D, Kane S, Rubin DT. Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience. Inflamm Bowel Dis. 2025 03 03; 31(3):746-750. PMID: 38217539.
      Citations: 1     Fields:    Translation:Humans
    108. Anand R, George AT, Rubin DT, Spiegel BMR, Bernstein CN. The role of virtual reality in managing inflammatory bowel disease: a novel approach to bridging mental and physical health. J Can Assoc Gastroenterol. 2025 Mar; 8(Suppl 2):S15-S20. PMID: 39990506; PMCID: PMC11842903.
      Citations: 1     
    109. Yanofsky R, Rubin DT. A practical approach to positioning therapies in ulcerative colitis. J Can Assoc Gastroenterol. 2025 Mar; 8(Suppl 2):S6-S14. PMID: 39990515; PMCID: PMC11842905.
      Citations: 3     
    110. Regueiro M, Fischer M, Bossuyt P, McGinnis K, Protic M, Hunter Gibble T, Panni T, Chan LS, Hibi T, Rubin DT. Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study. Inflamm Bowel Dis. 2025 02 06; 31(2):432-441. PMID: 39093640; PMCID: PMC11808575.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    111. Ermann J, Hong SJ, Stahly A, Dalal RS, Malik F, Scott FI, Click B, Way A, Davis JM, Shmais M, Raffals LE, Jan R, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland JE, Patel S, Kuhn KA, Weisman MH. Frequency of Spondyloarthritis Symptoms Among US Patients With Inflammatory Bowel Disease: A Cross-Sectional Multi-Center Study. Arthritis Care Res (Hoboken). 2025 06; 77(6):777-784. PMID: 39748206.
      Citations:    Fields:    Translation:Humans
    112. Olivas AD, Ngai PCM, Schahrer E, Olortegui KS, Cursio JF, Akiyama S, Chang EB, Shen L, Umanskiy K, Rubin DT, Zemmour D, Weber CR. Histopathologic Evaluation and Single-Cell Spatial Transcriptomics of the Colon Reveal Cellular and Molecular Abnormalities Linked to J-Pouch Failure in Patients with Inflammatory Bowel Disease. bioRxiv. 2025 Jan 28. PMID: 39974918; PMCID: PMC11838289.
      Citations:    
    113. Zhao Y, Zhou R, Xie B, Liu CY, Kalski M, Cham CM, Jiang Z, Koval J, Weber CR, Rubin DT, Sogin M, Crosson S, Chen M, Huang J, Fiebig A, Dalal S, Chang EB, Basu A, Pott S. Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patients. Nat Commun. 2025 Jan 21; 16(1):904. PMID: 39837850; PMCID: PMC11751449.
      Citations: 2     Fields:    Translation:HumansCells
    114. Mondro CA, Fedo CM, Grotzinger JP, Lamb MP, Gupta S, Dietrich WE, Banham S, Weitz CM, Gasda P, Edgar LA, Rubin D, Bryk AB, Kite ES, Caravaca G, Schieber J, Vasavada AR. Wave ripples formed in ancient, ice-free lakes in Gale crater, Mars. Sci Adv. 2025 Jan 17; 11(3):eadr0010. PMID: 39813357; PMCID: PMC11734734.
      Citations:    Fields:    
    115. Louis E, Peyrin-Biroulet L, Takeuchi K, Kalabic J, Schreiber S, Ferrante M, Panaccione R, Colombel JF, D'Haens G, Dubinsky M, Rubin DT, Chien KB, Chen S, Cheng L, Zhang Y, Duan WR, Vladea R, Hecht PM, Morisset P. Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies. J Crohns Colitis. 2025 Jan 11; 19(1). PMID: 39804294; PMCID: PMC11772864.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    116. Zhao Y, Zhou R, Xie B, Liu CY, Kalski M, Cham CM, Jiang Z, Koval J, Weber CR, Rubin DT, Sogin M, Crosson S, Chen M, Huang J, Fiebig A, Dalal S, Chang EB, Basu A, Pott S. Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patients. medRxiv. 2025 Jan 09. PMID: 38014192; PMCID: PMC10680893.
      Citations:    
    117. Perez-Sanchez A, Nathanson R, Coss E, Kuo L, Krugliak Cleveland N, Galen B, Echavarria J, Rubin DT, Shankar N, Samel NS, Soni NJ. Point-of-Care Ultrasound in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2025 Jul; 23(8):1277-1290. PMID: 39793722.
      Citations: 2     Fields:    Translation:Humans
    118. Vermeire S, Rubin DT, Peyrin-Biroulet L, Dubinsky MC, Regueiro M, Irving PM, Goetsch M, Lazin K, Gu G, Wu J, Modesto I, McDonnell A, Guo X, Green J, Dalam AB, Yarur AJ. Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis. BMJ Open Gastroenterol. 2025 Jan 08; 12(1). PMID: 39778975; PMCID: PMC11748931.
      Citations: 7     Fields:    Translation:Humans
    119. Dignass A, Vermeire S, Sands BE, Rubin DT, Loftus EV, Wolf DC, Panaccione R, Colombel JF, Regueiro M, Afzali A, Lawlor G, Ahmad HA, Wu H, Osterman MT, Jain A, D'Haens G. Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial. Am J Gastroenterol. 2025 Oct 01; 120(10):2339-2349. PMID: 39773524; PMCID: PMC12487659.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    120. Abraham B, Wu J, Vermeire S, Melmed G, Ungaro R, Charabaty A, Moses R, Chan-Diehl F, Paulissen J, Zhu B, Barnes EL, Ehrlich AC, Rubin DT. Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT Trials. Crohns Colitis 360. 2025 Apr; 7(2):otaf002. PMID: 40260308; PMCID: PMC12010086.
      Citations: 1     
    121. Sands BE, Panaccione R, D'Haens G, Schreiber S, Jairath V, DuVall A, Kierkus J, Walczak M, Naik S, Gilder K, Lindstrom B, Ogilvie K, Sandborn WJ, Vermeire S, Rubin DT, Peyrin-Biroulet L, Danese S. Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial. Lancet Gastroenterol Hepatol. 2025 03; 10(3):210-221. PMID: 39793589.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    122. Hong SJ, Dalal RS, Kuhn KA, Stahly A, Scott FI, Click BH, Way A, Malik F, Davis JM, Shmais M, Raffals LE, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland J, Patel S, Weisman MH, Ermann J, Jan R. Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2025 Oct 01; 120(10):2330-2338. PMID: 39760386.
      Citations:    Fields:    Translation:Humans
    123. Akiyama S, Ollech JE, Cohen NA, Traboulsi C, Rai V, Glick LR, Yi Y, Runde J, Cohen RD, Olortegui KBS, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2025 01 06; 31(1):63-71. PMID: 38916136; PMCID: PMC11700886.
      Citations: 2     Fields:    Translation:Humans
    124. Posner H, Lombard R, Akiyama S, Cohen NA, Rubin DT, Dubinsky MC, Dalal S, Kayal M. Extensive Disease and Exposure to Multiple Biologics Precolectomy Is Associated with Endoscopic Cuffitis Post-Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis. Inflamm Bowel Dis. 2025 01 06; 31(1):72-76. PMID: 38521548; PMCID: PMC12476942.
      Citations:    Fields:    Translation:Humans
    125. Figueroa EJ, Venkat PG, Issokson K, Rubin DT, Lewis JD. A Practical Guide to Diet and IBD. Am J Gastroenterol. 2024 Dec 31; 120(9):1941-1945. PMID: 39787366.
      Citations: 1     Fields:    
    126. Zhang L, Xu W, Meng HYH, Ching JYL, Liu Y, Wang S, Yan S, Lin L, Cheong PK, Ip KL, Peng Y, Zhu J, Cheung CP, Leung TF, Leung ASY, Tam WH, Leung TY, Chan PKS, Chang EB, Rubin DT, Claud EC, Wu WKK, Tun HM, Chan FKL, Ng SC. Impacts of COVID-19 pandemic on early life gut microbiome. Gut Microbes. 2025 12; 17(1):2443117. PMID: 41411654; PMCID: PMC12931694.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    127. St-Pierre J, Rubin DT. Challenging Conventional Care: Ethical Considerations of De-intensification of Therapy in IBD. Gastroenterology. 2025 Feb; 168(2):200-204. PMID: 39692680.
      Citations: 1     Fields:    
    128. Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A, QUASAR Study Group. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies. Lancet. 2025 01 04; 405(10472):33-49. PMID: 39706209.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    129. Vermeire S, Schreiber S, Rubin DT, D'Haens G, Reinisch W, Watanabe M, Mehta R, Roblin X, Beales I, Gietka P, Hibi T, Hospodarskyy I, Ritter T, Genovese MC, Kwon P, Santermans E, Le Brun FO, Barron R, Masior T, Danese S. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2025 02; 10(2):138-153. PMID: 39637881.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    130. George AT, Rubin DT. Artificial Intelligence in Inflammatory Bowel Disease. Gastrointest Endosc Clin N Am. 2025 Apr; 35(2):367-387. PMID: 40021234.
      Citations: 1     Fields:    Translation:Humans
    131. St-Pierre J, Klein J, Choi NK, Fear E, Pannain S, Rubin DT. Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2024 Dec; 69(12):4437-4445. PMID: 39516435.
      Citations: 11     Fields:    Translation:Humans
    132. Klein JA, St-Pierre J, Choi D, Lopez J, Rubin DT. Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss. ACG Case Rep J. 2024 Nov; 11(11):e01544. PMID: 39507506; PMCID: PMC11540429.
      Citations: 6     
    133. Choi D, McDonald B, Rubin DT. Immediate Infusion Reaction to Intravenous Risankizumab-rzaa but Subsequent Tolerance to Subcutaneous Risankizumab-rzaa. ACG Case Rep J. 2024 Nov; 11(11):e01546. PMID: 39507504; PMCID: PMC11540427.
      Citations: 1     
    134. Zamani M, Ebrahimtabar F, Alizadeh-Tabari S, Kasner SE, Elkind MSV, Ananthakrishnan AN, Choden T, Rubin DT, Malekzadeh R. Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2024 11 04; 30(11):2195-2204. PMID: 38271615.
      Citations: 11     Fields:    Translation:Humans
    135. Cleveland NK, Ghosh S, Kathe N, Umashankar K, Mirchandani K, Hait A, Paul R, Candela N, Fan T, Rubin DT. Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study. J Manag Care Spec Pharm. 2024 Nov; 30(11):1276-1287. PMID: 39471266; PMCID: PMC11522457.
      Citations:    Fields:    Translation:Humans
    136. Zinger A, Choi D, Choi N, Fear E, Fine Z, Cohen RD, Rubin DT. Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2025 Sep; 23(10):1817-1823. PMID: 39461462.
      Citations: 1     Fields:    Translation:Humans
    137. Krugliak Cleveland N, Candela N, Carter JA, Kuharic M, Qian J, Tang Z, Turpin R, Rubin DT. Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis. Crohns Colitis 360. 2024 Oct; 6(4):otae061. PMID: 39502268; PMCID: PMC11535256.
      Citations: 2     
    138. St-Pierre J, Shafrir A, Rubin DT. Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays. Expert Rev Gastroenterol Hepatol. 2024 Oct; 18(10):587-596. PMID: 39385720.
      Citations:    Fields:    Translation:Humans
    139. Derks MEW, Te Groen M, van Lierop LMA, Bessissow T, Nagtegaal ID, Derikx LAAP, Hoentjen F, Murthy S, Rubin DT, Bemelman WA. Management of Colorectal Neoplasia in IBD Patients: Current Practice and Future Perspectives. J Crohns Colitis. 2024 Oct 15; 18(10):1726-1735. PMID: 38741227; PMCID: PMC11479698.
      Citations: 3     Fields:    Translation:Humans
    140. Park S, St Pierre J, Onajin O, Rubin DT. Successful Treatment of Severe Pyoderma Gangrenosum and Ulcerative Colitis With Upadacitinib. ACG Case Rep J. 2024 Oct; 11(10):e01531. PMID: 39399247; PMCID: PMC11469854.
      Citations: 2     
    141. Lee SH, Bushra M, Qiu L, Griffiths AM, Turpin W, Croitoru K, Crohn’s and Colitis Canada-Genetic, Environmental, Microbial (CCC-GEM) Project Research Consortium, Lee SH, Bushra M, Shao J, Olivera PA, Leibovitzh H, Xue M, Xu W, Espin-Garcia O, Amuais GL, Huynh HQ, Panaccione R, Steinhart AH, Cino M, Mack D, Marshall J, Ropeleski M, Bitton A, Jacobson K, McGrath J, Yerushalmi B, Abreu MT, Bernstein CN, Radford-Smith G, Lees C, Turner D, Madsen K, Guttman DS, Silverberg M, Griffiths AM, Moayyedi P, Turpin W, Beck P, Dieleman L, Feagan BG, Kaplan G, Krause DO, Seidman E, Snapper S, Stadnyk A, Surette M, Walters T, Vallance B, Critch J, Denson L, Deslandres C, El-Matary W, Herfarth H, Higgins P, Hyams J, Otley A, Hedin C, Hussey S, Keljo D, Kevans D, Murthy S, Parekh N, Plamondon S, Rosh J, Rubin D, Schultz M, Siegel C, Croitoru K. Early Life Exposure to Parental Crohn's Disease Is Associated With Offspring's Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn's Disease. Gastroenterology. 2025 Feb; 168(2):385-388.e3. PMID: 39384162.
      Citations: 3     Fields:    
    142. Zheng J, Sun Q, Zhang M, Liu C, Su Q, Zhang L, Xu Z, Lu W, Ching J, Tang W, Cheung CP, Hamilton AL, Wilson O'Brien AL, Wei SC, Bernstein CN, Rubin DT, Chang EB, Morrison M, Kamm MA, Chan FKL, Zhang J, Ng SC. Noninvasive, microbiome-based diagnosis of inflammatory bowel disease. Nat Med. 2024 Dec; 30(12):3555-3567. PMID: 39367251; PMCID: PMC11645270.
      Citations: 58     Fields:    Translation:HumansCells
    143. Rubin DT, Torres J, Dotan I, Xu LT, Modesto I, Woolcott JC, Gardiner S, Sands BE. An Insight into Patients' Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts. Inflamm Bowel Dis. 2024 10 03; 30(10):1748-1758. PMID: 37934789; PMCID: PMC11447010.
      Citations: 4     Fields:    Translation:Humans
    144. Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflamm Bowel Dis. 2024 10 03; 30(10):1776-1787. PMID: 37921344; PMCID: PMC11447059.
      Citations: 7     Fields:    Translation:Humans
    145. Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, Rubin DT, Laurent O, Luo A, Nguyen DD, Lu J, Yen M, Leszczyszyn J, Kempinski R, McGovern DPB, Ma C, Ritter TE, Targan S, ARTEMIS-UC Study Group. Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis. N Engl J Med. 2024 09 26; 391(12):1119-1129. PMID: 39321363.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    146. Man B, Choi D, Rubin DT. Impact of a health-system specialty pharmacy on time to upadacitinib initiation. Am J Health Syst Pharm. 2024 09 23; 81(19):e594-e600. PMID: 38738829.
      Citations:    Fields:    Translation:Humans
    147. Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterol. 2024 Sep 17; 24(1):314. PMID: 39289603; PMCID: PMC11406817.
      Citations: 2     Fields:    Translation:Humans
    148. Hettinger G, Rubin D, Huang J. Refining Estimation of the Instantaneous Reproduction Number During Early Pandemic Stages: Addressing Case-Reporting Variability and Serial Interval Uncertainty. Am J Epidemiol. 2024 Sep 11. PMID: 39270679; PMCID: PMC12234227.
      Citations:    Fields:    
    149. Akiyama S, Cohen NA, Ollech JE, Traboulsi C, Rodriguez T, Rai V, Glick LR, Yi Y, Runde J, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. A Comparative Analysis of Clinical Symptoms and Modified Pouchitis Disease Activity Index Among Endoscopic Phenotypes of the J Pouch in Patients With Inflammatory Bowel Disease. Crohns Colitis 360. 2024 Jul; 6(3):otae045. PMID: 39347443; PMCID: PMC11438232.
      Citations: 2     
    150. Kennedy MS, Freiburger A, Cooper M, Beilsmith K, St George ML, Kalski M, Cham C, Guzzetta A, Ng SC, Chan FK, Rubin D, Henry CS, Bergelson J, Chang EB. Diet outperforms microbial transplant to drive microbiome recovery post-antibiotics. bioRxiv. 2024 Aug 01. PMID: 39211181; PMCID: PMC11361181.
      Citations:    
    151. Wang S, Liu Y, Tam WH, Ching JYL, Xu W, Yan S, Qin B, Lin L, Peng Y, Zhu J, Cheung CP, Ip KL, Wong YM, Cheong PK, Yeung YL, Kan WHB, Leung TF, Leung TY, Chang EB, Rubin DT, Claud EC, Wu WKK, Tun HM, Chan FKL, Ng SC, Zhang L. Maternal gestational diabetes mellitus associates with altered gut microbiome composition and head circumference abnormalities in male offspring. Cell Host Microbe. 2024 07 10; 32(7):1192-1206.e5. PMID: 38955186.
      Citations: 14     Fields:    Translation:HumansCells
    152. Wong SY, Rowan C, Brockmans ED, Law CCY, Giselbrecht E, Ang C, Khaitov S, Sachar D, Polydorides AD, Winata LS, Spinelli A, Rubin DT, Deepak P, McDonald BD, Lightner AL, Hamarth C, Geldof J, Dige A, Carvello M, Behrenbruch C, Ballard DH, Altinmakas E, Colombel JF, Verstockt B, McGovern DPB, Lung P, Lundby L, Holubar SD, Hanna L, Cohen BL, Bonifacio C, Bislenghi G, Sebastian S, Tozer P, Hart A. Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus. Clin Gastroenterol Hepatol. 2025 May; 23(6):927-945.e2. PMID: 38871152.
      Citations: 5     Fields:    Translation:Humans
    153. Lan T, Slezak T, Pu J, Zinkus-Boltz J, Adhikari S, Pekow JR, Taneja V, Zuniga J, Gómez-García IA, Regino-Zamarripa N, Ahmed M, Khader SA, Rubin DT, Kossiakoff AA, Dickinson BC. Development of Luminescent Biosensors for Calprotectin. ACS Chem Biol. 2024 06 21; 19(6):1250-1259. PMID: 38843544; PMCID: PMC12072359.
      Citations: 5     Fields:    Translation:Humans
    154. Travis S, Potts Bleakman A, Dubinsky MC, Schreiber S, Panaccione R, Hibi T, Hunter Gibble T, Kayhan C, Atkinson C, Sapin C, Flynn EJ, Rubin DT. The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis. Inflamm Bowel Dis. 2024 06 03; 30(6):939-949. PMID: 37603837; PMCID: PMC11144997.
      Citations: 19     Fields:    Translation:Humans
    155. Raine T, Ishiguro Y, Rubin DT, Finney-Hayward T, Vladea R, Liu J, Phillips C, Cheng E, Targownik L, Loftus EV. Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme. J Crohns Colitis. 2024 May 31; 18(5):695-707. PMID: 37942921; PMCID: PMC11140624.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    156. Cohen NA, Choden T, Dyer EC, Garcia NM, Choi NK, Rubin DT. Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary Center. Dig Dis Sci. 2024 Aug; 69(8):2955-2960. PMID: 38811503.
      Citations: 1     Fields:    Translation:Humans
    157. Heller C, Moss AC, Rubin DT. Overview to Challenges in IBD 2024-2029. Inflamm Bowel Dis. 2024 05 23; 30(Suppl 2):S1-S4. PMID: 38778626.
      Citations: 7     Fields:    Translation:Humans
    158. Lamb CA, Titterton C, Banerjee R, Gomberg A, Rubin DT, Hart AL. Inflammatory bowel disease has no borders: engaging patients as partners to deliver global, equitable and holistic health care. Lancet. 2024 08 03; 404(10451):414-417. PMID: 38768627.
      Citations: 4     Fields:    Translation:Humans
    159. St-Pierre J, Rubin DT. Endoscopy in Inflammatory Bowel Disease: Indications, Timing, and Biopsy Protocol. Gastrointest Endosc Clin N Am. 2025 Jan; 35(1):1-18. PMID: 39510681.
      Citations:    Fields:    Translation:Humans
    160. Schreiber S, Hunter Gibble T, Panaccione R, Rubin DT, Travis S, Hibi T, Potts Bleakman A, Panni T, Favia AD, Kayhan C, Atkinson C, Saxena S, Dubinsky MC. Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study. Dig Dis Sci. 2024 Jul; 69(7):2333-2344. PMID: 38700629; PMCID: PMC11258049.
      Citations: 8     Fields:    Translation:Humans
    161. Rubin D, Lo DF, Jammula S, Carroll N, Vasudevan M. Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension. J Hypertens. 2024 06 01; 42(6):1105-1106. PMID: 38690909.
      Citations:    Fields:    Translation:Humans
    162. Akiyama S, Barnes EL, Onoda T, Ishikawa N, Shiroyama M, Ito Y, Rubin DT, Tsuchiya K. Endoscopic assessment of the J pouch in ulcerative colitis: A narrative review. DEN Open. 2025 Apr; 5(1):e373. PMID: 38694540; PMCID: PMC11058686.
      Citations:    
    163. Vieujean S, D'Amico F, Ahuja V, Silverberg MS, Sood A, Yamamoto-Furusho JK, Nagahori M, Watanabe M, Koutroubakis IE, Foteinogiannopoulou K, Avni Biron I, Outtier A, Nordestgaard RLM, Abreu MT, Louis E, Dotan I, Reinisch W, Danese S, Rubin DT, Peyrin-Biroulet L, Lindsay JO, Walsh A, Dubinsky M, Siegel C. Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD. J Crohns Colitis. 2024 Apr 23; 18(4):548-559. PMID: 37864829.
      Citations: 4     Fields:    Translation:Humans
    164. Cohen NA, Weber CR, Cheng JX, Choi D, Garcia NM, Choi NK, Rubin DT. Ozanimod-exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histological Changes. J Crohns Colitis. 2024 Apr 23; 18(4):638-641. PMID: 37879626.
      Citations:    Fields:    Translation:Humans
    165. Allocca M, Dell'Avalle C, Zilli A, Furfaro F, D'Amico F, Jairath V, Rubin DT, Peyrin-Biroulet L, Fiorino G, Danese S. Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study. EClinicalMedicine. 2024 May; 71:102559. PMID: 38549587; PMCID: PMC10972812.
      Citations: 8     
    166. Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, Rubin DT, Lindsay JO, Siffledeen J, Lukin DJ, Wright J, Watanabe K, Schreiber S, Ford S, Remple VP, Lacerda AP, Dubcenco E, Garrison A, Zhou Q, Berg S, Anyanwu SI. Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure. Clin Gastroenterol Hepatol. 2024 10; 22(10):2096-2106. PMID: 38492904.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    167. Akiyama S, Miyatani Y, Rubin DT. The evolving understanding of histology as an endpoint in ulcerative colitis. Intest Res. 2024 Oct; 22(4):389-396. PMID: 38475998; PMCID: PMC11534446.
      Citations: 2     
    168. Axelrad JE, Rubin DT. The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024 06; 22(6):1181-1185. PMID: 38432648; PMCID: PMC11128355.
      Citations: 8     Fields:    Translation:Humans
    169. Ghosh S, Afzali A, Canavan JB, Danese S, Panaccione R, Abreu MT, Rubin DT, Dignass A, Wolf DC, Chiorean MV, Vermeire S, Jain A, Charles L, Lawlor G, Osterman MT, Wu H, Petersen A, Colombel JF, Regueiro M. Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension. J Crohns Colitis. 2024 Feb 26; 18(2):264-274. PMID: 37651686; PMCID: PMC10896634.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    170. Belton TD, Wu K, Steinway CM, Trachtenberg SW, Tchume-Johnson T, Shilly S, Austin T, Luma S, Smith K, Smith-Whitley K, Rubin D, Jan S. Training young adults as community health workers specializing in pediatric to adult health care transition to support emerging adults with sickle cell disease. Health Care Transit. 2024; 2:100050. PMID: 39712611; PMCID: PMC11657469.
      Citations: 3     
    171. Rubin D, Lo DF. Amending the Pain Scale Used for Postoperative Pain Studies. JAMA Dermatol. 2024 02 01; 160(2):238-239. PMID: 38150224.
      Citations:    Fields:    Translation:Humans
    172. Krugliak Cleveland N, St-Pierre J, Kellar A, Rubin DT. Clinical Application of Intestinal Ultrasound in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2024 Feb; 26(2):31-40. PMID: 38243153; PMCID: PMC11025373.
      Citations: 13     Fields:    Translation:Humans
    173. Rubin DT, Torres J, Regueiro M, Reinisch W, Prideaux L, Kotze PG, Tan FH, Gardiner S, Mundayat R, Cadatal MJ, Ng SC. Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis. Crohns Colitis 360. 2024 Jan; 6(1):otae004. PMID: 38425446; PMCID: PMC10904100.
      Citations: 3     
    174. Mullowney MW, Fiebig A, Schnizlein MK, McMillin M, Rose AR, Koval J, Rubin D, Dalal S, Sogin ML, Chang EB, Sidebottom AM, Crosson S. Microbially catalyzed conjugation of GABA and tyramine to bile acids. J Bacteriol. 2024 01 25; 206(1):e0042623. PMID: 38174933; PMCID: PMC10810215.
      Citations: 11     Fields:    Translation:HumansCells
    175. Wu K, Strane D, Kellom K, Stokes S, Brunisholz K, Rubin D, Klusaritz H, Cronholm PF. Implementing a Population-Based Social Determinants of Health Intervention: Early Lessons Learned from Collaboration between Clinical and Community Organizations. J Health Care Poor Underserved. 2024; 35(3):933-950. PMID: 39129611.
      Citations: 1     Fields:    Translation:Humans
    176. Schreiber S, Blumenstein I, Sands BE, Chiorean MV, Ungaro RC, Rubin DT. Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis. J Crohns Colitis. 2023 Dec 30; 17(12):2012-2025. PMID: 37436357; PMCID: PMC10798866.
      Citations: 24     Fields:    Translation:Humans
    177. Miyatani Y, Choi D, Choi NK, Rubin DT. Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Dig Dis Sci. 2024 Feb; 69(2):355-359. PMID: 38112840.
      Citations: 21     Fields:    Translation:Humans
    178. Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR, GALAXI-1 Study Group. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. Lancet Gastroenterol Hepatol. 2024 02; 9(2):133-146. PMID: 38104569.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    179. Mullowney MW, McMillin M, Koval J, Rubin D, Dalal S, Sogin ML, Chang EB, Sidebottom AM, Fiebig A, Schnizlein MK, Rose AR, Crosson S. Microbially-catalyzed conjugation of GABA and tyramine to bile acids. bioRxiv. 2023 Dec 13. PMID: 37808758; PMCID: PMC10557584.
      Citations:    
    180. Cohen NA, Choi D, Garcia N, Choi NK, Picker E, Krugliak Cleveland N, Cohen RD, Dalal SR, Pekow J, Rubin DT. Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center. Dig Dis Sci. 2024 Feb; 69(2):579-587. PMID: 38087126.
      Citations: 6     Fields:    Translation:Humans
    181. Chavannes M, Kysh L, Allocca M, Krugliak Cleveland N, Dolinger MT, Robbins TS, Rubin DT, Sagami S, Verstockt B, Novak K. Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol. BMJ Open Gastroenterol. 2023 12 11; 10(1). PMID: 38081777; PMCID: PMC10729253.
      Citations:    Fields:    Translation:Humans
    182. Weber M, Rubin D, Baratta JL. Regional anesthesia and POCUS in the intensive care unit. Int Anesthesiol Clin. 2024 Jan 01; 62(1):35-42. PMID: 38063036.
      Citations: 2     Fields:    
    183. Fiebig A, Schnizlein MK, Pena-Rivera S, Trigodet F, Dubey AA, Hennessy MK, Basu A, Pott S, Dalal S, Rubin D, Sogin ML, Eren AM, Chang EB, Crosson S. Bile acid fitness determinants of a Bacteroides fragilis isolate from a human pouchitis patient. mBio. 2024 01 16; 15(1):e0283023. PMID: 38063424; PMCID: PMC10790697.
      Citations: 11     Fields:    Translation:HumansCells
    184. Zinger A, Choi D, Choi N, Cohen RD, Rubin DT. Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center. Clin Gastroenterol Hepatol. 2024 Jun; 22(6):1336-1338.e2. PMID: 38065372.
      Citations: 6     Fields:    Translation:Humans
    185. Krugliak Cleveland N, Miyatani Y, Picker EA, Rubin DT. At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2023 12 05; 29(12):1997-1998. PMID: 37843049; PMCID: PMC11491621.
      Citations: 1     Fields:    Translation:Humans
    186. Validova A, Strane D, Matone M, Wang X, Rosenquist R, Luan X, Rubin D. Underinsurance Among Children With Special Health Care Needs in the United States. JAMA Netw Open. 2023 12 01; 6(12):e2348890. PMID: 38147335; PMCID: PMC10751585.
      Citations: 7     Fields:    Translation:Humans
    187. Rubin DT. Highlights in Crohn's Disease From the American College of Gastroenterology (ACG) 2023 Annual Scientific Meeting: Commentary. Gastroenterol Hepatol (N Y). 2023 Dec; 19(12 Suppl 8):23-27. PMID: 38444457; PMCID: PMC10910453.
      Citations:    
    188. Peyrin-Biroulet L, Arenson E, Rubin DT, Siegel CA, Lee S, Zhou W, Finney-Hayward T, Sanchez Gonzalez Y, Shields AL, Stephen Laroux F. A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index. J Crohns Colitis. 2023 Nov 24; 17(11):1733-1743. PMID: 37225135; PMCID: PMC10673803.
      Citations: 14     Fields:    Translation:Humans
    189. Schreiber S, Ng SC, Peyrin-Biroulet L, Modesto I, Guo X, Su C, Kwok KK, Jo H, Chen Y, Yndestad A, Reinisch W, Dubinsky MC, Rubin DT, Danese S. Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. J Crohns Colitis. 2023 Nov 24; 17(11):1761-1770. PMID: 37402275; PMCID: PMC10673809.
      Citations: 9     Fields:    Translation:Humans
    190. Danese S, Tran J, D'Haens G, Rubin DT, Aoyama N, Zhou W, Ilo D, Yao X, Sanchez Gonzalez Y, Panaccione R. Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data. Inflamm Bowel Dis. 2023 11 02; 29(11):1723-1729. PMID: 36790041; PMCID: PMC10628919.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    191. Singh S, Velayos FS, Rubin DT. Common Instances of Low-value Care in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2024 05; 22(5):923-932. PMID: 37879517.
      Citations: 5     Fields:    Translation:Humans
    192. Fiebig A, Schnizlein MK, Pena-Rivera S, Trigodet F, Dubey AA, Hennessy M, Basu A, Pott S, Dalal S, Rubin D, Sogin ML, Murat Eren A, Chang EB, Crosson S. Bile acid fitness determinants of a Bacteroides fragilis isolate from a human pouchitis patient. bioRxiv. 2023 Oct 17. PMID: 37214927; PMCID: PMC10197588.
      Citations:    
    193. D'Amico F, Solitano V, Magro F, Olivera PA, Halfvarson J, Rubin D, Dignass A, Al Awadhi S, Kobayashi T, Queiroz NSF, Calvo M, Kotze PG, Ghosh S, Peyrin-Biroulet L, Danese S. Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus. J Clin Med. 2023 Oct 03; 12(19). PMID: 37834994; PMCID: PMC10574001.
      Citations: 8     
    194. Choi DK, Cohen NA, Choden T, Cohen RD, Rubin DT. Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 10 03; 29(10):1658-1661. PMID: 36715294.
      Citations: 9     Fields:    Translation:Humans
    195. Yau YK, Wong SH, Guo CL, Ip M, Ng SC, Lau LHS, Lui RNS, Mak JWY, Ching JYL, Kamm MA, Rubin DT, Chan PKS, Chan FKL. Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry. Clin Gastroenterol Hepatol. 2024 03; 22(3):611-620.e12. PMID: 37734581.
      Citations: 12     Fields:    Translation:HumansCells
    196. Jamil OK, Shaw D, Deng Z, Dinardi N, Fillman N, Khanna S, Krugliak Cleveland N, Sakuraba A, Weber CR, Cohen RD, Dalal S, Jabri B, Rubin DT, Pekow J. Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis. Therap Adv Gastroenterol. 2023; 16:17562848231184985. PMID: 37692199; PMCID: PMC10486214.
      Citations: 3     
    197. Wils P, Jairath V, Sands BE, Magro F, Reinisch W, Rubin D, Danese S, Baumann C, Peyrin-Biroulet L. Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease. United European Gastroenterol J. 2023 10; 11(8):797-806. PMID: 37670487; PMCID: PMC10576605.
      Citations: 2     Translation:Humans
    198. Evaristo G, Szczepanski J, Farag MS, Rubin DT, Campbell LK, Marcus VA, Lamps LW, Hart J. Crohn's Disease Features in Anastomotic Biopsies from Patients With and Without Crohn's Disease: Diagnostic and Prognostic Value. Mod Pathol. 2023 11; 36(11):100325. PMID: 37660927.
      Citations:    Fields:    Translation:Humans
    199. Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A, QUASAR Study Group. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study. Gastroenterology. 2023 12; 165(6):1443-1457. PMID: 37659673.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    200. Akiyama S, Cohen NA, Rubin DT, Kayal M, Dubinsky MC, Colombel JF. Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States. Inflamm Bowel Dis. 2023 09 01; 29(9):1504-1507. PMID: 36745039; PMCID: PMC10472733.
      Citations: 11     Fields:    Translation:Humans
    201. Dubinsky MC, Gardiner S, Hur P, Mundayat R, Rubin DT, Biedermann L, Vermeire S, Fellmann M, Panés J. Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflamm Bowel Dis. 2023 09 01; 29(9):1370-1379. PMID: 36242764; PMCID: PMC10472737.
      Citations:    Fields:    Translation:Humans
    202. Janwadkar A, Duran G, Irving TD, Shah D, Arevalo R, Sanchez M, Adjo J, Rubin D. Perception of pacifier use among caregivers of infants 0-1?years of age. J Investig Med. 2023 12; 71(8):941-945. PMID: 37530133.
      Citations:    Fields:    Translation:Humans
    203. Rubin DT, Salese L, Cohen M, Kotze PG, Woolcott JC, Su C, Mundayat R, Paulissen J, Torres J, Long MD. Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program. Therap Adv Gastroenterol. 2023; 16:17562848231189122. PMID: 37560161; PMCID: PMC10408314.
      Citations:    
    204. Scott FI, Ehrlich O, Wood D, Viator C, Rains C, DiMartino L, McArdle J, Adams G, Barkoff L, Caudle J, Cheng J, Kinnucan J, Persley K, Sariego J, Heller C, Rubin DT, Shah S. Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation. Inflamm Bowel Dis. 2023 08 01; 29(8):1177-1190. PMID: 36271884; PMCID: PMC10393070.
      Citations: 1     Fields:    Translation:Humans
    205. Sood A, Singh A, Mahajan R, Midha V, Bernstein CN, Rubin DT. (Re)Appraising Remission in Ulcerative Colitis. Inflamm Bowel Dis. 2023 08 01; 29(8):1317-1326. PMID: 35917172.
      Citations: 2     Fields:    Translation:Humans
    206. Parigi TL, D'Amico F, Abreu MT, Dignass A, Dotan I, Magro F, Griffiths AM, Jairath V, Iacucci M, Mantzaris GJ, O'Morain C, Reinisch W, Sachar DB, Turner D, Yamamoto T, Rubin DT, Peyrin-Biroulet L, Ghosh S, Danese S. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023 09; 8(9):853-859. PMID: 37423233.
      Citations: 52     Fields:    Translation:Humans
    207. Ahmad HA, Adsul S, Germinaro M, Neimark E, Wichary J, Bouhnik Y, Peyrin-Biroulet L, Uzzan M, Abreu M, Carlier H, Dubinsky M, Jairath V, Modesto I, Mortensen E, Narula N, Oortwijn A, Protic M, Rubin DT, Oh YS, Reinisch W. Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions. J Crohns Colitis. 2023 Jul 05; 17(7):1066-1078. PMID: 36738443.
      Citations: 12     Fields:    Translation:Humans
    208. Runde J, Veseli I, Fogarty EC, Watson AR, Clayssen Q, Yosef M, Shaiber A, Verma R, Quince C, Gerasimidis K, Rubin DT, Eren AM. Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's Disease. J Crohns Colitis. 2023 Jul 05; 17(7):1103-1113. PMID: 36934439.
      Citations: 1     Fields:    Translation:HumansCells
    209. Rubin DT, Gottlieb K, Colombel JF, Schott JP, Erisson L, Prucka B, Phillips SA, Kwon J, Ng J, McGill J. Development of a Novel Ulcerative Colitis Endoscopic Mayo Score Prediction Model Using Machine Learning. Gastro Hep Adv. 2023; 2(7):935-942. PMID: 39130760; PMCID: PMC11307476.
      Citations: 1     
    210. Shaw DG, Aguirre-Gamboa R, Vieira MC, Gona S, DiNardi N, Wang A, Dumaine A, Gelderloos-Arends J, Earley ZM, Meckel KR, Ciszewski C, Castillo A, Monroe K, Torres J, Shah SC, Colombel JF, Itzkowitz S, Newberry R, Cohen RD, Rubin DT, Quince C, Cobey S, Jonkers IH, Weber CR, Pekow J, Wilson PC, Barreiro LB, Jabri B. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat Med. 2023 06; 29(6):1520-1529. PMID: 37322120; PMCID: PMC10287559.
      Citations: 18     Fields:    Translation:Humans
    211. Bleakman AP, Dignass A, Redondo I, Gibble TH, Kayhan C, Dubinsky M, Panaccione R, Hibi T, Schreiber S, Rubin D, Travis S. Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions. Am J Gastroenterol. 2023 11 01; 118(11):1940-1953. PMID: 37436151; PMCID: PMC10617668.
      Citations: 23     Fields:    Translation:Humans
    212. Mak JWY, Sun Y, Limsrivilai J, Abdullah M, Kaibullayeva J, Balderramo D, Vergara BI, Paudel MS, Banerjee R, Hilmi I, Ali RAR, Wei SC, Ng KK, Altuwaijri M, Kelly P, Yamamoto-Furusho JK, Kotze PG, Ahuja V, Chong VH, Dao HV, Abbey Y, Ching JYL, Ho A, Chan AKW, Bernstein CN, Gearry RB, Abreu M, Rubin DT, Dotan I, Hracs L, Kaplan GG, Ng SC, GIVES-21 Consortium. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21). BMC Med Res Methodol. 2023 05 25; 23(1):129. PMID: 37231405; PMCID: PMC10209572.
      Citations: 24     Fields:    Translation:Humans
    213. Ceranoglu A, Doyle R, Faraone SV, Geller D, Joshi G, Rubin D, Spencer T, Surman C, Uchida M, Wilens T, Wozniak J. Joseph Biederman, MD (1947-2023). J Am Acad Child Adolesc Psychiatry. 2023 May 16. PMID: 37201710.
      Citations:    Fields:    
    214. Yuan W, Marwaha JS, Rakowsky ST, Palmer NP, Kohane IS, Rubin DT, Brat GA, Feuerstein JD. Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis. Inflamm Bowel Dis. 2023 05 02; 29(5):695-704. PMID: 35786768; PMCID: PMC10152283.
      Citations: 4     Fields:    Translation:Humans
    215. Watson AR, Veseli I, DeLongchamp JZ, Silva M, Trigodet F, Lolans K, Shaiber A, Fogarty E, Runde JM, Quince C, Yu MK, Morrison HG, Lee STM, Kao D, Rubin DT, Jabri B, Louie T, Eren AM, Füssel J, Söylev A. Metabolic independence drives gut microbial colonization and resilience in health and disease. Genome Biol. 2023 04 17; 24(1):78. PMID: 37069665; PMCID: PMC10108530.
      Citations: 49     Fields:    Translation:Humans
    216. Choi DK, Rubin DT, Puangampai A, Lach M. Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center. Crohns Colitis 360. 2023 Apr; 5(2):otad018. PMID: 37082614; PMCID: PMC10111283.
      Citations: 7     
    217. Matone M, Wang X, Marshall D, Huang J, Worsley D, Filograna C, Rubin D. Association of In-person vs Virtual Education With Community COVID-19 Case Incidence Following School Reopenings in the First Year of the COVID-19 Pandemic. JAMA Netw Open. 2023 04 03; 6(4):e238300. PMID: 37058303; PMCID: PMC10105309.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    218. Zorzi F, Rubin DT, Cleveland NK, Monteleone G, Calabrese E. Ultrasonographic Transmural Healing in Crohn's Disease. Am J Gastroenterol. 2023 06 01; 118(6):961-969. PMID: 36988302.
      Citations: 11     Fields:    Translation:Humans
    219. Dolinger MT, Krugliak Cleveland N, Rubin DT, Dubinsky MC. Guide to Intestinal Ultrasound Credentialing, Documentation, and Billing for Gastroenterologists in the United States. Am J Gastroenterol. 2023 09 01; 118(9):1528-1531. PMID: 36940447.
      Citations: 4     Fields:    Translation:Humans
    220. Jairath V, Abreu MT, Rubin DT, Reinisch W, Danese S, Olivera PA, Lasa JS, Zubiaurre I, Magro F, Rahier JF, Rabaud C, Peyrin-Biroulet L. Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Crohns Colitis. 2023 Mar 18; 17(2):199-210. PMID: 36087107.
      Citations: 6     Fields:    Translation:Humans
    221. Friedberg S, Choi D, Hunold T, Choi NK, Garcia NM, Picker EA, Cohen NA, Cohen RD, Dalal SR, Pekow J, Sakuraba A, Krugliak Cleveland N, Rubin DT. Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience. Clin Gastroenterol Hepatol. 2023 07; 21(7):1913-1923.e2. PMID: 36898598; PMCID: PMC11016252.
      Citations: 71     Fields:    Translation:Humans
    222. Cleveland NK, Picker EA, Dolinger MT, Rubin DT. The Arrival of Intestinal Ultrasound for Inflammatory Bowel Disease Care in the United States. Gastroenterol Hepatol (N Y). 2023 Mar; 19(3):147-154. PMID: 37706105; PMCID: PMC10496276.
      Citations: 11     
    223. Kassim G, Yzet C, Nair N, Debebe A, Rendon A, Traboulsi C, Rubin DT, Maroli A, Coppola E, Carvello MM, Ben David N, De Lucia F, Sacchi M, Danese S, Spinelli A, Hirdes MMC, Ten Hove J, Oldenburg B, Cholapranee A, Riter M, Lukin D, Scherl E, Eren E, Sultan KS, Axelrad J, Sachar DB, Colombel JF. Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study. Inflamm Bowel Dis. 2023 03 01; 29(3):417-422. PMID: 35522225; PMCID: PMC10210615.
      Citations: 3     Fields:    Translation:Humans
    224. Miyatani Y, Choi D, Du X, Hart J, Rubin DT. Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib. ACG Case Rep J. 2023 Feb; 10(2):e00979. PMID: 36788789; PMCID: PMC9916037.
      Citations: 4     
    225. Rubin DT. Transmural Healing in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2023 Feb; 19(2):101-103. PMID: 36866113; PMCID: PMC9972610.
      Citations: 3     
    226. Mikolajczyk AE, Cohen NA, Watson S, Ackerman M, Goeppinger SR, Hart J, Turner JR, Rubin DT. Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis. Inflamm Bowel Dis. 2023 02 01; 29(2):222-227. PMID: 35436339; PMCID: PMC10686247.
      Citations: 4     Fields:    Translation:Humans
    227. Allocca M, Rubin DT, Kucharzik T. Intestinal Ultrasound in the Assessment and Management of Inflammatory Bowel Disease: Is It Ready for Standard Practice? Gastroenterology. 2023 05; 164(6):851-855. PMID: 36708790.
      Citations: 8     Fields:    Translation:Humans
    228. Lin DJ, Schwier M, Geiger B, Raithel E, von Busch H, Fritz J, Kline M, Brooks M, Dunham K, Shukla M, Alaia EF, Samim M, Joshi V, Walter WR, Ellermann JM, Ilaslan H, Rubin D, Winalski CS, Recht MP. Deep Learning Diagnosis and Classification of Rotator Cuff Tears on Shoulder MRI. Invest Radiol. 2023 06 01; 58(6):405-412. PMID: 36728041.
      Citations: 17     Fields:    Translation:Humans
    229. Garcia NM, Cohen NA, Rubin DT. Treat-to-target and sequencing therapies in Crohn's disease. United European Gastroenterol J. 2022 12; 10(10):1121-1128. PMID: 36507876; PMCID: PMC9752313.
      Citations: 20     Translation:Humans
    230. Fenton D, Choi NK, Garcia NM, Dyer EC, Cohen NA, Rubin DT. Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project. Crohns Colitis 360. 2022 Oct; 4(4):otac042. PMID: 36778515; PMCID: PMC9802166.
      Citations: 3     
    231. Zisman-Ilani Y, Thompson KD, Siegel LS, Mackenzie T, Crate DJ, Korzenik JR, Melmed GY, Kozuch P, Sands BE, Rubin DT, Regueiro MD, Cross R, Wolf DC, Hanson JS, Schwartz RM, Vrabie R, Kreines MD, Scherer T, Dubinsky MC, Siegel CA. Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. Aliment Pharmacol Ther. 2023 01; 57(2):205-214. PMID: 36377259; PMCID: PMC9790033.
      Citations: 7     Fields:    Translation:Humans
    232. Shamsunder MG, Sheckter CC, Sheinin A, Rubin D, Parikh RP, Rose J, Momoh AO, Offodile AC, Matros E. Impact of High-Deductible Health Plans on Breast Reconstruction: Considerations for Financial Toxicity. Plast Reconstr Surg. 2023 02 01; 151(2):245-253. PMID: 36696302; PMCID: PMC10586232.
      Citations: 3     Fields:    Translation:Humans
    233. Rubin DT. Highlights in Ulcerative Colitis From the ACG Annual Scientific Meeting: Commentary. Gastroenterol Hepatol (N Y). 2022 Nov; 18(11 Suppl 3):13-16. PMID: 36866201; PMCID: PMC9972644.
      Citations:    
    234. Biedermann L, Dubinsky MC, Vermeire S, Fellmann M, Gardiner S, Hur P, Mundayat R, Panés J, Rubin DT. Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflamm Bowel Dis. 2022. View Publication.
    235. Cohen NA, Steinberg JM, Silfen A, Traboulsi C, Rodriguez TG, Singer JM, Patel S, Cohen RD, Dalal SR, Sakuraba A, Pekow J, Micic D, Rubin DT. Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes. Dig Dis Sci. 2023 04; 68(4):1464-1472. PMID: 36242686.
      Citations: 3     Fields:    Translation:Humans
    236. Tarabar D, El Jurdi K, Traboulsi C, Yvellez O, Milenkovic Z, Petrovic S, Subotic B, Gils A, Brocic T, Brcerevic I, Latinovic O, Jocic T, Rubin DT. A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab. Inflamm Bowel Dis. 2022 10 03; 28(10):1549-1554. PMID: 35078235.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    237. Cohen NA, Rubin DT. Endoscopic Management of Colitis-Associated Neoplasia. Gastrointest Endosc Clin N Am. 2022 Oct; 32(4):863-873. PMID: 36202521.
      Citations:    Fields:    Translation:Humans
    238. Runde J, Erondu A, Akiyama S, Traboulsi C, Rai V, Glick LR, Yi Y, Ollech JE, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis. Inflamm Bowel Dis. 2022 09 01; 28(9):1386-1394. PMID: 35040964; PMCID: PMC9434476.
      Citations: 5     Fields:    Translation:Humans
    239. Hanzel J, Jairath V, De Cruz P, Guizzetti L, Shackelton LM, Bossuyt P, Duijvestein M, Dulai PS, Hirten RP, Khanna R, Panes J, Regueiro M, Rubin DT, Singh S, Stidham RW, Sandborn WJ, Feagan BG, D'Haens GR, Ma C, Grossmann J, Peyrin-Biroulet L. Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease. Inflamm Bowel Dis. 2022 09 01; 28(9):1321-1331. PMID: 34791254; PMCID: PMC9756946.
      Citations: 6     Fields:    Translation:Humans
    240. Christensen B, Prentice RE, Al-Ani AH, Zhang E, Bedell A, Rubin DT. Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. Inflamm Bowel Dis. 2022 09 01; 28(9):1465-1468. PMID: 35286382.
      Citations: 3     Fields:    Translation:Humans
    241. Chen B, Zhong J, Li X, Pan F, Ding Y, Zhang Y, Chen H, Liu F, Zhang Z, Zhang L, Drozda R, Oliinyk O, Goh AH, Chen X, Sun X, Rubin DT, Sandborn WJ, Chen M. Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study. Gastroenterology. 2022 12; 163(6):1555-1568. PMID: 35963369.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    242. Choi DK, Rubin DT, Puangampai A, Cleveland N. Hypertensive Emergency After Initiating Ozanimod: A Case Report. Inflamm Bowel Dis. 2022 08 01; 28(8):e114-e115. PMID: 35212384.
      Citations: 1     Fields:    Translation:Humans
    243. Rubin D, Sansom CE, Richards DJ, Lucas NT, Garden AL, Saldivia Pérez PR, Lord JM, Perry NB. Halimane Diterpenes in the Alpine Daisy Celmisia viscosa: Absolute Configuration, 2,6-Dideoxyhexopyran-3-ulosides, Conformational Flexibility, and Intraspecific Variation. J Nat Prod. 2022 08 26; 85(8):1893-1903. PMID: 35881529.
      Citations: 1     Fields:    Translation:AnimalsCells
    244. Rubin D, Sansom CE, Lucas NT, McAdam CJ, Simpson J, Lord JM, Perry NB. O-Acylated Flavones in the Alpine Daisy Celmisia viscosa: Intraspecific Variation. J Nat Prod. 2022 08 26; 85(8):1904-1911. PMID: 35876856.
      Citations: 2     Fields:    Translation:Humans
    245. Cohen NA, Dalal SR, Choi D, Rubin DT. Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis. ACG Case Rep J. 2022 Jul; 9(7):e00832. PMID: 35919406; PMCID: PMC9302285.
      Citations: 7     
    246. Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Gearry RB, Ng SC, Mak JWY, Abreu MT, Rubin DT, Bernstein CN, Banerjee R, Yamamoto-Furusho JK, Panaccione R, Seow CH, Ma C, Underwood FE, Ahuja V, Panaccione N, Shaheen AA, Holroyd-Leduc J, Kaplan GG, Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group, Chong VH, Dutta U, Simadibrata M, Kaibullayeva J, Sun Y, Hilmi I, Raja Ali RA, Paudel MS, Altuwaijri M, Hartono JL, Wei SC, Limsrivilai J, El Ouali S, Dao VH, Kelly P, Hodges P, Miao Y, Li M, Kotze PG, Balderramo D, Juliao-Baños F, Vergara BI. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses. Clin Gastroenterol Hepatol. 2023 08; 21(9):2211-2221. PMID: 35863682.
      Citations: 132     Fields:    Translation:Humans
    247. Akiyama S, Dyer EC, Rubin DT. Diagnostic and Management Considerations for the IPAA With Crohn's Disease-Like Features. Dis Colon Rectum. 2022 12 01; 65(S1):S77-S84. PMID: 35867686.
      Citations: 10     Fields:    Translation:Humans
    248. Kiran RP, Kochhar GS, Kariv R, Rex DK, Sugita A, Rubin DT, Navaneethan U, Hull TL, Ko HM, Liu X, Kachnic LA, Strong S, Iacucci M, Bemelman W, Fleshner P, Safyan RA, Faiz O, Lo S, Ashburn JH, Spinelli A, Bernstein CN, Kane SV, Cross RK, Schairer J, McCormick JT, Farraye FA, Chang S, Scherl EJ, Schwartz DA, Bruining DH, Philpott J, Bentley-Hibbert S, El-Hachem S, Sandborn WJ, Silverberg MS, Pardi DS, Church JM, Shen B, Kotze PG, D'Hoore A, Tarabar D. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 09; 7(9):871-893. PMID: 35798022.
      Citations: 7     Fields:    Translation:Humans
    249. Cohen NA, Zafer M, Setia N, Anderson MJ, Sakuraba A, Dalal S, Pekow J, Cohen RD, Rubin DT, Micic D. Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis. Dig Dis Sci. 2023 03; 68(3):897-901. PMID: 35781654.
      Citations: 2     Fields:    Translation:HumansCells
    250. CORE-IBD Collaborators, Ma C, Hanzel J, Panaccione R, Sandborn WJ, D'Haens GR, Ahuja V, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen B, Colombel JF, Danese S, Dignass A, Dubinsky MC, Fleshner PR, Gearry RB, Hanauer SB, Hart A, Lakatos PL, Leong RW, Ran Z, Regueiro M, Singh S, Spinelli A, Steinhart AH, Travis SP, van der Woude CJ, Yacyshyn B, Yamamoto T, Bemelman WA, Lightner AL, Rubin DT, Scherl EJ, Siegel CA, Silverberg MS, Vermeire S, Parker CE, McFarlane SC, Guizzetti L, Smith MI, Vande Casteele N, Feagan BG, Jairath V, Atreya R, Kotze PG, Kucharzik T, Magro F, Panés J, Peyrin-Biroulet L, Allez M, Louis E. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology. 2022 10; 163(4):950-964. PMID: 35788348.
      Citations: 38     Fields:    Translation:Humans
    251. Rubin DT. Highlights in Ulcerative Colitis From Digestive Disease Week 2022: Commentary. Gastroenterol Hepatol (N Y). 2022 Jul; 18(7 Suppl 2):12-16. PMID: 36756652; PMCID: PMC9671064.
      Citations: 2     
    252. Friedberg S, Hanan I, Hyman N, Rubio G, Sharma A, Rubin DT. Ileal Desmoid Tumor in Ileal Crohn's: Coincidence or Connection? Dig Dis Sci. 2023 03; 68(3):1071-1073. PMID: 35713837.
      Citations:    Fields:    Translation:Humans
    253. Traboulsi C, Ayoub F, Silfen A, Rodriguez TG, Rubin DT. Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center. Dig Dis Sci. 2023 02; 68(2):385-388. PMID: 35695972.
      Citations: 15     Fields:    Translation:Humans
    254. D'Haens G, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, Ferrante M, Panés J. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Lancet. 2022 05 28; 399(10340):2015-2030. PMID: 35644154.
      Citations: 170     Fields:    Translation:Humans
    255. Ferrante M, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, D'Haens G, Panés J. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. Lancet. 2022 05 28; 399(10340):2031-2046. PMID: 35644155.
      Citations: 128     Fields:    Translation:HumansCTClinical Trials
    256. Fehily SR, Al-Ani AH, Abdelmalak J, Rentch C, Zhang E, Denholm JT, Johnson D, Ng SC, Sharma V, Rubin DT, Gibson PR, Christensen B. Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management. Aliment Pharmacol Ther. 2022 07; 56(1):6-27. PMID: 35596242; PMCID: PMC9325436.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    257. McDonald BD, Dyer EC, Rubin DT. IL-23 Monoclonal Antibodies for IBD: So Many, So Different? J Crohns Colitis. 2022 May 11; 16(Supplement_2):ii42-ii53. PMID: 35553664; PMCID: PMC9097671.
      Citations: 13     Fields:    Translation:Humans
    258. Parigi TL, D'Amico F, Abreu MT, Rubin DT, Dignass A, Dotan I, Jairath V, Peyrin-Biroulet L, Ghosh S, Danese S, Magro F. Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey. Lancet Gastroenterol Hepatol. 2022 05; 7(5):390-391. PMID: 35397241.
      Citations: 8     Fields:    Translation:Humans
    259. Choden T, Cohen NA, Rubin DT. Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2022 May; 18(5):265-271. PMID: 36397756; PMCID: PMC9666818.
      Citations: 24     
    260. Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, Agrawal M, Tiong JHT, Steinberg J, Kruis W, Ahuja V, Ng SC, Rubin DT, Colombel JF, Gearry R, International Organization for Study of Inflammatory Bowel Diseases, Steinwurz F. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. Lancet Gastroenterol Hepatol. 2022 07; 7(7):666-678. PMID: 35487235.
      Citations: 68     Fields:    Translation:Humans
    261. Friedberg S, Rubin DT. Intestinal Cancer and Dysplasia in Crohn's Disease. Gastroenterol Clin North Am. 2022 06; 51(2):369-379. PMID: 35595420.
      Citations: 3     Fields:    Translation:Humans
    262. Guber K, Zilinyi RS, Driggin E, Soroush A, Welinsky S, Nathanson J, Sethi A, Rubin D. Rare Complication of Endoscopic Variceal Therapy: Wide-Complex Tachycardia Associated With Embolization of Glue and Coil. JACC Case Rep. 2022 Apr 06; 4(7):433-437. PMID: 35693901; PMCID: PMC9175143.
      Citations: 2     
    263. Cohen NA, Choi D, Choden T, Cleveland NK, Cohen RD, Rubin DT. Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center. Clin Gastroenterol Hepatol. 2023 08; 21(9):2407-2409.e2. PMID: 35381385; PMCID: PMC11009929.
      Citations: 5     Fields:    Translation:Humans
    264. Rubin DT. Highlights in Ulcerative Colitis From the 17th Congress of the European Crohn's and Colitis Organisation: Commentary. Gastroenterol Hepatol (N Y). 2022 Apr; 18(4 Suppl 1):13-16. PMID: 35610991; PMCID: PMC9122072.
      Citations:    
    265. Shaffer SR, Erondu AI, Traboulsi C, Rai V, Krugliak Cleveland N, Israel A, Christensen B, Rubin DT. Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia. Inflamm Bowel Dis. 2022 03 30; 28(4):553-559. PMID: 34037230; PMCID: PMC9122749.
      Citations: 6     Fields:    Translation:Humans
    266. Choi DK, Puangampai A, Rubin DT. Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease. Ann Pharmacother. 2022 Mar 18; 10600280221080986. PMID: 35300521.
      Citations: 2     Fields:    
    267. Anyane-Yeboa A, Quezada S, Rubin DT, Balzora S. The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 11; 20(11):2427-2434. PMID: 35307597.
      Citations: 25     Fields:    Translation:Humans
    268. Akiyama S, Ollech JE, Traboulsi C, Rai V, Glick LR, Yi Y, Runde J, Olivas AD, Weber CR, Cohen RD, Olortegui KBS, Hurst RD, Umanskiy K, Shogan BD, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Hart J, Hyman NH, Rubin DT. Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis. Dig Dis Sci. 2022 08; 67(8):4020-4031. PMID: 35288827; PMCID: PMC10966959.
      Citations: 5     Fields:    Translation:Humans
    269. Click B, Barnes EL, Cohen BL, Sands BE, Hanson JS, Rubin DT, Dubinsky MC, Regueiro M, Gazis D, Crawford JM, Long MD. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD. BMC Gastroenterol. 2022 Feb 19; 22(1):71. PMID: 35183108; PMCID: PMC8858477.
      Citations: 2     Fields:    Translation:Humans
    270. Abreu MT, Siegel CA, Panaccione R, Sands BE, Dignass A, Turner D, Dotan I, Hart AL, Ahuja V, Ananthakrishnan AN, Ghosh S, Griffiths AM, Kaser A, Koutroubakis IE, Lakatos PL, Levine A, Lewis JD, Mantzaris GJ, O'Morain C, Ran Z, Reinisch W, Rogler G, Sachar DB, Silverberg MS, Sood A, Spinelli A, Schreiber S, Rubin DT, Sandborn WJ, Danese S, Caron B, Allez M, Halfvarson J, Kotze PG, Magro F, Siegmund B, Steinwurz F, Tysk C, Yamamoto-Furusho JK, Peyrin-Biroulet L. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. Clin Gastroenterol Hepatol. 2022 11; 20(11):2619-2627.e1. PMID: 35189386.
      Citations: 7     Fields:    Translation:Humans
    271. Quera R, Rubin DT, Núñez F P. Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget. World J Gastrointest Endosc. 2022 Feb 16; 14(2):85-95. PMID: 35316980; PMCID: PMC8908328.
      Citations: 4     
    272. Hart AL, Rubin DT. Entering the Era of Disease Modification in Inflammatory Bowel Disease. Gastroenterology. 2022 04; 162(5):1367-1369. PMID: 35202593.
      Citations: 11     Fields:    Translation:Humans
    273. Ayoub F, Odenwald M, Micic D, Dalal SR, Pekow J, Cohen RD, Rubin DT, Sakuraba A. Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis. Intest Res. 2022 Apr; 20(2):240-250. PMID: 35124951; PMCID: PMC9081994.
      Citations: 11     
    274. Sandborn WJ, D'Haens GR, Reinisch W, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG, GALAXI-1 Investigators, Panés J. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology. 2022 05; 162(6):1650-1664.e8. PMID: 35134323.
      Citations: 84     Fields:    Translation:HumansCTClinical Trials
    275. Krugliak Cleveland N, Rubin DT, Torres J. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented? Gastroenterology. 2022 04; 162(5):1396-1408. PMID: 35101421.
      Citations: 88     Fields:    Translation:Humans
    276. Guillo L, Abreu M, Panaccione R, Sandborn WJ, Gensler L, Moghaddam B, Ahuja V, Ali SA, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Koutroubakis IE, Lakatos PL, Lindsay JO, Mantzaris GJ, Ng SC, O'Morain C, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Steinwurz F, Vavricka S, Verstraete SG, Haemel AK, Dignass A, Sands BE, Danese S, Azevedo VF, Allez M, Kotze PG, Magro F, Panés J, Siegmund B, Tysk C, Brezin AP, Peyrin-Biroulet L. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022 03; 7(3):254-261. PMID: 35051383.
      Citations: 15     Fields:    Translation:Humans
    277. Zafer M, Zhang H, Dwadasi S, Goens D, Paknikar R, Dalal S, Cohen RD, Pekow J, Rubin DT, Sakuraba A, Micic D. A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis. Crohns Colitis 360. 2022 Jan; 4(1):otab082. PMID: 36777555; PMCID: PMC9802419.
      Citations: 5     
    278. Rubin DT, Peyrin-Biroulet L, Reinisch W, Tole S, Sullivan L, Park KT, Regueiro M. Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis. Crohns Colitis 360. 2021 Oct; 3(4):otab079. PMID: 36777264; PMCID: PMC9802428.
      Citations: 9     
    279. Rubin D, Panaccione R, Potts Bleakman A, Kayhan C, Atkinson C, Hunter Gibble T, Ellis H, Healey K, Shan M, Hibi T. P028 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Patient and Healthcare Professional Perspectives on Experience of Ulcerative Colitis Symptoms. Am J Gastroenterol. 2021 Dec 01; 116(Suppl 1):S7. PMID: 37461947.
      Citations: 2     Fields:    
    280. Kuharic M, Krugliak Cleveland N, Candela N, Carter J, Qian J, Rusibamayila N, Turpin R, Rubin D. P042 Early Versus Later Use of Vedolizumab In IBD: Patient Characteristics And Treatment Patterns In The Real World (RALEE). Am J Gastroenterol. 2021 Dec 01; 116(Suppl 1):S11. PMID: 37461960.
      Citations:    Fields:    
    281. Melmed GY, Oliver B, Hou JK, Lum D, Singh S, Crate D, Almario C, Bray H, Bresee C, Gerich M, Gerner D, Heagy E, Holthoff M, Hudesman D, McCutcheon Adams K, Mattar MC, Metwally M, Nelson E, Ostrov A, Rubin DT, Scott F, Samir S, van Deen W, Younes Z, Oberai R, Weaver A, Siegel CA, IBD Qorus. Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 12 01; 116(12):2410-2418. PMID: 34797226.
      Citations: 16     Fields:    Translation:Humans
    282. Rubin D, Panaccione R, Potts Bleakman A, Kayhan C, Atkinson C, Hunter Gibble T, Ellis H, Healey K, Shan M, Hibi T. P028 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Patient and Healthcare Professional Perspectives on Experience of Ulcerative Colitis Symptoms. Am J Gastroenterol. 2021 Dec 01; 116(Suppl 1):S7. PMID: 35006156.
      Citations:    
    283. Akiyama S, Lin A, Traboulsi C, Rubin DT. Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib. ACG Case Rep J. 2021 Nov; 8(11):e00690. PMID: 34840997; PMCID: PMC8613360.
      Citations: 4     
    284. Rubin DT, Dotan I, DuVall A, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, HIBISCUS Study Group, Bouhnik Y, Panés J. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. Lancet Gastroenterol Hepatol. 2022 01; 7(1):17-27. PMID: 34798036.
      Citations: 45     Fields:    Translation:HumansCTClinical Trials
    285. Curtis JR, Zhou X, Rubin DT, Reinisch W, Yazdany J, Robinson PC, Chen Y, Benda B, Madsen A, Geier J. Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study. J Rheumatol. 2022 03; 49(3):320-329. PMID: 34782447.
      Citations: 13     Fields:    Translation:HumansCells
    286. Rubin DT, Sninsky C, Hart A, Bressler B, Armuzzi A, Afzali A, Siegmund B, Sans M, Bouhnik Y. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflamm Bowel Dis. 2021 11 15; 27(12):1942-1953. PMID: 33512475; PMCID: PMC8637792.
      Citations: 52     Fields:    Translation:Humans
    287. Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, El-Hachem S, Sehgal P, Picoraro JA, Sandborn WJ, Silverberg MS, Pardi DS, D'Hoore A, Kotze PG, Tarabar D, Vermeire S. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 01; 7(1):69-95. PMID: 34774224.
      Citations: 44     Fields:    Translation:HumansPHPublic Health
    288. Coffin SE, Rubin D. Yes, Children Can Transmit COVID, but We Need Not Fear. JAMA Pediatr. 2021 11 01; 175(11):1110-1112. PMID: 34398229.
      Citations: 6     Fields:    Translation:HumansCells
    289. Dwadasi S, Zafer M, Goens D, Paknikar R, Dalal S, Cohen RD, Pekow J, Rubin DT, Sakuraba A, Micic D. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1620-1625. PMID: 33319248; PMCID: PMC8682443.
      Citations: 4     Fields:    Translation:Humans
    290. Rubin DT, Modesto I, Danese S, Ng SC, Kwok KK, Koram N, Jones TV, Vermeire S. Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis. Aliment Pharmacol Ther. 2022 02; 55(3):302-310. PMID: 34626429; PMCID: PMC9293472.
      Citations: 17     Fields:    Translation:Humans
    291. Bressler B, Yarur A, Silverberg MS, Bassel M, Bellaguarda E, Fourment C, Gatopoulou A, Karatzas P, Kopylov U, Michalopoulos G, Michopoulos S, Navaneethan U, Rubin DT, Siffledeen J, Singh A, Soufleris K, Stein D, Demuth D, Mantzaris GJ. Vedolizumab and Anti-Tumour Necrosis Factor a Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study. J Crohns Colitis. 2021 Oct 07; 15(10):1694-1706. PMID: 33786600; PMCID: PMC8495488.
      Citations: 59     Fields:    Translation:Humans
    292. Ayoub F, Ouni A, Rubin DT, Case R, Ladna M, Shah H. Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count. Am J Gastroenterol. 2021 10 01; 116(10):2137-2139. PMID: 33767107.
      Citations: 4     Fields:    Translation:Humans
    293. Krugliak Cleveland N, Rai V, El Jurdi K, Rao SS, Giurcanu MC, Rubin DT. Ulcerative Colitis Patients Have Reduced Rectal Compliance Compared With Non-Inflammatory Bowel Disease Controls. Gastroenterology. 2022 01; 162(1):331-333.e1. PMID: 34597674; PMCID: PMC8678316.
      Citations: 14     Fields:    Translation:Humans
    294. Cohen NA, Silfen A, Rubin DT. Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease. Gastroenterology. 2022 01; 162(1):17-21. PMID: 34562464; PMCID: PMC8678318.
      Citations: 16     Fields:    Translation:Humans
    295. Johnson T, McMurry-Heath M, Okon T, Rubin D, Carlson RW. NCCN Policy Summit: Innovative Solutions to Drive Down Healthcare Costs: Implications for Access to High-Quality Cancer Care. J Natl Compr Canc Netw. 2021 09 20; 19(9):1021-1026. PMID: 34551389.
      Citations: 1     Fields:    Translation:Humans
    296. Akiyama S, Rodriguez TG, Rubin DT. Stratifying Risks of Ileal Pouch Outcomes. Clin Gastroenterol Hepatol. 2022 07; 20(7):1620-1621. PMID: 34481959.
      Citations: 3     Fields:    Translation:Humans
    297. Fortin K, Vasan A, Wilson-Hall CL, Brooks E, Rubin D, Scribano PV. Using Quality Improvement and Technology to Improve Social Supports for Hospitalized Children. Hosp Pediatr. 2021 10; 11(10):1120-1129. PMID: 34475224.
      Citations: 14     Fields:    Translation:Humans
    298. Shaffer SR, Rubin DT. Response to Tetangco and Hanauer. Am J Gastroenterol. 2021 09 01; 116(9):1959-1960. PMID: 34101668.
      Citations:    Fields:    
    299. Aby ES, Kriss M, Rubin DT, Pillai A. How to Navigate National Societal Organizations for Leadership Development and Academic Promotion: A Guide for Trainees and Young Faculty. Gastroenterology. 2021 11; 161(5):1361-1365. PMID: 34464630.
      Citations: 1     Fields:    Translation:Humans
    300. Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Ng SC, Papa A, Raine T, Rubin DT, Danese S, Olivera PA, Zuily S, Kotze PG, Louis E, Magro F, Teixeira FV, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021 12; 18(12):857-873. PMID: 34453143; PMCID: PMC8395387.
      Citations: 59     Fields:    Translation:Humans
    301. Wu K, Steinway C, Greenberg A, Gajary Z, Rubin D, Jan S, Szalda D. Increasing Pediatric to Adult Healthcare Transition Services Through Clinical Decision Supports. J Pediatr Nurs. 2021 Nov-Dec; 61:292-297. PMID: 34450469.
      Citations: 1     Fields:    Translation:Humans
    302. Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, D'Hoore A, Kotze PG, Tarabar D, Vermeire S. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021 10; 6(10):826-849. PMID: 34416186.
      Citations: 51     Fields:    Translation:Humans
    303. Buisson A, Cannon L, Umanskiy K, Hurst RD, Hyman NH, Sakuraba A, Pekow J, Dalal S, Cohen RD, Pereira B, Rubin DT. Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease. Intest Res. 2022 Jul; 20(3):303-312. PMID: 34333909; PMCID: PMC9344250.
      Citations: 9     
    304. Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021 10; 161(4):1118-1132. PMID: 34358489; PMCID: PMC8564770.
      Citations: 404     Fields:    Translation:Humans
    305. Rai V, Traboulsi C, Silfen A, Ackerman MT, Erondu AI, Karpin JE, Gulotta G, Rubin DT. Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease. Crohns Colitis 360. 2021 Jul; 3(3). PMID: 35531367; PMCID: PMC9075692.
      Citations: 2     
    306. Cleveland NK, Rubin DT. CANCER PREVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Pract Gastroenterol. 2021 Aug; 45(8):12-28. PMID: 34707325; PMCID: PMC8547793.
      Citations: 4     
    307. Rubin D, Eisen M, Collins S, Pennington JW, Wang X, Coffin S. SARS-CoV-2 Infection in Public School District Employees Following a District-Wide Vaccination Program - Philadelphia County, Pennsylvania, March 21-April 23, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 30; 70(30):1040-1043. PMID: 34324479; PMCID: PMC8323551.
      Citations: 4     Fields:    Translation:Humans
    308. Rubin DT, Griffith J, Zhang Q, Hepp Z, Keshishian A. The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies. Inflamm Bowel Dis. 2021 07 27; 27(8):1201-1209. PMID: 33107564; PMCID: PMC8600026.
      Citations: 5     Fields:    Translation:Humans
    309. Normatov I, Fluxa D, Wang JD, Ollech JE, Gulotta GE, Patel S, Quintero MA, De la Torre B, Solis N, Damas OM, Deshpande AR, Kerman DH, Abreu MT, Rubin DT. Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction. Crohns Colitis 360. 2021 Jul; 3(3):otab048. PMID: 36776674; PMCID: PMC9802083.
      Citations: 3     
    310. Maltz RM, McNicol M, Wingate L, Buchanan S, Sandell A, Kim SC, Rubin DT. There Is No Substitute for Effective Education About Biosimilars. Crohns Colitis 360. 2021 Oct; 3(4):otab047. PMID: 36777278; PMCID: PMC9802262.
      Citations: 3     
    311. Su C, Lawendy N, Kobayashi T, Sandborn WJ, Rubin DT, Modesto I, Gardiner S, Kulisek N, Zhang H, Wang W, Vermeire S, Panés J. Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial. J Crohns Colitis. 2021 Jul 05; 15(7):1130-1141. PMID: 33290538; PMCID: PMC8256630.
      Citations: 32     Fields:    Translation:Humans
    312. Cohen NA, Rubin DT. New targets in inflammatory bowel disease therapy: 2021. Curr Opin Gastroenterol. 2021 07 01; 37(4):357-363. PMID: 34059604; PMCID: PMC8544288.
      Citations: 31     Fields:    Translation:Humans
    313. El Ouali S, Rubin DT, Cohen BL, Regueiro MD, Rieder F. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic. Curr Opin Gastroenterol. 2021 07 01; 37(4):313-319. PMID: 33859104; PMCID: PMC8285035.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    314. Dubinsky MC, Dotan I, Rubin DT, Bernauer M, Patel D, Cheung R, Modesto I, Latymer M, Keefer L. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Expert Rev Gastroenterol Hepatol. 2021 Sep; 15(9):985-997. PMID: 34130572.
      Citations: 34     Fields:    Translation:Humans
    315. Buisson A, Mak WY, Andersen MJ, Lei D, Pekow J, Cohen RD, Kahn SA, Rubin DT, Pereira B. Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location. Inflamm Bowel Dis. 2021 06 15; 27(7):1008-1016. PMID: 33107563; PMCID: PMC8600021.
      Citations: 14     Fields:    Translation:Humans
    316. Rubin DT, Hart A, Panaccione R, Suvanto U, Deuring JJ, Woolcott J, Cappelleri JC, Steinberg K, Wingate L, Schreiber S, Armuzzi A. Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians. Inflamm Bowel Dis. 2021 06 15; 27(7):1096-1106. PMID: 33057598; PMCID: PMC8214018.
      Citations: 27     Fields:    Translation:Humans
    317. Barnes EL, Hanson JS, Regueiro MD, Saha S, Sands BE, Rubin DT, Dubinsky MC, Siegel CA, Gazis DR, Crawford JM, Long MD. Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD. J Clin Gastroenterol. 2022 07 01; 56(6):529-535. PMID: 34115661.
      Citations: 2     Fields:    Translation:Humans
    318. Trinh NH, O'Hair C, Agrawal S, Dean T, Emmerich A, Rubin D, Wozniak J. Lessons Learned: Developing an Online Training Program for Cultural Sensitivity in an Academic Psychiatry Department. Psychiatr Serv. 2021 10 01; 72(10):1233-1236. PMID: 34106742.
      Citations: 3     Fields:    Translation:Humans
    319. Khanna S, Tande A, Rubin DT, Khoruts A, Kahn SA, Pardi DS. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations. Mayo Clin Proc. 2021 06; 96(6):1418-1425. PMID: 34088413; PMCID: PMC8169126.
      Citations: 12     Fields:    Translation:HumansCells
    320. Krugliak Cleveland N, Quera R, Rubin DT, Núñez F P. Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis. World J Gastroenterol. 2021 May 28; 27(20):2521-2530. PMID: 34092973; PMCID: PMC8160621.
      Citations: 13     Fields:    Translation:Humans
    321. Akiyama S, Yamada A, Ollech JE, Komaki Y, Komaki F, Pekow J, Dalal SR, Cohen RD, Rubin DT, Sakuraba A. Predictability of simple endoscopic score for Crohn's disease for postoperative outcomes in Crohn's disease. J Gastroenterol Hepatol. 2021 Oct; 36(10):2785-2793. PMID: 33973282.
      Citations: 3     Fields:    Translation:Humans
    322. Lin A, Roth H, Anyane-Yeboa A, Rubin DT, Paul S. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2021 05 17; 27(6):947-955. PMID: 32780094; PMCID: PMC8600033.
      Citations: 39     Fields:    Translation:Humans
    323. Bernstein CN, Ng SC, Banerjee R, Steinwurz F, Shen B, Hamid S, Sood A, Yamamoto-Furusho JK, Griffiths A, Benchimol EI, Travis S, Rubin DT, Kaplan GG, Armstrong D, Gearry R, IBD-Emerging Nations Consortium and the WGO IBD Task Force on COVID-19, Carbonnel F, Lopes S. Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Inflamm Bowel Dis. 2021 05 17; 27(6):836-847. PMID: 32793973; PMCID: PMC7454666.
      Citations: 18     Fields:    Translation:HumansCells
    324. Rubin DT, Reinisch W, Mundayat R, Maller E, Lawendy N, Modesto I, Lichtenstein GR, Greuter T, Kotze PG, Pinheiro M, Fellmann M, Vavricka SR. Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. Therap Adv Gastroenterol. 2021; 14:17562848211005708. PMID: 34035832; PMCID: PMC8132089.
      Citations: 12     
    325. Shaffer SR, Traboulsi C, Krugliak Cleveland N, Rubin DT. Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis. ACG Case Rep J. 2021 May; 8(5):e00604. PMID: 34007860; PMCID: PMC8126549.
      Citations: 16     
    326. Click B, Barnes EL, Cohen BL, Sands BE, Hanson JS, Regueiro M, Rubin DT, Dubinsky MC, Gazis DR, Dalfonso L, Hildebrand JS, Crawford JM, Long MD. Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD. Crohns Colitis 360. 2021 Jul; 3(3):otab023. PMID: 36776639; PMCID: PMC9802086.
      Citations: 4     
    327. D'Amico F, Rubin DT, Kobayashi T, Bossuyt P, Pouillon L, Ghosh S, Danese S, Kotze PG, Magro F, Siegmund B, Olivera PA, Louis E, Domènech E, Peyrin-Biroulet L. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterol J. 2021 05; 9(4):451-460. PMID: 33961734; PMCID: PMC8259254.
      Citations: 31     Translation:Humans
    328. Rubin DT, Pariente B, Laharie D, Roblin X, Peyrin-Biroulet L, USTEK Post-Op study group, Buisson A, Nancey S, Manlay L, Hebuterne X, Fumery M, Bommelaer G, Pereira B, Vuitton L. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. United European Gastroenterol J. 2021 06; 9(5):552-560. PMID: 33951350; PMCID: PMC8259431.
      Citations: 20     Translation:HumansPHPublic Health
    329. Fendrick AM, Brixner D, Rubin DT, Mease P, Liu H, Davis M, Mittal M. Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit. J Manag Care Spec Pharm. 2021 Aug; 27(8):1086-1095. PMID: 33843252; PMCID: PMC10394214.
      Citations: 11     Fields:    Translation:Humans
    330. Melmed G, Rubin DT, McGovern D. Reply. Gastroenterology. 2021 07; 161(1):369-370. PMID: 33831380; PMCID: PMC8162783.
      Citations:    Fields:    
    331. Rubin GA, Desai AD, Chai Z, Wang A, Chen Q, Wang AS, Kemal C, Baksh H, Biviano A, Dizon JM, Yarmohammadi H, Ehlert F, Saluja D, Rubin DA, Morrow JP, Avula UMR, Berman JP, Kushnir A, Abrams MP, Hennessey JA, Elias P, Poterucha TJ, Uriel N, Kubin CJ, LaSota E, Zucker J, Sobieszczyk ME, Schwartz A, Garan H, Waase MP, Wan EY. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic. JAMA Netw Open. 2021 04 01; 4(4):e216842. PMID: 33890991; PMCID: PMC8065381.
      Citations: 31     Fields:    Translation:HumansCells
    332. Rubin D, Coffin S. On the Value of COVID-19 Testing for Children Beyond the Spring of 2021. JAMA Netw Open. 2021 04 01; 4(4):e217850. PMID: 33890994.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    333. Yi Y, Sossenheimer PH, Erondu AI, Skowron KB, Rai V, Singer JM, El Jurdi K, Hyman NH, Rubin DT. Using Wearable Biosensors to Predict Length of Stay for Patients with IBD After Bowel Surgery. Dig Dis Sci. 2022 03; 67(3):844-853. PMID: 33761092; PMCID: PMC8564769.
      Citations: 12     Fields:    Translation:Humans
    334. Sidebottom AM, Rodriguez TG, Karpin JE, Rubin DT. Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract. 2021; 2021:6689443. PMID: 33747075; PMCID: PMC7960036.
      Citations: 6     
    335. Shamsunder MG, Sheckter CC, Sheinin A, Rubin D, Berlin NL, Mehrara B, Matros E. Variation in Payment per Work Relative Value Unit for Breast Reconstruction and Nonbreast Microsurgical Reconstruction: An All-Payer Claims Database Analysis. Plast Reconstr Surg. 2021 03 01; 147(3):505-513. PMID: 33587555; PMCID: PMC8415094.
      Citations: 1     Fields:    Translation:Humans
    336. Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Sandborn WJ, Sands BE, Reinisch W, Bemelman W, Danese S, Rubin D, Colombel JF, Dotan I, Abreu MT, Dignass A, International Organization for the Study of IBD, Bettenworth D, Schölmerich J, Mary JY, Peyrin-Biroulet L. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021 04; 160(5):1570-1583. PMID: 33359090.
      Citations: 1203     Fields:    Translation:Humans
    337. Yamada A, Komaki Y, Komaki F, Haider H, Micic D, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Shogan BD, Hurst R, Hyman N, Rubin DT, Sakuraba A. The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn's Disease. Digestion. 2021; 102(5):767-775. PMID: 33556932.
      Citations: 8     Fields:    Translation:Humans
    338. Cohen RD, Feuerstein JD, Rubin DT. Reply. Gastroenterology. 2021 06; 160(7):2627. PMID: 33561439; PMCID: PMC7867470.
      Citations:    Fields:    
    339. Karpin J, Rodriguez TG, Traboulsi C, Rai V, Gibbons RD, Rubin DT. Assessment of Comorbid Depression and Anxiety in Inflammatory Bowel Disease Using Adaptive Testing Technology. Crohns Colitis 360. 2021 Jan; 3(1). PMID: 34746788; PMCID: PMC8570563.
      Citations: 5     
    340. Akiyama S, Ollech JE, Rai V, Glick LR, Yi Y, Traboulsi C, Runde J, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes. Clin Gastroenterol Hepatol. 2022 02; 20(2):293-302.e9. PMID: 33549868; PMCID: PMC8339185.
      Citations: 22     Fields:    Translation:Humans
    341. Gearry RB, McCombie AM, Vatn M, Rubin DT, Steinwurz F, Loftus EV, Kruis W, Tysk C, Colombel JF, Ng SC, Van Assche G, Bernstein CN. What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries. Inflamm Intest Dis. 2021 May; 6(2):78-86. PMID: 34124179; PMCID: PMC8160566.
      Citations: 4     
    342. Hong SJ, Krugliak Cleveland N, Akiyama S, Zullow S, Yi Y, Shaffer SR, Malter LB, Axelrad JE, Chang S, Hudesman DP, Rubin DT. Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States. Crohns Colitis 360. 2021 Jan; 3(1):otab002. PMID: 36777067; PMCID: PMC9802405.
      Citations: 20     
    343. Rubin DT, Traboulsi C, Rai V. A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2021 Feb; 17(2):59-66. PMID: 34035764; PMCID: PMC8132723.
      Citations: 3     
    344. Rao VL, Aronsohn A, Rubin DT, Siegler M. How to Integrate a Medical Ethics Curriculum into Gastroenterology Fellowships. Gastroenterology. 2021 03; 160(4):1003-1006. PMID: 33497657.
      Citations: 1     Fields:    Translation:Humans
    345. Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC, International Organization for the Study of Inflammatory Bowel Disease (IOIBD), International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut. 2021 Apr; 70(4):635-640. PMID: 33472895; PMCID: PMC7818789.
      Citations: 104     Fields:    Translation:HumansCellsPHPublic Health
    346. Feld LD, Mergener K, Rubin DT, Rao VL. Management of code status in the periendoscopic period: a national survey of current practices and beliefs of U.S. gastroenterologists. Gastrointest Endosc. 2021 07; 94(1):172-177.e2. PMID: 33476610.
      Citations: 2     Fields:    Translation:Humans
    347. Yvellez OV, Rai V, Sossenheimer PH, Hart J, Turner JR, Weber C, El Jurdi K, Rubin DT. Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study. Inflamm Bowel Dis. 2021 01 19; 27(2):203-206. PMID: 32152624; PMCID: PMC7813748.
      Citations: 18     Fields:    Translation:Humans
    348. Patel P, Gao G, Gulotta G, Dalal S, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 01 19; 27(2):236-241. PMID: 32219391; PMCID: PMC7813746.
      Citations: 8     Fields:    Translation:Humans
    349. Shaffer SR, Huang E, Patel S, Rubin DT. Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis. Am J Gastroenterol. 2021 01 01; 116(1):125-133. PMID: 32947317; PMCID: PMC8075066.
      Citations: 6     Fields:    Translation:Humans
    350. Ungaro RC, Kappelman MD, Rubin DT, Colombel JF. COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions. Gastroenterology. 2021 04; 160(5):1447-1451. PMID: 33387525; PMCID: PMC7832021.
      Citations: 11     Fields:    Translation:HumansCells
    351. Christensen B, Rubin DT. Reply. Clin Gastroenterol Hepatol. 2021 11; 19(11):2452-2454. PMID: 33278575.
      Citations:    Fields:    
    352. Schreiber S, Dignass A, Rogge A, Rubin DT. Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic Is Not a Responsible Act. J Crohns Colitis. 2020 Dec 02; 14(12):1765-1768. PMID: 32582946; PMCID: PMC7337647.
      Citations:    Fields:    Translation:HumansPHPublic Health
    353. Akiyama S, Rai V, Rubin DT. Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment. Intest Res. 2021 Jan; 19(1):1-11. PMID: 33138344; PMCID: PMC7873408.
      Citations: 20     
    354. Van Pelt A, Glick HA, Yang W, Rubin D, Feldman M, Kimmel SE. Evaluation of COVID-19 Testing Strategies for Repopulating College and University Campuses: A Decision Tree Analysis. J Adolesc Health. 2021 01; 68(1):28-34. PMID: 33153883; PMCID: PMC7606071.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    355. Narula N, Aruljothy A, Alshahrani AA, Fadida M, Al-Saedi M, Marshall JK, Rubin DT, Christensen B. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Aliment Pharmacol Ther. 2020 12; 52(11-12):1676-1682. PMID: 33131108.
      Citations: 14     Fields:    Translation:Humans
    356. Hogan AK, Galligan MM, Stack NJ, Leach KF, Aredas BL, English R, Dye M, Rubin D. A Tertiary Care-based Complex Care Program: Improving Care for Children With Medical Complexity. Med Care. 2020 11; 58(11):958-962. PMID: 33055568.
      Citations: 5     Fields:    Translation:Humans
    357. Ollech JE, Avni-Biron I, Glick L, Haider H, Dalal SR, Micic D, Pekow J, Yanai H, Cohen RD, Dotan I, Rubin DT, Sakuraba A. Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes. Clin Gastroenterol Hepatol. 2021 11; 19(11):2444-2446.e2. PMID: 33223497.
      Citations: 5     Fields:    Translation:Humans
    358. Fleshner P, Gearry R, Lakatos PL, Rubin DT, Allez M. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic. J Crohns Colitis. 2020 Oct 21; 14(14 Suppl 3):S774-S779. PMID: 32722757; PMCID: PMC7454473.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    359. Fenster M, Alayo QA, Khatiwada A, Wang W, Dimopoulos C, Gutierrez A, Ciorba MA, Christophi GP, Hirten RP, Ha C, Beniwal-Patel P, Cohen BL, Syal G, Yarur A, Patel A, Colombel JF, Pekow J, Ungaro RC, Rubin DT, Deepak P. Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium. Clin Gastroenterol Hepatol. 2021 10; 19(10):2207-2209.e3. PMID: 33068786; PMCID: PMC8044250.
      Citations: 15     Fields:    Translation:Humans
    360. Melmed GY, Rubin DT, McGovern DPB. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic. Gastroenterology. 2021 02; 160(3):639-644. PMID: 33065064; PMCID: PMC7553998.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    361. Christensen B, Hanauer SB, Gibson PR, Turner JR, Hart J, Rubin DT. Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. J Crohns Colitis. 2020 Oct 05; 14(10):1345-1353. PMID: 32267926; PMCID: PMC7533894.
      Citations: 9     Fields:    Translation:Humans
    362. Kelly CR, Yen EF, Grinspan AM, Kahn SA, Atreja A, Lewis JD, Moore TA, Rubin DT, Kim AM, Serra S, Nersesova Y, Fredell L, Hunsicker D, McDonald D, Knight R, Allegretti JR, Pekow J, Absah I, Hsu R, Vincent J, Khanna S, Tangen L, Crawford CV, Mattar MC, Chen LA, Fischer M, Arsenescu RI, Feuerstadt P, Goldstein J, Kerman D, Ehrlich AC, Wu GD, Laine L. Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry. Gastroenterology. 2021 01; 160(1):183-192.e3. PMID: 33011173; PMCID: PMC8034505.
      Citations: 94     Fields:    Translation:HumansCells
    363. Lichtenstein GR, Rubin DT. Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician. Am J Gastroenterol. 2020 10; 115(10):1566-1569. PMID: 32833732; PMCID: PMC7499877.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    364. Shaffer SR, Witt J, Targownik LE, Kao D, Lee C, Smieliauskas F, Rubin DT, Singh H, Bernstein CN. Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection. J Infect. 2020 11; 81(5):758-765. PMID: 32980389.
      Citations: 5     Fields:    Translation:HumansCells
    365. Friedman MV, Hillen TJ, Misra S, Hildebolt CF, Rubin DA. Quantitative Variable Assessment of Patellar Instability: An MRI-Based Study. AJR Am J Roentgenol. 2020 11; 215(5):1163-1170. PMID: 32901564.
      Citations: 11     Fields:    Translation:Humans
    366. Loftus EV, Feagan BG, Panaccione R, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Colombel JF, Vermeire S. Long-term safety of vedolizumab for inflammatory bowel disease. Aliment Pharmacol Ther. 2020 10; 52(8):1353-1365. PMID: 32876349; PMCID: PMC7540482.
      Citations: 95     Fields:    Translation:HumansCTClinical Trials
    367. Rubin GA, Wan EY, Saluja D, Thomas G, Slotwiner DJ, Goldbarg S, Chaudhary S, Turitto G, Dizon J, Yarmohammadi H, Ehlert F, Rubin DA, Morrow JP, Waase M, Berman J, Kushnir A, Abrams MP, Halik C, Kumaraiah D, Schwartz A, Kirtane A, Kodali S, Goldenthal I, Garan H, Biviano A. Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide From a New York City Hospital Network. Crit Pathw Cardiol. 2020 09; 19(3):105-111. PMID: 32324622; PMCID: PMC7188041.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    368. Greuter T, Rieder F, Kucharzik T, Schoepfer AM, Rubin DT, Vavricka SR, Peyrin-Biroulet L. Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021 04; 70(4):796-802. PMID: 32847845; PMCID: PMC9014274.
      Citations: 53     Fields:    Translation:Humans
    369. Shafer LA, Sofia MA, Rubin DT, Steinhart AH, Ng SC, Reches L, Israeli E, Bernstein CN. An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI. Clin Gastroenterol Hepatol. 2021 12; 19(12):2524-2531. PMID: 32858200.
      Citations: 8     Fields:    Translation:Humans
    370. Li K, Marano C, Zhang H, Yang F, Sandborn WJ, Sands BE, Feagan BG, Rubin DT, Friedman JR, De Hertogh G, Peyrin-Biroulet L. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis. Gastroenterology. 2020 12; 159(6):2052-2064. PMID: 32853634.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    371. Krugliak Cleveland N, Masching A, Rubin DT. Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease. ACG Case Rep J. 2020 Aug; 7(8):e00449. PMID: 32904020; PMCID: PMC7449253.
      Citations: 5     
    372. Sood A, Singh A, Midha V, Mahajan R, Kao D, Rubin DT, Bernstein CN. Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy. Crohns Colitis 360. 2020 Oct; 2(4):otaa067. PMID: 36777748; PMCID: PMC9802301.
      Citations: 9     
    373. Stevens TW, Gecse K, Turner JR, de Hertogh G, Rubin DT, D'Haens GR. Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021 11; 19(11):2333-2342. PMID: 32801008; PMCID: PMC8140548.
      Citations: 18     Fields:    Translation:Humans
    374. Wolf DC, Wolf CH, Rubin DT. Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate. Am J Gastroenterol. 2020 08; 115(8):1298. PMID: 32516203; PMCID: PMC7302082.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    375. Berger M, Yamada A, Komaki Y, Komaki F, Cohen RD, Dalal S, Hurst RD, Hyman N, Pekow J, Shogan BD, Umanskiy K, Rubin DT, Sakuraba A, Micic D. Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications. Crohns Colitis 360. 2020 Jul; 2(3):otaa064. PMID: 36776498; PMCID: PMC9802466.
      Citations: 8     
    376. Ollech JE, Normatov I, Peleg N, Dalal SR, Pekow J, Micic D, Cohen RD, Rubin DT, Sakuraba A. Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116. PMID: 32710391.
      Citations: 2     Fields:    Translation:Humans
    377. Sofia MA, Lipowska AM, Zmeter N, Perez E, Kavitt R, Rubin DT. Poor Sleep Quality in Crohn's Disease Is Associated With Disease Activity and Risk for Hospitalization or Surgery. Inflamm Bowel Dis. 2020 07 17; 26(8):1251-1259. PMID: 31820780; PMCID: PMC7365809.
      Citations: 22     Fields:    Translation:Humans
    378. Anyane-Yeboa A, Li B, Traboulsi C, Erondu AI, Sossenheimer P, Rai V, Rubin DT. Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea. Dig Dis Sci. 2021 07; 66(7):2200-2206. PMID: 32638203.
      Citations: 8     Fields:    Translation:Humans
    379. Deepak P, Alayo QA, Khatiwada A, Lin B, Fenster M, Dimopoulos C, Bader G, Weisshof R, Jacobs M, Gutierrez A, Ciorba MA, Christophi GP, Patel A, Hirten RP, Colombel JF, Rubin DT, Ha C, Beniwal-Patel P, Ungaro RC, Syal G, Pekow J, Cohen BL, Yarur A. Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021 08; 19(8):1592-1601.e3. PMID: 32629130; PMCID: PMC7779667.
      Citations: 41     Fields:    Translation:Humans
    380. Rubin D, Huang J, Fisher BT, Gasparrini A, Tam V, Song L, Wang X, Kaufman J, Fitzpatrick K, Jain A, Griffis H, Crammer K, Morris J, Tasian G. Association of Social Distancing, Population Density, and Temperature With the Instantaneous Reproduction Number of SARS-CoV-2 in Counties Across the United States. JAMA Netw Open. 2020 07 01; 3(7):e2016099. PMID: 32701162; PMCID: PMC7378754.
      Citations: 88     Fields:    Translation:HumansCellsPHPublic Health
    381. Rosen MH, Axelrad J, Hudesman D, Rubin DT, Chang S. Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature. Inflamm Bowel Dis. 2020 06 18; 26(7):971-973. PMID: 32393973; PMCID: PMC7239163.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    382. Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA. Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflamm Bowel Dis. 2020 06 18; 26(7):1118. PMID: 32374862; PMCID: PMC7301401.
      Citations: 7     Fields:    
    383. Neumann H, Bokemeyer B, Guda N, Tajiri H, Matsumoto T, Rubin DT, Emura F. Practical advice for management of inflammatory bowel diseases patients during the COVID-19 pandemic: World Endoscopy Organization Statement. Dig Endosc. 2020 Jul; 32(5):658-662. PMID: 32369646.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    384. Al-Ani AH, Prentice RE, Rentsch CA, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae FA, Ng SC, Rubin DT, Christensen B. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther. 2020 07; 52(1):54-72. PMID: 32348598; PMCID: PMC7267115.
      Citations: 65     Fields:    Translation:HumansCellsPHPublic Health
    385. Gondal B, Haider H, Komaki Y, Komaki F, Micic D, Rubin DT, Sakuraba A. Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: A systematic review and network meta-analysis. World J Gastrointest Endosc. 2020 May 16; 12(5):159-171. PMID: 32477450; PMCID: PMC7243576.
      Citations: 9     
    386. Wang J, Prenner J, Wang W, Sakuraba A, Hyman N, Dalal S, Hurst R, Cohen RD, Umanskiy K, Shogan BD, Alpert L, Rubin DT, Colwell J, Pekow J. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020 06; 51(12):1365-1372. PMID: 32383278.
      Citations: 5     Fields:    Translation:Humans
    387. Rubin GA, Biviano A, Dizon J, Yarmohammadi H, Ehlert F, Saluja D, Rubin DA, Morrow JP, Waase M, Berman J, Kushnir A, Abrams MP, Garan H, Wan EY. Performance of electrophysiology procedures at an academic medical center amidst the 2020 coronavirus (COVID-19) pandemic. J Cardiovasc Electrophysiol. 2020 06; 31(6):1249-1254. PMID: 32281214; PMCID: PMC7262273.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    388. Rubin DT, Feuerstein JD, Wang AY, Cohen RD. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Gastroenterology. 2020 Jul; 159(1):350-357. PMID: 32283100; PMCID: PMC7151253.
      Citations: 143     Fields:    Translation:HumansCellsPHPublic Health
    389. Rubin DT, Abreu MT, Rai V, Siegel CA, International Organization for the Study of Inflammatory Bowel Disease. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. Gastroenterology. 2020 Jul; 159(1):6-13.e6. PMID: 32272113; PMCID: PMC7194599.
      Citations: 114     Fields:    Translation:HumansCellsPHPublic Health
    390. Akiyama S, Traboulsi C, Rai V, Rubin DT. Re: 18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial. Eur J Nucl Med Mol Imaging. 2020 09; 47(10):2247. PMID: 32242252.
      Citations: 1     Fields:    Translation:Humans
    391. Sharp D, Ringer S, Park KT, Tole S, Rubin DT, Regueiro M. Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases. Crohns Colitis 360. 2020 Jan; 2(1):otaa011. PMID: 36777962; PMCID: PMC9802181.
      Citations: 4     
    392. Kelleher KJ, Rubin D, Hoagwood K. Policy and Practice Innovations to Improve Prescribing of Psychoactive Medications for Children. Psychiatr Serv. 2020 07 01; 71(7):706-712. PMID: 32188362.
      Citations: 5     Fields:    Translation:Humans
    393. Ollech JE, Normatov I, Peleg N, Wang J, Patel SA, Rai V, Yi Y, Singer J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2021 01; 19(1):104-110. PMID: 32109634; PMCID: PMC8665415.
      Citations: 47     Fields:    Translation:Humans
    394. Panchal H, Shamsunder MG, Sheinin A, Sheckter CC, Berlin NL, Nelson JA, Allen R, Rubin D, Kozlow JH, Matros E. Impact of Physician Payments on Microvascular Breast Reconstruction: An All-Payer Claim Database Analysis. Plast Reconstr Surg. 2020 Feb; 145(2):333-339. PMID: 31985616; PMCID: PMC7048410.
      Citations: 4     Fields:    Translation:Humans
    395. Rao VL, Feld LD, Rubin DT. Periendoscopic code status. Gastrointest Endosc. 2020 02; 91(2):453. PMID: 32036948.
      Citations:    Fields:    Translation:Humans
    396. Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT. Inpatient Management of Inflammatory Bowel Disease-Related Complications. Clin Gastroenterol Hepatol. 2020 05; 18(6):1346-1355. PMID: 31927105.
      Citations: 23     Fields:    Translation:Humans
    397. Lewis JD, Rutgeerts P, Feagan BG, D'haens G, Danese S, Colombel JF, Reinisch W, Rubin DT, Selinger C, Bewtra M, Barcomb L, Lacerda AP, Wallace K, Butler JW, Wu M, Zhou Q, Liao X, Sandborn WJ. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease. Inflamm Bowel Dis. 2020 01 06; 26(2):304-313. PMID: 31644790.
      Citations: 30     Fields:    Translation:Humans
    398. Gaines S, Hyoju S, Williamson AJ, van Praagh JB, Zaborina O, Rubin DT, Alverdy JC, Shogan BD, Hyman N. Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis. J Gastrointest Surg. 2020 11; 24(11):2637-2642. PMID: 31898107; PMCID: PMC7931774.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    399. Pasha SF, Pennazio M, Rondonotti E, Wolf D, Buras MR, Cohen SA, D'Haens G, Eliakim R, Rubin DT, Leighton JA, Albert JG, Cotter J. Capsule Retention in Crohn's Disease: A Meta-analysis. Inflamm Bowel Dis. 2020 01 01; 26(1):33-42. PMID: 31050736.
      Citations: 32     Fields:    Translation:Humans
    400. Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflamm Bowel Dis. 2020 01 01; 26(1):1-10. PMID: 31112238; PMCID: PMC7534391.
      Citations: 234     Fields:    Translation:Humans
    401. Ollech JE, Dwadasi S, Rai V, Peleg N, Normatov I, Israel A, Sossenheimer PH, Christensen B, Pekow J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis. Aliment Pharmacol Ther. 2020 03; 51(6):637-643. PMID: 31875986.
      Citations: 34     Fields:    Translation:Humans
    402. Christensen B, Erlich J, Gibson PR, Turner JR, Hart J, Rubin DT. Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing. Clin Gastroenterol Hepatol. 2020 10; 18(11):2518-2525.e1. PMID: 31812654; PMCID: PMC7586726.
      Citations: 35     Fields:    Translation:Humans
    403. Lei DK, Ollech JE, Andersen M, Weisshof R, Zmeter N, Sossenheimer P, Rubin DT. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence. Am J Gastroenterol. 2019 12; 114(12):1904-1908. PMID: 31714359.
      Citations: 18     Fields:    Translation:HumansCells
    404. Rubin DT. Restarting Biologic Agents After a Drug Holiday. Gastroenterol Hepatol (N Y). 2019 Nov; 15(11):612-615. PMID: 31802986; PMCID: PMC6883732.
      Citations: 9     
    405. Bertucci Zoccali M, Hyman NH, Skowron KB, Rubin M, Cannon LM, Hurst RD, Umanskiy K, Rubin DT, Shogan BD. Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis. Dis Colon Rectum. 2019 11; 62(11):1344-1351. PMID: 31596761.
      Citations: 17     Fields:    Translation:Humans
    406. Micic D, Rao VL, Rubin DT. Clinical Approach to Lactose Intolerance. JAMA. 2019 Oct 22; 322(16):1600-1601. PMID: 31556907.
      Citations: 5     Fields:    
    407. Glick LR, Sossenheimer PH, Ollech JE, Cohen RD, Hyman NH, Hurst RD, Rubin DT. Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study. J Crohns Colitis. 2019 Sep 19; 13(9):1158-1162. PMID: 30809655; PMCID: PMC6939874.
      Citations: 23     Fields:    Translation:HumansPHPublic Health
    408. Weisshof R, Ollech JE, El Jurdi K, Yvellez OV, Cohen RD, Sakuraba A, Dalal S, Pekow J, Rubin DT. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe. J Crohns Colitis. 2019 Sep 19; 13(9):1105-1110. PMID: 30726894; PMCID: PMC7327272.
      Citations: 17     Fields:    Translation:Humans
    409. Brixner D, Mittal M, Rubin DT, Mease P, Liu HH, Davis M, Ganguli A, Fendrick AM. Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population. Patient Prefer Adherence. 2019; 13:1545-1556. PMID: 31571837; PMCID: PMC6750846.
      Citations: 12     
    410. Wang W, Cleveland NK, Ollech J, Rubin DT. Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis. ACG Case Rep J. 2019 Sep; 6(9):e00226. PMID: 31750389; PMCID: PMC6831149.
      Citations: 8     
    411. Malter LB, Israel A, Rubin DT. Proposal to Update the Curriculum in Inflammatory Bowel Diseases for Categorical Gastroenterology Fellows. Inflamm Bowel Dis. 2019 08 20; 25(9):1443-1449. PMID: 31115448.
      Citations: 4     Fields:    Translation:Humans
    412. Buisson A, Mak WY, Andersen MJ, Lei D, Kahn SA, Pekow J, Cohen RD, Zmeter N, Rubin DT, Pereira B. Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2019 Aug 14; 13(8):1012-1024. PMID: 30726887; PMCID: PMC6939876.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    413. Pekow J, Hernandez K, Meckel K, Deng Z, Haider HI, Khalil A, Zhang C, Talisila N, Siva S, Jasmine F, Li YC, Rubin DT, Hyman N, Bissonnette M, Weber C, Kibriya MG. IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers. J Crohns Colitis. 2019 Jul 25; 13(7):884-893. PMID: 30753380; PMCID: PMC7327274.
      Citations: 15     Fields:    Translation:HumansCells
    414. Wang Y, Wang J, Pekow J, Dalal S, Cohen RD, Ollech J, Israel A, Shogan BD, Micic D, Cannon L, Umanskiy K, Hurst R, Hyman N, Rubin DT, Sakuraba A. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095. PMID: 31169926.
      Citations: 6     Fields:    Translation:Humans
    415. Israel A, Christensen B, El Jurdi K, Rai V, Ollech JE, Cohen RD, Sakuraba A, Dalal SR, Rubin DT. Follow-Up of Patients With Ulcerative Colitis and Histological Normalization. Clin Gastroenterol Hepatol. 2020 04; 18(4):987-988.e1. PMID: 31228567; PMCID: PMC6923607.
      Citations: 3     Fields:    Translation:Humans
    416. Ollech JE, Rubin DT, Glick L, Weisshof R, El Jurdi K, Israel A, Krugliak Cleveland N, Hyman N, Sakuraba A, Pekow J, Cohen RD, Dalal SR. Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. Dig Dis Sci. 2019 12; 64(12):3596-3601. PMID: 31187322; PMCID: PMC6858501.
      Citations: 32     Fields:    Translation:Humans
    417. Boeri M, Myers K, Ervin C, Marren A, DiBonaventura M, Cappelleri JC, Hauber B, Rubin DT. Patient and physician preferences for ulcerative colitis treatments in the United States. Clin Exp Gastroenterol. 2019; 12:263-278. PMID: 31354328; PMCID: PMC6572717.
      Citations: 27     
    418. Israel A, Jurdi KE, Rubin DT. Treatment De-Escalation in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2019 Jun; 15(6):335-341. PMID: 31391803; PMCID: PMC6676361.
      Citations: 4     
    419. Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Heller CA, Hurtado-Lorenzo A. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis. 2019 05 16; 25(Suppl 2):S40-S47. PMID: 31095704.
      Citations: 17     Fields:    Translation:Humans
    420. Brixner D, Rubin DT, Mease P, Mittal M, Liu H, Davis M, Ganguli A, Fendrick AM. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. J Manag Care Spec Pharm. 2019 Jul; 25(7):770-779. PMID: 31081461; PMCID: PMC10398065.
      Citations: 30     Fields:    Translation:Humans
    421. Alpert L, Yassan L, Poon R, Kadri S, Niu N, Patil SA, Mujacic I, Montes D, Galbo F, Wurst MN, Zhen CJ, Cohen RD, Rubin DT, Pekow JR, Weber CR, Xiao SY, Hart J, Segal J, Setia N. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Hum Pathol. 2019 07; 89:44-50. PMID: 31054900.
      Citations: 12     Fields:    Translation:Humans
    422. Long MD, Rubin DT. Histologic Remission in Ulcerative Colitis: Are We There Yet? Am J Gastroenterol. 2019 05; 114(5):713-715. PMID: 31021831.
      Citations: 3     Fields:    Translation:Humans
    423. He L, Du J, Chen Y, Liu C, Zhou M, Adhikari S, Rubin DT, Pekow J, Li YC. Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway. Am J Physiol Gastrointest Liver Physiol. 2019 06 01; 316(6):G774-G784. PMID: 30995068; PMCID: PMC6620584.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    424. Dwadasi S, Israel A, Rubin DT. The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know? Gastrointest Endosc Clin N Am. 2019 Jul; 29(3):405-419. PMID: 31078244.
      Citations:    Fields:    Translation:Humans
    425. Aharoni Golan M, Weisshof R, Wang Y, Rubin DT. New Diagnosis of Acquired Immunodeficiency Syndrome in a Patient With Crohn's Disease. ACG Case Rep J. 2019 Apr; 6(4):e00056. PMID: 31616737; PMCID: PMC6658050.
      Citations: 2     
    426. Sossenheimer PH, Glick LR, Dachman AH, Skowron KB, Rubin MA, Umanskiy K, Smith R, Cannon LM, Hurst RD, Cohen RD, Hyman NH, Rubin DT. Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients. Dis Colon Rectum. 2019 04; 62(4):463-469. PMID: 30540661.
      Citations: 13     Fields:    Translation:Humans
    427. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 03; 114(3):384-413. PMID: 30840605.
      Citations: 738     Fields:    Translation:Humans
    428. Rao VL, Feld LD, Rubin DT. Discussion of Code Status in the Peri-Endoscopic Period. Am J Gastroenterol. 2019 03; 114(3):372-374. PMID: 30333550.
      Citations: 1     Fields:    Translation:Humans
    429. Swaminath A, Berlin EP, Cheifetz A, Hoffenberg E, Kinnucan J, Wingate L, Buchanan S, Zmeter N, Rubin DT. The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information. Inflamm Bowel Dis. 2019 02 21; 25(3):427-435. PMID: 30358848; PMCID: PMC7534377.
      Citations: 25     Fields:    Translation:Humans
    430. Weisshof R, Aharoni Golan M, Sossenheimer PH, El Jurdi K, Ollech JE, Pekow J, Cohen RD, Sakuraba A, Dalal S, Rubin DT. Real-World Experience with Tofacitinib in IBD at a Tertiary Center. Dig Dis Sci. 2019 07; 64(7):1945-1951. PMID: 30734234; PMCID: PMC6935176.
      Citations: 47     Fields:    Translation:Humans
    431. Ollech JE, Aharoni-Golan M, Weisshof R, Normatov I, Sapp AR, Kalakonda A, Israel A, Glick LR, Karrison T, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease. Gastrointest Endosc. 2019 08; 90(2):269-275. PMID: 30738034; PMCID: PMC6774247.
      Citations: 19     Fields:    Translation:Humans
    432. Borden BA, Lee SM, Danahey K, Galecki P, Patrick-Miller L, Siegler M, Sorrentino MJ, Sacro Y, Davis AM, Rubin DT, Lipstreuer K, Polonsky TS, Nanda R, Harper WR, Koyner JL, Burnet DL, Stadler WM, Kavitt RT, Meltzer DO, Ratain MJ, O'Donnell PH. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537. PMID: 30713337; PMCID: PMC6980369.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    433. Feagan BG, Sandborn WJ, Byrne SO, Khalid JM, Kempf C, Geransar P, Bhayat F, Rubin DT, Colombel JF. Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials. J Crohns Colitis. 2019 Jan 01; 13(1):50-57. PMID: 30203005; PMCID: PMC6302953.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    434. Lindsay JO, Sands BE, Su C, Friedman G, Zhang H, Yarlas A, Bayliss M, Maher S, Cappelleri JC, Bushmakin AG, Rubin DT, Panés J, Vermeire S. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. J Crohns Colitis. 2019 01 01; 13(1):139-140. PMID: 30412228; PMCID: PMC6302951.
      Citations: 4     Fields:    
    435. Micic D, Komaki Y, Alavanja A, Rubin DT, Sakuraba A. Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies. J Clin Gastroenterol. 2019 01; 53(1):e1-e11. PMID: 28737645; PMCID: PMC5776073.
      Citations: 19     Fields:    Translation:Humans
    436. Feld LD, Rubin DT, Feld AD. Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer. Am J Gastroenterol. 2018 11; 113(11):1577-1579. PMID: 30008471.
      Citations: 3     Fields:    Translation:Humans
    437. Weisshof R, El Jurdi K, Zmeter N, Rubin DT. Emerging Therapies for Inflammatory Bowel Disease. Adv Ther. 2018 11; 35(11):1746-1762. PMID: 30374806; PMCID: PMC6224002.
      Citations: 40     Fields:    Translation:Humans
    438. Reinisch W, Gottlieb K, Colombel JF, Danese S, Panaccione R, Panes J, Peyrin-Biroulet L, Rubin D, Sands BE, Vermeire S, Mulberg A, Sandborn B, Schreiber S. Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development. Clin Gastroenterol Hepatol. 2019 08; 17(9):1673-1679.e1. PMID: 31352970.
      Citations: 15     Fields:    Translation:Humans
    439. Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT. Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 10; 63(10):2815. PMID: 30136047.
      Citations:    Fields:    
    440. Sheckter CC, Panchal HJ, Razdan SN, Rubin D, Yi D, Disa JJ, Mehrara B, Matros E. The Influence of Physician Payments on the Method of Breast Reconstruction: A National Claims Analysis. Plast Reconstr Surg. 2018 10; 142(4):434e-442e. PMID: 29979366; PMCID: PMC6156943.
      Citations: 14     Fields:    Translation:Humans
    441. Krugliak Cleveland N, Rubin DT. Response. Gastrointest Endosc. 2018 10; 88(4):783-784. PMID: 30217250.
      Citations:    Fields:    
    442. Colman RJ, Lawton RC, Dubinsky MC, Rubin DT. Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2018 09 15; 24(10):2135-2141. PMID: 29688409; PMCID: PMC6994018.
      Citations: 11     Fields:    Translation:Humans
    443. Raffals LE, Nguyen GC, Rubin DT. Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 04; 17(5):818-823. PMID: 30196164.
      Citations: 9     Fields:    Translation:Humans
    444. Anyane-Yeboa A, Yamada A, Haider H, Wang Y, Komaki Y, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease. Aliment Pharmacol Ther. 2018 11; 48(9):933-940. PMID: 30126019; PMCID: PMC6669906.
      Citations: 7     Fields:    Translation:Humans
    445. Melmed GY, Dubinsky MC, Rubin DT, Fleisher M, Pasha SF, Sakuraba A, Tiongco F, Shafran I, Fernandez-Urien I, Papageorgiou NP, Leighton JA, Rosa B. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study. Gastrointest Endosc. 2018 12; 88(6):947-955.e2. PMID: 30086261.
      Citations: 18     Fields:    Translation:Humans
    446. Wang J, Bhatia A, Krugliak Cleveland N, Gupta N, Dalal S, Rubin DT, Sakuraba A. Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion. ACG Case Rep J. 2018; 5:e56. PMID: 30105273; PMCID: PMC6072803.
      Citations: 35     
    447. Micic D, Hirsch A, Setia N, Rubin DT. Enteric infections complicating ulcerative colitis. Intest Res. 2018 Jul; 16(3):489-493. PMID: 30090049; PMCID: PMC6077301.
      Citations: 5     
    448. Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases. J Clin Gastroenterol. 2018 07; 52(6):537-544. PMID: 28723860.
      Citations: 7     Fields:    Translation:HumansCells
    449. Schöffel N, Liehr RM, Bünger C, Krüger K, Rubin D. [Nephrotic syndrome and microhematuria in a patient with nutcracker syndrome: Report of a case and review of the literature]. Internist (Berl). 2018 06; 59(6):608-614. PMID: 29181552.
      Citations:    Fields:    Translation:Humans
    450. Patel P, Yarur A, Dalal S, Sakuraba A, Rubin DT, Hanauer SB, Hanan I, Raffals LH, Cohen RD, Pekow J. Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy. Inflamm Bowel Dis. 2018 05 18; 24(6):1291-1297. PMID: 29506124; PMCID: PMC7190889.
      Citations: 1     Fields:    Translation:Humans
    451. Christensen B, Gibson PR, Micic D, Colman RJ, Goeppinger SR, Kassim O, Yarur A, Weber CR, Cohen RD, Rubin DT. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 02; 17(3):486-493. PMID: 29751166; PMCID: PMC7034423.
      Citations: 43     Fields:    Translation:Humans
    452. Krugliak Cleveland N, Ollech JE, Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Hurst R, Rubin DT. Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia. Clin Gastroenterol Hepatol. 2019 01; 17(1):205-206. PMID: 29751167; PMCID: PMC7034413.
      Citations: 13     Fields:    Translation:Humans
    453. Christensen B, Gibson PR, Rubin DT. Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply. Aliment Pharmacol Ther. 2018 05; 47(10):1423-1424. PMID: 29676007.
      Citations: 3     Fields:    Translation:Humans
    454. Feagan BG, Schwartz D, Danese S, Rubin DT, Lissoos TW, Xu J, Lasch K. Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2. J Crohns Colitis. 2018 Apr 27; 12(5):621-626. PMID: 29471381; PMCID: PMC6018899.
      Citations: 50     Fields:    Translation:HumansCTClinical Trials
    455. Weisshof R, Golan MA, Yvellez OV, Rubin DT. The use of tofacitinib in the treatment of inflammatory bowel disease. Immunotherapy. 2018 08; 10(10):837-849. PMID: 29701124.
      Citations: 2     Fields:    Translation:Humans
    456. Yarlas A, Rubin DT, Lindsay JO, Bayliss M, Cappelleri JC, Maher S, Bushmakin AG, Chen LA, DiBonaventura M, Panés J, Vermeire S. Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey. J Crohns Colitis. 2018 Apr 27; 12(5):600-609. PMID: 29718244.
      Citations: 44     Fields:    Translation:Humans
    457. Pekow J, Meckel K, Dougherty U, Haider HI, Deng Z, Hart J, Rubin DT, Bissonnette M. Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis. Oncotarget. 2018 Apr 17; 9(29):20709-20720. PMID: 29755683; PMCID: PMC5945498.
      Citations: 4     Fields:    
    458. Skowron KB, Shogan BD, Rubin DT, Hyman NH. The New Frontier: the Intestinal Microbiome and Surgery. J Gastrointest Surg. 2018 07; 22(7):1277-1285. PMID: 29633119.
      Citations: 8     Fields:    Translation:Humans
    459. Wali RK, Bianchi L, Kupfer S, De La Cruz M, Jovanovic B, Weber C, Goldberg MJ, Rodriguez LM, Bergan R, Rubin D, Tull MB, Richmond E, Parker B, Khan S, Roy HK. Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial. PLoS One. 2018; 13(4):e0193544. PMID: 29617381; PMCID: PMC5884487.
      Citations:    Fields:    Translation:Humans
    460. Danese S, Bonovas S, Fiorino G, Sandborn WJ, Rubin DT, Kamm MA, Colombel JF, Sands BE, Vermeire S, Rogler G, D'Haens G, Lopez A, Panes J, Peyrin-Biroulet L. Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease. Gastroenterology. 2018 07; 155(1):76-87. PMID: 29601825.
      Citations: 20     Fields:    Translation:Humans
    461. Christensen B, Colman RJ, Micic D, Gibson PR, Goeppinger SR, Yarur A, Weber CR, Cohen RD, Rubin DT. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860. PMID: 29562271; PMCID: PMC6196763.
      Citations: 20     Fields:    Translation:Humans
    462. Mak WY, Buisson A, Andersen MJ, Lei D, Pekow J, Cohen RD, Kahn SA, Rubin DT, Pereira B. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Dig Dis Sci. 2018 May; 63(5):1294-1301. PMID: 29468374.
      Citations: 28     Fields:    Translation:Humans
    463. Yamada A, Komaki Y, Patel N, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Inflamm Bowel Dis. 2018 02 15; 24(3):502-509. PMID: 29462385.
      Citations: 28     Fields:    Translation:HumansPHPublic Health
    464. Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024. PMID: 29417331.
      Citations: 8     Fields:    Translation:HumansCells
    465. Christensen B, Micic D, Gibson PR, Yarur A, Bellaguarda E, Corsello P, Gaetano JN, Kinnucan J, Rao VL, Reddy S, Singh S, Pekow J, Rubin DT. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762. PMID: 29377235; PMCID: PMC5821055.
      Citations: 25     Fields:    Translation:Humans
    466. Lindsay JO, Sands BE, Su C, Friedman G, Zhang H, Yarlas A, Bayliss M, Maher S, Cappelleri JC, Bushmakin AG, Rubin DT, Panés J, Vermeire S. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. J Crohns Colitis. 2018 Jan 24; 12(2):145-156. PMID: 29028981; PMCID: PMC5881763.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    467. Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointest Endosc. 2018 May; 87(5):1304-1309. PMID: 29307473; PMCID: PMC9646239.
      Citations: 4     Fields:    Translation:Humans
    468. Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 12 04; 11(12):1510. PMID: 28453665; PMCID: PMC5951008.
      Citations:    Fields:    
    469. Rubin DT, Gomberg A. Meet the Master: Joseph Barnett Kirsner (1909-2012). VideoGIE. 2017 Dec; 2(12):323-325. PMID: 29916487; PMCID: PMC6004029.
      Citations:    
    470. Rubin DT. Recent Research on Joint Pain and Arthritis in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Nov; 13(11):688-690. PMID: 29230148; PMCID: PMC5717884.
      Citations: 4     
    471. Castro A, Raver C, Li Y, Uddin O, Rubin D, Ji Y, Masri R, Keller A. Cortical Regulation of Nociception of the Trigeminal Nucleus Caudalis. J Neurosci. 2017 11 22; 37(47):11431-11440. PMID: 29066554; PMCID: PMC5700425.
      Citations: 15     Fields:    Translation:AnimalsCells
    472. Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, Castaño-Rodríguez N. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis. 2017 Oct 01; 11(10):1180-1199. PMID: 28486648.
      Citations: 226     Fields:    Translation:Humans
    473. Gibofsky A, Skup M, Mittal M, Johnson SJ, Davis M, Chao J, Rubin DT. Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors. Curr Med Res Opin. 2017 11; 33(11):1945-1953. PMID: 28870101.
      Citations: 12     Fields:    Translation:Humans
    474. Micic D, Gaetano JN, Rubin JN, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900. PMID: 28837634; PMCID: PMC5570509.
      Citations: 22     Fields:    Translation:Humans
    475. Hutchison AL, Meckel K, Harrington K, Deng Z, Talasila N, Rubin DT, Hanauer SB, Hurst R, Umanskiy K, Fichera A, Hart J, Dinner AR, Bissonnette M, Pekow J. miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling. Inflamm Bowel Dis. 2017 08; 23(8):1328-1337. PMID: 28594651; PMCID: PMC5535754.
      Citations: 18     Fields:    Translation:HumansCells
    476. Krugliak Cleveland N, Rubin DT, Hart J, Weber CR, Meckel K, Tran AL, Aelvoet AS, Pan I, Gonsalves A, Gaetano JN, Williams KM, Wroblewski K, Jabri B, Pekow J. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):68-74. PMID: 28756053; PMCID: PMC5735030.
      Citations: 25     Fields:    Translation:Humans
    477. Yamada A, Komaki Y, Patel N, Komaki F, Aelvoet AS, Tran AL, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab. Am J Gastroenterol. 2017 Sep; 112(9):1423-1429. PMID: 28719595.
      Citations: 37     Fields:    Translation:Humans
    478. Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 Jul 01; 11(7):785-791. PMID: 28333362; PMCID: PMC5881669.
      Citations: 30     Fields:    Translation:Humans
    479. O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJ. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869. PMID: 28398598; PMCID: PMC5636653.
      Citations: 39     Fields:    Translation:Humans
    480. Pekow J, Meckel K, Dougherty U, Huang Y, Chen X, Almoghrabi A, Mustafi R, Ayaloglu-Butun F, Deng Z, Haider HI, Hart J, Rubin DT, Kwon JH, Bissonnette M. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clin Cancer Res. 2017 Sep 01; 23(17):5281-5291. PMID: 28600480; PMCID: PMC5581687.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    481. Lee STM, Kahn SA, Delmont TO, Shaiber A, Hubert NA, Morrison HG, Antonopoulos DA, Rubin DT, Eren AM, Esen ÖC. Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome. 2017 05 04; 5(1):50. PMID: 28473000; PMCID: PMC5418705.
      Citations: 49     Fields:    Translation:HumansCells
    482. Ruhnke GW, Manning WG, Rubin DT, Meltzer DO. The Drivers of Discretionary Utilization: Clinical History Versus Physician Supply. Acad Med. 2017 05; 92(5):703-708. PMID: 28441679; PMCID: PMC5407298.
      Citations: 2     Fields:    Translation:Humans
    483. Patel H, Lissoos T, Rubin DT. Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States. PLoS One. 2017; 12(4):e0175099. PMID: 28426675; PMCID: PMC5398513.
      Citations: 21     Fields:    Translation:Humans
    484. McKillip RP, Borden BA, Galecki P, Ham SA, Patrick-Miller L, Hall JP, Hussain S, Danahey K, Siegler M, Sorrentino MJ, Sacro Y, Davis AM, Rubin DT, Lipstreuer K, Polonsky TS, Nanda R, Harper WR, Koyner JL, Burnet DL, Stadler WM, Ratain MJ, Meltzer DO, O'Donnell PH. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Clin Pharmacol Ther. 2017 07; 102(1):106-114. PMID: 27981566; PMCID: PMC5474215.
      Citations: 14     Fields:    Translation:Humans
    485. Loftus EV, Feagan BG, Vermeire S, Sandborn WJ, Sands BE, Danese S, D'Haens GR, Kaser A, Panaccione R, Rubin DT, Shafran I, McAuliffe M, Kaviya A, Sankoh S, Mody R, Abhyankar B, Smyth M, Colombel JF. Long-term Efficacy of Vedolizumab for Ulcerative Colitis. J Crohns Colitis. 2017 Apr 01; 11(4):400-411. PMID: 27683800.
      Citations: 104     Fields:    Translation:HumansCTClinical Trials
    486. Vermeire S, Loftus EV, Feagan BG, Sandborn WJ, Sands BE, Danese S, D'Haens GR, Kaser A, Panaccione R, Rubin DT, Shafran I, McAuliffe M, Kaviya A, Sankoh S, Mody R, Abhyankar B, Smyth M, Colombel JF. Long-term Efficacy of Vedolizumab for Crohn's Disease. J Crohns Colitis. 2017 Apr 01; 11(4):412-424. PMID: 27683798.
      Citations: 103     Fields:    Translation:Humans
    487. Sofia MA, Rubin DT. The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions. Dig Dis Sci. 2017 04; 62(4):833-842. PMID: 28197743.
      Citations: 3     Fields:    Translation:HumansAnimals
    488. Dubinsky MC, Martino S, Hewett KA, Rubin DT, Panés J. Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits. Inflamm Bowel Dis. 2017 04; 23(4):494-501. PMID: 28296817; PMCID: PMC5495553.
      Citations: 30     Fields:    Translation:Humans
    489. Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis. J Manag Care Spec Pharm. 2017 Aug; 23(8):859-867. PMID: 28737994; PMCID: PMC10397981.
      Citations: 43     Fields:    Translation:Humans
    490. Rubin DT, Naik S, Kondragunta V, Rao T, Jain A. Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay. Curr Med Res Opin. 2017 May; 33(5):837-843. PMID: 28145781.
      Citations: 2     Fields:    Translation:Humans
    491. Dalal S, Antonopoulos D, Hubert N, Raffals LH, Dolan K, Weber C, Messer JS, Jabri B, Bendelac A, Eren AM, Rubin DT, Sogin M, Chang EB, Huang Y. Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. Inflamm Bowel Dis. 2017 03; 23(3):366-378. PMID: 28221248; PMCID: PMC5988644.
      Citations: 22     Fields:    Translation:HumansCells
    492. Christensen B, Hanauer SB, Erlich J, Kassim O, Gibson PR, Turner JR, Hart J, Rubin DT. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes. Clin Gastroenterol Hepatol. 2017 Oct; 15(10):1557-1564.e1. PMID: 28238954; PMCID: PMC5618439.
      Citations: 83     Fields:    Translation:Humans
    493. Huang Y, Dalal S, Antonopoulos D, Hubert N, Raffals LH, Dolan K, Weber C, Messer JS, Jabri B, Bendelac A, Eren AM, Rubin DT, Sogin M, Chang EB. Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. Inflamm Bowel Dis. 2017 Feb 13. PMID: 28248733.
      Citations:    
    494. Feld LD, Goeppinger SR, Margolese J, Rosh J, Rubin M, Kim S, Rodriquez DM, Wingate L, Rubin DT. The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access. Inflamm Bowel Dis. 2017 02; 23(2):224-232. PMID: 27997434.
      Citations: 20     Fields:    Translation:Humans
    495. Sofia MA, Sakuraba A, Rubin DT. Two Complex Cases of Hermansky-Pudlak Syndrome Highlight a Potential Biologic Explanation for an Associated Crohn's Disease Phenotype. ACG Case Rep J. 2017; 4:e14. PMID: 28144619; PMCID: PMC5247631.
      Citations: 6     
    496. Rubin DT, Patel H, Shi S, Mody R. Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn's disease in the United States: a claims data analysis. Curr Med Res Opin. 2017 03; 33(3):529-536. PMID: 27903084.
      Citations: 4     Fields:    Translation:Humans
    497. Rubin DT, Gulotta G, Wroblewski K, Pekow J, Siva S. Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 01; 23(1):152-157. PMID: 27930412; PMCID: PMC5177471.
      Citations: 82     Fields:    Translation:Humans
    498. Paramsothy S, Cleveland NK, Zmeter N, Rubin DT. The Role of Biosimilars in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Dec; 12(12):741-751. PMID: 28035201; PMCID: PMC5193082.
      Citations: 6     
    499. Rubin DT, Krugliak Cleveland N, Rodriquez DM. Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center. Gastrointest Endosc. 2016 12; 84(6):1078-1079. PMID: 27855794.
      Citations: 3     Fields:    Translation:Humans
    500. Feagan BG, Patel H, Colombel JF, Rubin DT, James A, Mody R, Lasch K. Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial. Aliment Pharmacol Ther. 2017 01; 45(2):264-275. PMID: 27859410; PMCID: PMC5215718.
      Citations: 26     Fields:    Translation:Humans
    501. Vineis JH, Ringus DL, Morrison HG, Delmont TO, Dalal S, Raffals LH, Antonopoulos DA, Rubin DT, Eren AM, Chang EB, Sogin ML. Patient-Specific Bacteroides Genome Variants in Pouchitis. mBio. 2016 11 15; 7(6). PMID: 27935837; PMCID: PMC5111406.
      Citations: 26     Fields:    Translation:HumansCells
    502. Baker JC, Kyriakos M, McDonald DJ, Rubin DA. Primary Rosai-Dorfman disease of the femur. Skeletal Radiol. 2017 Jan; 46(1):129-135. PMID: 27785544.
      Citations: 12     Fields:    Translation:Humans
    503. Feagan BG, Rubin DT, Danese S, Vermeire S, Abhyankar B, Sankoh S, James A, Smyth M. Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists. Clin Gastroenterol Hepatol. 2017 02; 15(2):229-239.e5. PMID: 27639327.
      Citations: 107     Fields:    Translation:Humans
    504. Cleveland NK, Rodriquez D, Wichman A, Pan I, Melmed GY, Rubin DT. Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis. Dig Dis Sci. 2016 10; 61(10):2972-2976. PMID: 27557706.
      Citations: 21     Fields:    Translation:HumansCells
    505. Griffis H, Matone M, Kellom K, Concors E, Quarshie W, French B, Rubin D, Cronholm PF. Home visiting and perinatal smoking: a mixed-methods exploration of cessation and harm reduction strategies. BMC Public Health. 2016 08 11; 16(1):764. PMID: 27514836; PMCID: PMC4982407.
      Citations: 1     Fields:    Translation:Humans
    506. Lee SD, Rubin DT, Sandborn WJ, Randall C, Younes Z, Schreiber S, Schwartz DA, Burakoff R, Binion D, Dassopoulos T, Arsenescu R, Gutierrez A, Scherl E, Kayhan C, Hasan I, Kosutic G, Spearman M, Sen D, Coarse J, Hanauer S. Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study. Inflamm Bowel Dis. 2016 08; 22(8):1870-80. PMID: 27400222; PMCID: PMC4949014.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    507. Rubin DT. Home Sweet Home? Will Medical Homes Be Coming to Your Neighborhood Sometime Soon? Inflamm Bowel Dis. 2016 08; 22(8):1981-3. PMID: 27416047.
      Citations: 1     Fields:    Translation:Humans
    508. Sandborn WJ, Rubin DT, Harper JR, Bosworth BP. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies. Inflamm Bowel Dis. 2016 08; 22(8):1881-6. PMID: 27416045; PMCID: PMC4949012.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    509. Lawler D, Becker J, Reetz J, Goodmann P, Evans R, Rubin D, Tangredi B, Widga C, Sackman J, Martin T, Kohn L, Smith G. Pathology of Gray Wolf Shoulders: Lessons in Species and Aging. Anat Rec (Hoboken). 2016 10; 299(10):1338-47. PMID: 27415465; PMCID: PMC7159715.
      Citations:    Fields:    Translation:Animals
    510. Colman RJ, Rubin DT. Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review. Intest Res. 2016 Jul; 14(3):202-10. PMID: 27433141; PMCID: PMC4945523.
      Citations: 26     
    511. Katsanos KH, Micic D, Van Assche G, Lee JC, Lindsay JO, Rubin DT, Panaccione R, Torres J, Caprioli F, Lobatón T, Zerôncio M, Colombel JF. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis. 2016 Dec; 10(12):1385-1394. PMID: 27282402; PMCID: PMC5174730.
      Citations: 66     Fields:    Translation:Humans
    512. Meckel K, Li YC, Lim J, Kocherginsky M, Weber C, Almoghrabi A, Chen X, Kaboff A, Sadiq F, Hanauer SB, Cohen RD, Kwon J, Rubin DT, Hanan I, Sakuraba A, Yen E, Bissonnette M, Pekow J. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr. 2016 07; 104(1):113-20. PMID: 27281309; PMCID: PMC4919525.
      Citations: 45     Fields:    Translation:Humans
    513. Shi Y, Liu T, He L, Dougherty U, Chen L, Adhikari S, Alpert L, Zhou G, Liu W, Wang J, Deb DK, Hart J, Liu SQ, Kwon J, Pekow J, Rubin DT, Zhao Q, Bissonnette M, Li YC. Activation of the Renin-Angiotensin System Promotes Colitis Development. Sci Rep. 2016 06 08; 6:27552. PMID: 27271344; PMCID: PMC4897651.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    514. Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Cheifetz AS, Jones J, Kaplan GG, Siegel CA, Devlin SM. Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel. Inflamm Bowel Dis. 2016 06; 22(6):1418-24. PMID: 27057680.
      Citations: 5     Fields:    Translation:Humans
    515. Kahn SA, Rubin DT. When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation. Am J Gastroenterol. 2016 11; 111(11):1508-1510. PMID: 27166127.
      Citations: 4     Fields:    Translation:Humans
    516. Saad AM, Czul F, Sakuraba A, Rubin DT, Cohen RD. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease. Inflamm Bowel Dis. 2016 May; 22(5):1027-31. PMID: 26919459.
      Citations: 7     Fields:    Translation:Humans
    517. Sofia MA, Rubin DT. Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis. Therap Adv Gastroenterol. 2016 Jul; 9(4):548-59. PMID: 27366223; PMCID: PMC4913335.
      Citations: 9     
    518. Ward MA, Pierre JF, Leal RF, Huang Y, Shogan B, Dalal SR, Weber CR, Leone VA, Musch MW, An GC, Rao MC, Rubin DT, Raffals LE, Antonopoulos DA, Sogin ML, Hyman NH, Alverdy JC, Chang EB. Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility. Am J Physiol Gastrointest Liver Physiol. 2016 06 01; 310(11):G973-88. PMID: 27079612; PMCID: PMC4935476.
      Citations: 14     Fields:    Translation:HumansAnimals
    519. Lapin B, Rubin M, Hurst RD, Rubin DT, Hyman NH, Umanskiy K, Skowron KB. Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure? Inflamm Bowel Dis. 2016 Apr; 22(4):902-11. PMID: 26891259.
      Citations: 10     Fields:    Translation:HumansCells
    520. Connor SJ, Walls DM, Gollins J, Stewart SK, Bewtra M, Baumblatt GL, Holubar SD, Greenup AJ, Sechi A, Girgis A, Rubin DT, Siegel CA, Thompson KD. Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications. Inflamm Bowel Dis. 2016 Apr; 22(4):940-7. PMID: 26950308.
      Citations: 13     Fields:    Translation:Humans
    521. Wichmann A, Krugliak Cleveland N, Rubin DT. Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab. Am J Gastroenterol. 2016 04; 111(4):577. PMID: 27125715.
      Citations: 10     Fields:    Translation:Humans
    522. Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Rubin DT, Krugliak Cleveland N. Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis. 2016 Mar; 22(3):631-7. PMID: 26658214; PMCID: PMC5058785.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    523. Rubin DT, Inglis S, Magee E, Solomon D, D'Haens G, Ulcerative Colitis Remission Study Group, Bradette M, Gabalec L, Dobru D, Márquez J. Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial. J Crohns Colitis. 2016 Aug; 10(8):925-33. PMID: 26908939; PMCID: PMC4962361.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    524. Tarabar D, Hirsch A, Rubin DT. Vedolizumab in the treatment of Crohn's disease. Expert Rev Gastroenterol Hepatol. 2016; 10(3):283-90. PMID: 26810276.
      Citations: 2     Fields:    Translation:HumansAnimals
    525. Christensen B, Rubin DT. Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice. Curr Gastroenterol Rep. 2016 Jan; 18(1):5. PMID: 26759147.
      Citations: 21     Fields:    Translation:Humans
    526. Parian A, Koh J, Limketkai BN, Eluri S, Rubin DT, Brant SR, Ha CY, Bayless TM, Giardiello F, Hart J, Montgomery E, Lazarev MG. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016 Jul; 84(1):87-95.e1. PMID: 26709112; PMCID: PMC5555397.
      Citations: 13     Fields:    Translation:Humans
    527. Roy HK, Turzhitsky V, Wali R, Radosevich AJ, Jovanovic B, Della'Zanna G, Umar A, Rubin DT, Goldberg MJ, Bianchi L, De La Cruz M, Bogojevic A, Helenowski IB, Rodriguez L, Chatterton R, Skripkauskas S, Page K, Weber CR, Huang X, Richmond E, Bergan RC, Backman V. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut. 2017 02; 66(2):285-292. PMID: 26503631; PMCID: PMC5108693.
      Citations: 22     Fields:    Translation:Humans
    528. Szilagyi MA, Rosen DS, Rubin D, Zlotnik S, COUNCIL ON FOSTER CARE, ADOPTION, AND KINSHIP CARE, COMMITTEE ON ADOLESCENCE, COUNCIL ON EARLY CHILDHOOD. Health Care Issues for Children and Adolescents in Foster Care and Kinship Care. Pediatrics. 2015 Oct; 136(4):e1142-66. PMID: 26416934.
      Citations: 36     Fields:    Translation:Humans
    529. Rubin DT, Sandborn WJ, Bosworth B, Zakko S, Gordon GL, Sale ME, Rolleri RL, Golden PL, Barrett AC, Bortey E, Forbes WP. Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis. Dig Dis Sci. 2015 Nov; 60(11):3408-17. PMID: 26386854; PMCID: PMC4621699.
      Citations: 7     Fields:    Translation:Humans
    530. Kinnucan J, Tomal J, Rubin DT. U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis. Inflamm Bowel Dis. 2015 Sep; 21(9):2154-7. PMID: 26197447.
      Citations: 3     Fields:    Translation:Humans
    531. Rubin DT. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2015 Sep; 11(9):618-20. PMID: 27482184; PMCID: PMC4965622.
      Citations: 2     
    532. Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV, Munkholm P, Murdoch TB, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, O'Donnell S, Winer S, Hanauer S, Colombel JF, Peyrin-Biroulet L, Marteau P, Ordás I, Panes J, Bouguen G, Pariente B. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol. 2015 Sep; 110(9):1324-38. PMID: 26303131.
      Citations: 736     Fields:    Translation:Humans
    533. Hirsch A, Yarur AJ, Dezheng H, Rodriquez D, Krugliak Cleveland N, Ali T, Hurst RD, Umanskiy K, Hyman N, Colwell J, Rubin DT. Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients. J Gastrointest Surg. 2015 Oct; 19(10):1852-61. PMID: 26264361.
      Citations: 8     Fields:    Translation:Humans
    534. Park KT, Colletti RB, Rubin DT, Sharma BK, Thompson A, Krueger A. Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States. Am J Gastroenterol. 2016 Jan; 111(1):15-23. PMID: 26195179.
      Citations: 47     Fields:    Translation:Humans
    535. Hirsch A, Colman RJ, Lang GD, Rubin DT. Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash. ACG Case Rep J. 2015 Jul; 2(4):236-8. PMID: 26203450; PMCID: PMC4508952.
      Citations:    
    536. Mikolajczyk AE, Watson S, Surma BL, Rubin DT. Assessment of Tandem Measurements of pH and Total Gut Transit Time in Healthy Volunteers. Clin Transl Gastroenterol. 2015 Jul 09; 6:e100. PMID: 26158610; PMCID: PMC4816255.
      Citations: 16     Fields:    
    537. Yarur AJ, Rubin DT. Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2015 Jul; 21(7):1709-18. PMID: 25901974.
      Citations: 29     Fields:    Translation:Humans
    538. Ali R, Wild D, Shieh F, Diehl DL, Fischer M, Tamura W, Rubin DT, Kumbhari V, Okolo P, Storm A, Halpern Z, Neumann H, Khara HS, Pochapin MB, Gross SA. Deep enteroscopy with a conventional colonoscope: initial multicenter study by using a through-the-scope balloon catheter system. Gastrointest Endosc. 2015 Nov; 82(5):855-60. PMID: 26092618.
      Citations: 17     Fields:    Translation:Humans
    539. Rubin DT. When Should Therapy for Inflammatory Bowel Disease Be Stopped? Gastroenterol Hepatol (N Y). 2015 Jun; 11(6):400-2. PMID: 27118934; PMCID: PMC4843034.
      Citations: 3     
    540. Rao VL, Micic D, Rubin DT. Hematochezia and a Mesenteric Mass. Gastroenterology. 2015 Jul; 149(1):e12-3. PMID: 26026749.
      Citations:    Fields:    Translation:Humans
    541. Bellaguarda E, Keyashian K, Pekow J, Rubin DT, Cohen RD, Sakuraba A. Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):1919-25. PMID: 26001336; PMCID: PMC4795937.
      Citations: 10     Fields:    Translation:HumansCells
    542. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology. 2015 Jul; 149(1):223-37. PMID: 25982290; PMCID: PMC4755303.
      Citations: 276     Fields:    Translation:HumansCells
    543. Rubin DT, Krugliak Cleveland N. Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease. Am J Gastroenterol. 2015 Sep; 110(9):1252-6. PMID: 25848924.
      Citations: 17     Fields:    Translation:Humans
    544. Rubin DT, Kahn SA. Can we improve on the "see one, do one, teach one" paradigm in training fellows to care for patients with inflammatory bowel disease? Inflamm Bowel Dis. 2015 Apr; 21(4):766-7. PMID: 25719529.
      Citations:    Fields:    Translation:Humans
    545. Rubin DT. The rationale and growth of advanced training in inflammatory bowel disease. Gastroenterology. 2015 Apr; 148(4):696-700. PMID: 25724456.
      Citations: 9     Fields:    Translation:Humans
    546. Rubin DT. The Rationale and Growth of Advanced Training in Inflammatory Bowel Disease. Gastroenterology. 2015 Feb 04. PMID: 25659281.
      Citations:    Fields:    
    547. Colman RJ, Rubin DT. Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease. J Crohns Colitis. 2015 Apr; 9(4):312-7. PMID: 25616487; PMCID: PMC4621545.
      Citations: 15     Fields:    Translation:Humans
    548. Coronel E, Micic D, Rubin DT. Patchy colitis and interstitial lung disease. Gastroenterology. 2015 Jan; 148(1):26-7. PMID: 25450070.
      Citations: 1     Fields:    Translation:Humans
    549. Rubin DT. Why it's time for updated U.S. colorectal cancer prevention guidelines in inflammatory bowel disease. Gastrointest Endosc. 2014 Nov; 80(5):849-51. PMID: 25436396.
      Citations: 2     Fields:    Translation:Humans
    550. Stein AC, Rubin DT, Hanauer SB, Cohen RD. Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease. Inflamm Bowel Dis. 2014 Oct; 20(10):1722-8. PMID: 25171509.
      Citations: 7     Fields:    Translation:Humans
    551. Nannegari V, Roque S, Rubin DT, Quera R. A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation. Gastroenterol Hepatol (N Y). 2014 Oct; 10(10):626-30. PMID: 27540334; PMCID: PMC4988220.
      Citations: 5     
    552. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2014 12; 8(12):1569-81. PMID: 25223604; PMCID: PMC4296742.
      Citations: 228     Fields:    Translation:Humans
    553. Kahn SA, Goeppinger SR, Rubin DT. Fecal microbiota transplantation: an interest in IBD? Nestle Nutr Inst Workshop Ser. 2014; 79:101-14. PMID: 25227298.
      Citations:    Fields:    Translation:Humans
    554. Shah SA, Rubin DT, Farraye FA. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease. Curr Gastroenterol Rep. 2014 Sep; 16(9):407. PMID: 25113042.
      Citations: 4     Fields:    Translation:Humans
    555. Stein AC, Appannagari A, Habib I, Semrad CE, Rubin DT. A rapid and accurate method to detect active small bowel gastrointestinal bleeding on video capsule endoscopy. Dig Dis Sci. 2014 Oct; 59(10):2503-7. PMID: 25146843.
      Citations: 3     Fields:    Translation:Humans
    556. Wade R, Shea JA, Rubin D, Wood J. Adverse childhood experiences of low-income urban youth. Pediatrics. 2014 Jul; 134(1):e13-20. PMID: 24935995.
      Citations: 90     Fields:    Translation:Humans
    557. Chapman CG, Rubin DT. The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014 Jul; 24(3):353-65. PMID: 24975527; PMCID: PMC4165430.
      Citations: 9     Fields:    Translation:Humans
    558. Sofia MA, Rubin DT, Hou N, Pekow J. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Dig Dis Sci. 2014 Sep; 59(9):2228-35. PMID: 24752402; PMCID: PMC4180597.
      Citations: 21     Fields:    Translation:Humans
    559. Chapman CG, Bochenek A, Stein AC, Rubin DT. Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis. ACG Case Rep J. 2014 Apr; 1(3):148-50. PMID: 26157857; PMCID: PMC4435295.
      Citations: 3     
    560. Rubin DT, Mody R, Davis KL, Wang CC. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther. 2014 May; 39(10):1143-55. PMID: 24697826.
      Citations: 55     Fields:    Translation:Humans
    561. Rubin DT, Becker S, Siegler M. Ethical considerations for clinical trials in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2014 Jan; 10(1):37-41. PMID: 24799837; PMCID: PMC4008957.
      Citations: 6     
    562. Liao C, Fichera A, Rubin DT, Pekow J, Nelson R. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis. 2014 Jan; 20(1):14-20. PMID: 24297054; PMCID: PMC4017597.
      Citations: 23     Fields:    Translation:Humans
    563. Rubin DT. Introduction to the 80th anniversary issue of Digestive Diseases and Sciences. Dig Dis Sci. 2014 Jan; 59(1):2-5. PMID: 24370783.
      Citations:    Fields:    
    564. Micic D, Rubin DT. Describing the clinical phenotypes of Crohn's disease: lessons from the past: commentary on: the broadening conception of regional ileitis. Dig Dis Sci. 2014 Jan; 59(1):6-8. PMID: 24374644.
      Citations:    Fields:    Translation:Humans
    565. Kinnucan JA, Rubin DT, Ali T. Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol Hepatol (N Y). 2013 Nov; 9(11):718-27. PMID: 24764789; PMCID: PMC3995194.
      Citations: 39     
    566. Sakuraba A, Annunziata ML, Cohen RD, Hanauer SB, Rubin DT. Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease. Inflamm Bowel Dis. 2013 Nov; 19(12):2577-83. PMID: 24132161.
      Citations: 13     Fields:    Translation:Humans
    567. Rubin DT. Curbing our enthusiasm for fecal transplantation in ulcerative colitis. Am J Gastroenterol. 2013 Oct; 108(10):1631-3. PMID: 24091506.
      Citations: 12     Fields:    Translation:Humans
    568. Madhoun MF, Orr WC, Rubin DT, Ali T. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013 Oct; 19(11):2440-3. PMID: 23945186.
      Citations: 71     Fields:    Translation:Humans
    569. Rubin DT, Goeppinger SR. Initial experience of a through-the-scope balloon device for ileal intubation in Crohn's disease. Gastrointest Endosc. 2013 Oct; 78(4):669-70. PMID: 24054746.
      Citations: 2     Fields:    Translation:Humans
    570. Branas CC, Rubin D, Guo W. Vacant Properties and Violence in Neighborhoods. ISRN Public Health. 2013 Sep 10; 2012:246142. PMID: 23814668; PMCID: PMC3693396.
      Citations: 34     
    571. Weber CR, Rubin DT. Chronic pouchitis versus recurrent Crohn's disease: a diagnostic challenge. Dig Dis Sci. 2013 Oct; 58(10):2748-50. PMID: 23925821; PMCID: PMC3805823.
      Citations: 1     Fields:    Translation:Humans
    572. Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013 Dec; 11(12):1601-8.e1-4. PMID: 23872237; PMCID: PMC3840031.
      Citations: 111     Fields:    Translation:Humans
    573. Mikolajczyk AE, Rubin DT, McConville JF. A diagnosis that eats at you. Gastroenterology. 2013 Aug; 145(2):289, 489. PMID: 23810344.
      Citations: 1     Fields:    Translation:Humans
    574. Kahn SA, Vachon A, Rodriquez D, Goeppinger SR, Surma B, Marks J, Rubin DT. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis. 2013 Jun; 19(7):1506-13. PMID: 23624888; PMCID: PMC3780382.
      Citations: 41     Fields:    Translation:Humans
    575. Rubin DT. What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis. Gastroenterology. 2013 Jul; 145(1):45-47. PMID: 23726879.
      Citations: 2     Fields:    Translation:Humans
    576. Chiu YL, Rubin DT, Vermeire S, Louis E, Robinson AM, Lomax KG, Pollack PF, Paulson SK. Serum adalimumab concentration and clinical remission in patients with Crohn's disease. Inflamm Bowel Dis. 2013 May; 19(6):1112-22. PMID: 23584130.
      Citations: 44     Fields:    Translation:Humans
    577. Sakuraba A, Keyashian K, Correia C, Melek J, Cohen RD, Hanauer SB, Rubin DT. Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center. Inflamm Bowel Dis. 2013 Mar; 19(3):621-6. PMID: 23429449; PMCID: PMC4779049.
      Citations: 15     Fields:    Translation:Humans
    578. Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, Dassopoulos T, Denson LA, Dudley-Brown S, Garb A, Hanauer SB, Kappelman MD, Lewis JD, Lynch I, Moynihan A, Rubin DT, Sartor RB, Schwartz RM, Wolf DC, Ullman TA. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013 Mar; 19(3):662-8. PMID: 23388547.
      Citations: 64     Fields:    Translation:Humans
    579. McKeag H, Christian CW, Rubin D, Daymont C, Pollock AN, Wood J. Subdural hemorrhage in pediatric patients with enlargement of the subarachnoid spaces. J Neurosurg Pediatr. 2013 Apr; 11(4):438-44. PMID: 23394356; PMCID: PMC8502493.
      Citations: 23     Fields:    Translation:Humans
    580. Hoentjen F, Seinen ML, Hanauer SB, de Boer NK, Rubin DT, Bouma G, Harrell LE, van Bodegraven AA. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2013 Feb; 19(2):363-9. PMID: 22605661.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    581. Kisiel JB, Yab TC, Nazer Hussain FT, Taylor WR, Garrity-Park MM, Sandborn WJ, Loftus EV, Wolff BG, Smyrk TC, Itzkowitz SH, Rubin DT, Zou H, Mahoney DW, Ahlquist DA. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013 Mar; 37(5):546-54. PMID: 23347191; PMCID: PMC3869396.
      Citations: 45     Fields:    Translation:Humans
    582. Hoentjen F, Hanauer SB, Hart J, Rubin DT. Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy. J Clin Gastroenterol. 2013 Jan; 47(1):52-7. PMID: 22858512; PMCID: PMC3874322.
      Citations: 14     Fields:    Translation:Humans
    583. Erichsen D, Godoy C, Axelsson J, Rubin D, Gozal D, Gränse F. Screening for sleep disorders in pediatric primary care: are we there yet? Clin Pediatr (Phila). 2012 Dec; 51(12):1125-9. PMID: 23203980.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    584. Kahn SA, Young S, Rubin DT. Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child. Am J Gastroenterol. 2012 Dec; 107(12):1930-1. PMID: 23211865.
      Citations: 14     Fields:    Translation:HumansCells
    585. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):286-92; quiz e24. PMID: 23200982; PMCID: PMC3913646.
      Citations: 122     Fields:    Translation:Humans
    586. Hanauer SB, Rubin DT. In memoriam. Inflamm Bowel Dis. 2012 Nov; 18(11):2001-3. PMID: 23070951.
      Citations:    Fields:    Translation:Humans
    587. Hanauer SB, Rubin DT. Joseph Barnett Kirsner, MD, PhD. Dig Dis Sci. 2012 Nov; 57(11):2722-4. PMID: 23236606.
      Citations:    Fields:    Translation:Humans
    588. Hanauer SB, Rubin DT. Joseph Barnett Kirsner, MD, PhD. Clin Gastroenterol Hepatol. 2012 Nov; 10(11):1181-2. PMID: 23084570.
      Citations:    Fields:    Translation:Humans
    589. Hanauer SB, Rubin D. Joseph Barnett Kirsner, MD, PhD. Gastrointest Endosc. 2012 Oct; 76(4):730-2. PMID: 22985640.
      Citations:    Fields:    
    590. Hanauer SB, Rubin DT. In memoriam: Dr Joseph Barnett Kirsner. Gut. 2012 Nov; 61(11):1636-7. PMID: 22976043.
      Citations:    Fields:    Translation:Humans
    591. Henderson TO, Oeffinger KC, Whitton J, Leisenring W, Neglia J, Meadows A, Crotty C, Rubin DT, Diller L, Inskip P, Smith SA, Stovall M, Constine LS, Hammond S, Armstrong GT, Robison LL, Nathan PC. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med. 2012 Jun 05; 156(11):757-66, W-260. PMID: 22665813; PMCID: PMC3554254.
      Citations: 71     Fields:    Translation:HumansPHPublic Health
    592. Henderson TO, Oeffinger KC, Whitton J, Leisenring W, Neglia J, Meadows A, Crotty C, Rubin DT, Diller L, Inskip P, Smith SA, Stovall M, Constine LS, Hammond S, Armstrong GT, Robison LL, Nathan PC. Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors. Ann Intern Med. 2012 Jun 05; 156(11):I-36. PMID: 22665822.
      Citations:    Fields:    Translation:HumansPHPublic Health
    593. Rubin DT, Uluscu O, Sederman R. Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data. Inflamm Bowel Dis. 2012 Dec; 18(12):2225-31. PMID: 22359399.
      Citations: 34     Fields:    Translation:Humans
    594. Leung Y, Kaplan GG, Rioux KP, Hubbard J, Kamhawi S, Stasiak L, Cohen RD, Devlin SM, Panaccione R, Hanauer SB, Rubin DT. Assessment of variables associated with smoking cessation in Crohn's disease. Dig Dis Sci. 2012 Apr; 57(4):1026-32. PMID: 22311366.
      Citations: 8     Fields:    Translation:Humans
    595. Ali T, Yun L, Rubin DT. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. World J Gastroenterol. 2012 Jan 21; 18(3):197-204. PMID: 22294822; PMCID: PMC3261536.
      Citations: 14     Fields:    Translation:Humans
    596. Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohns Colitis. 2012 Aug; 6(7):756-62. PMID: 22398093.
      Citations: 15     Fields:    Translation:Humans
    597. Wright CS, Weiner M, Localio R, Song L, Chen P, Rubin D. Misreport of gestational weight gain (GWG) in birth certificate data. Matern Child Health J. 2012 Jan; 16(1):197-202. PMID: 21132523.
      Citations: 15     Fields:    Translation:Humans
    598. Hoentjen F, Hanauer SB, de Boer NK, Rubin DT. Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction. Dig Dis Sci. 2012 Jan; 57(1):250-3. PMID: 22147254; PMCID: PMC3253335.
      Citations: 2     Fields:    Translation:Humans
    599. Rubin DT, Sohi S, Glathar M, Thomas T, Yadron N, Surma BL. Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study. Gastroenterol Res Pract. 2011; 2011:106978. PMID: 22114587; PMCID: PMC3216319.
      Citations: 12     
    600. Hoentjen F, Rubin DT. Infectious proctitis: when to suspect it is not inflammatory bowel disease. Dig Dis Sci. 2012 Feb; 57(2):269-73. PMID: 21994137.
      Citations: 20     Fields:    Translation:HumansCells
    601. Fichera A, Zoccali M, Felice C, Rubin DT. Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution. J Gastrointest Surg. 2011 Nov; 15(11):1909-16. PMID: 21909842.
      Citations: 9     Fields:    Translation:Humans
    602. Rubin DT, Mulani P, Chao J, Pollack PF, Bensimon AG, Yu AP, Ghosh S. Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial. Inflamm Bowel Dis. 2012 May; 18(5):818-25. PMID: 21887727.
      Citations: 8     Fields:    Translation:Humans
    603. Rubin DT, Panaccione R, Chao J, Robinson AM. A practical, evidence-based guide to the use of adalimumab in Crohn's disease. Curr Med Res Opin. 2011 Sep; 27(9):1803-13. PMID: 21809894.
      Citations: 3     Fields:    Translation:Humans
    604. Kahn SA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? Inflamm Bowel Dis. 2012 Apr; 18(4):676-84. PMID: 21618362; PMCID: PMC3183116.
      Citations: 28     Fields:    Translation:Humans
    605. Pekow JR, Dougherty U, Mustafi R, Zhu H, Kocherginsky M, Rubin DT, Hanauer SB, Hart J, Chang EB, Fichera A, Joseph LJ, Bissonnette M. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis. 2012 Jan; 18(1):94-100. PMID: 21557394; PMCID: PMC3931730.
      Citations: 61     Fields:    Translation:HumansCells
    606. St Jacques PL, Kragel PA, Rubin DC. Dynamic neural networks supporting memory retrieval. Neuroimage. 2011 Jul 15; 57(2):608-16. PMID: 21550407; PMCID: PMC3114167.
      Citations: 56     Fields:    Translation:Humans
    607. Cohen RD, Lewis JR, Turner H, Harrell LE, Hanauer SB, Rubin DT. Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center. Inflamm Bowel Dis. 2012 Jan; 18(1):10-6. PMID: 21456032.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    608. Rubin DT. We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing? Clin Gastroenterol Hepatol. 2011 Jun; 9(6):456-7. PMID: 21421077.
      Citations: 6     Fields:    Translation:Humans
    609. Oto A, Kayhan A, Williams JT, Fan X, Yun L, Arkani S, Rubin DT. Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging. 2011 Mar; 33(3):615-24. PMID: 21563245.
      Citations: 68     Fields:    Translation:HumansCells
    610. Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L, Baron JA, Sørensen HT. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011 Jul; 60(7):937-43. PMID: 21339206.
      Citations: 102     Fields:    Translation:Humans
    611. Lichtenstein GR, Ramsey D, Rubin DT. Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis. Aliment Pharmacol Ther. 2011 Mar; 33(6):672-8. PMID: 21255059.
      Citations: 32     Fields:    Translation:Humans
    612. Hanauer SB, Kornbluth AA, Messick J, Rubin DT, Sandborn WJ, Sands BE. Clinical scenarios in IBD: optimizing the use of conventional and biologic agents. Inflamm Bowel Dis. 2010 Dec; 16 Suppl 1:S1-11. PMID: 21104734.
      Citations: 8     Fields:    Translation:Humans
    613. Rubin DT, Rothe JA. The peri-appendiceal red patch in ulcerative colitis: review of the University of Chicago experience. Dig Dis Sci. 2010 Dec; 55(12):3495-501. PMID: 20936357.
      Citations: 15     Fields:    Translation:Humans
    614. Siegel CA, Schwartz LM, Woloshin S, Cole EB, Rubin DT, Vay T, Baars J, Sands BE. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis. 2010 Oct; 16(10):1658-62. PMID: 20186940; PMCID: PMC2927807.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    615. Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis. 2010 Aug; 16(8):1352-6. PMID: 20027656; PMCID: PMC3046461.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    616. Rubin D, Noonan K. What do Romanian children living in orphanages manifesting repetitive behaviors and American children in foster care with abnormal cortisol levels have in common? More than you would think. Arch Pediatr Adolesc Med. 2010 May; 164(5):492-3. PMID: 20439804.
      Citations: 1     Fields:    Translation:Humans
    617. Ince EE, Rubin D, Christian CW. Parental perceptions of hospital care in children with accidental or alleged non-accidental trauma. Child Abuse Negl. 2010 Jun; 34(6):403-6. PMID: 20409585.
      Citations: 3     Fields:    Translation:Humans
    618. Rosenberg JA, Rubin DT. Performance of CT colonography in clinical trials. Gastrointest Endosc Clin N Am. 2010 Apr; 20(2):193-207. PMID: 20451810.
      Citations:    Fields:    Translation:HumansPHPublic Health
    619. Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 2010 Jan; 16(1):125-33. PMID: 19572335.
      Citations: 32     Fields:    Translation:Humans
    620. Zisman TL, Rubin DT. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Med Clin North Am. 2010 Jan; 94(1):155-78. PMID: 19944803.
      Citations: 2     Fields:    
    621. Zisman TL, Rubin DT. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Gastroenterol Clin North Am. 2009 Dec; 38(4):729-52. PMID: 19913211.
      Citations: 3     Fields:    Translation:Humans
    622. Rubin DT, Gandhi RK, Hetzel JT, Kinnear SH, Aronsohn A, Wood G, Yadron N. Do colorectal cancer patients understand that their family is at risk? Dig Dis Sci. 2009 Nov; 54(11):2473-83. PMID: 19731030.
      Citations: 7     Fields:    Translation:Humans
    623. Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J. The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci. 2010 Apr; 55(4):1044-52. PMID: 20155319.
      Citations: 24     Fields:    Translation:Humans
    624. Afif W, Leighton JA, Hanauer SB, Loftus EV, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis. 2009 Sep; 15(9):1302-7. PMID: 19408340.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    625. Lewis JR, Konda V, Rubin DT. Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members. Genet Test Mol Biomarkers. 2009 Aug; 13(4):495-503. PMID: 19580441.
      Citations: 7     Fields:    Translation:Humans
    626. Bezabeh T, Somorjai R, Dolenko B, Bryskina N, Levin B, Bernstein CN, Jeyarajah E, Steinhart AH, Rubin DT, Smith IC. Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts. NMR Biomed. 2009 Jul; 22(6):593-600. PMID: 19259992.
      Citations: 23     Fields:    Translation:Humans
    627. Dinani A, Ktaich N, Urban C, Rubin D. Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis. J Med Microbiol. 2009 Oct; 58(Pt 10):1385-1387. PMID: 19541783.
      Citations: 3     Fields:    Translation:HumansCells
    628. Huo D, Hetzel JT, Roy H, Rubin DT. Association of colorectal cancer and prostate cancer and impact of radiation therapy. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):1979-85. PMID: 19531678.
      Citations: 19     Fields:    Translation:Humans
    629. Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study. Acad Radiol. 2009 Oct; 16(10):1223-30. PMID: 19524458.
      Citations: 13     Fields:    Translation:Humans
    630. Hanauer SB, Present DH, Rubin DT. Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes. Gastroenterol Hepatol (N Y). 2009 Jun; 5(6 Suppl):4-16. PMID: 20574506; PMCID: PMC2886411.
      Citations: 4     
    631. Rubin DT, Surma BL, Gavzy SJ, Schnell KM, Bunnag AP, Huo D, Appelbaum DE. Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission. Inflamm Bowel Dis. 2009 May; 15(5):750-5. PMID: 19090558.
      Citations: 12     Fields:    Translation:Humans
    632. Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, Loftus EV, Hopper J. Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009 Apr; 15(4):581-8. PMID: 19067414.
      Citations: 46     Fields:    Translation:Humans
    633. Silverberg MS, Rubin DT, Steinhart AH, Cohen LB, Rotter JI. Israel-Gaza conflict. Lancet. 2009 Mar 14; 373(9667):891-2. PMID: 19286075.
      Citations:    Fields:    Translation:Humans
    634. Kim K, Velez I, Rubin D. A rare case of granulocytic sarcoma in the mandible of a 4-year-old child: a case report and review of the literature. J Oral Maxillofac Surg. 2009 Feb; 67(2):410-6. PMID: 19138619.
      Citations: 5     Fields:    Translation:Humans
    635. Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009 Feb 01; 29(3):247-57. PMID: 18945258.
      Citations: 62     Fields:    Translation:Humans
    636. Loftus EV, Feagan BG, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P, Colombel JF. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008 Dec; 103(12):3132-41. PMID: 18853973.
      Citations: 66     Fields:    Translation:HumansCTClinical Trials
    637. Nathanson JW, Zisman TL, Julian C, McCaffrey S, Rubin DT. Identification of patients at increased risk for colorectal cancer in an open access endoscopy center. J Clin Gastroenterol. 2008 Oct; 42(9):1025-31. PMID: 18719509.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    638. Rubin DT. An updated approach to dysplasia in IBD. J Gastrointest Surg. 2008 Dec; 12(12):2153-6. PMID: 18766409.
      Citations:    Fields:    Translation:Humans
    639. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008 Oct; 88(10):1110-20. PMID: 18711353; PMCID: PMC2586671.
      Citations: 213     Fields:    Translation:HumansCells
    640. Calderwood AH, Huo D, Rubin DT. Association between colorectal cancer and urologic cancers. Arch Intern Med. 2008 May 12; 168(9):1003-9. PMID: 18474765.
      Citations: 14     Fields:    Translation:Humans
    641. Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008 May 07; 14(17):2662-9. PMID: 18461651; PMCID: PMC2709054.
      Citations: 56     Fields:    Translation:HumansPHPublic Health
    642. Herrerias JM, Leighton JA, Costamagna G, Infantolino A, Eliakim R, Fischer D, Rubin DT, Manten HD, Scapa E, Morgan DR, Bergwerk AJ, Koslowsky B, Adler SN. Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc. 2008 May; 67(6):902-9. PMID: 18355824.
      Citations: 66     Fields:    Translation:HumansPHPublic Health
    643. Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzkowitz S, 5-ASA in Colorectal Cancer Prevention Meeting Group. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Inflamm Bowel Dis. 2008 Feb; 14(2):265-74. PMID: 17932965.
      Citations: 27     Fields:    Translation:Humans
    644. Kane SV, Brixner D, Rubin DT, Sewitch MJ. The challenge of compliance and persistence: focus on ulcerative colitis. J Manag Care Pharm. 2008 Jan; 14(1 Suppl A):s2-12; quiz s13-5. PMID: 18240888; PMCID: PMC10438168.
      Citations: 21     Fields:    Translation:Humans
    645. Lichtenstein GR, Rubin DT, Sabesin SM, Velayos FS, Vitat P. Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis. Rev Gastroenterol Disord. 2008; 8(1):21-30; quiz 31-2. PMID: 18477967.
      Citations: 1     Fields:    Translation:Humans
    646. Dugdale LS, Siegler M, Rubin DT. Medical professionalism and the doctor-patient relationship. Perspect Biol Med. 2008; 51(4):547-53. PMID: 18997357.
      Citations: 6     Fields:    Translation:Humans
    647. Dalal A, Urban C, Ahluwalia M, Rubin D. Corynebacterium bovis line related septicemia: a case report and review of the literature. Scand J Infect Dis. 2008; 40(6-7):575-7. PMID: 18584551.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    648. Nathanson JW, Yadron NE, Farnan J, Kinnear S, Hart J, Rubin DT. p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease. Dig Dis Sci. 2008 Feb; 53(2):474-80. PMID: 17676397.
      Citations: 12     Fields:    Translation:Humans
    649. Rubin DT, Ulitsky A, Poston J, Day R, Huo D. What is the most effective way to communicate results after endoscopy? Gastrointest Endosc. 2007 Jul; 66(1):108-12. PMID: 17591482.
      Citations: 11     Fields:    Translation:Humans
    650. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007 Jun; 65(7):998-1004. PMID: 17451704.
      Citations: 54     Fields:    Translation:HumansPHPublic Health
    651. Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Apr; 13(4):367-71. PMID: 17206695.
      Citations: 39     Fields:    Translation:Humans
    652. LoSavio AD, Bunnag AP, Rubin DT. Colonic infiltration with chronic myelomonocytic leukemia. Nat Clin Pract Gastroenterol Hepatol. 2007 Apr; 4(4):229-33. PMID: 17404590.
      Citations: 2     Fields:    Translation:Humans
    653. Cummings SA, Rubin DT. The complexity and challenges of genetic counseling and testing for inflammatory bowel disease. J Genet Couns. 2006 Dec; 15(6):465-76. PMID: 17106630.
      Citations: 5     Fields:    Translation:Humans
    654. Kupfer SS, Rubin DT. Inflammatory Bowel Disease and Cerebral Venous Sinus Thrombosis. Gastroenterol Hepatol (N Y). 2006 Dec; 2(12):914-917. PMID: 28331482; PMCID: PMC5359939.
      Citations: 6     
    655. Rubin DT, Turner JR. Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1309-13. PMID: 17110299; PMCID: PMC1829445.
      Citations: 12     Fields:    Translation:Humans
    656. Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1346-50. PMID: 17059900.
      Citations: 35     Fields:    Translation:Humans
    657. Dachman AH, Dawson DO, Lefere P, Yoshida H, Khan NU, Cipriani N, Rubin DT. Comparison of routine and unprepped CT colonography augmented by low fiber diet and stool tagging: a pilot study. Abdom Imaging. 2007 Jan-Feb; 32(1):96-104. PMID: 16969601.
      Citations: 8     Fields:    Translation:Humans
    658. Rubin DT, Kavitt RT. Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am. 2006 Sep; 35(3):581-604. PMID: 16952742.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    659. Bosworth HB, Rockey DC, Paulson EK, Niedzwiecki D, Davis W, Sanders LL, Yee J, Henderson J, Hatten P, Burdick S, Sanyal A, Rubin DT, Sterling M, Akerkar G, Bhutani MS, Binmoeller K, Garvie J, Bini EJ, McQuaid K, Foster WL, Thompson WM, Dachman A, Halvorsen R. Prospective comparison of patient experience with colon imaging tests. Am J Med. 2006 Sep; 119(9):791-9. PMID: 16945615.
      Citations: 18     Fields:    Translation:Humans
    660. Rubin DT, Sohi S, Shilling RA, White SR. Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease. Gastroenterol Hepatol (N Y). 2006 Aug; 2(8):592-596. PMID: 28316528; PMCID: PMC5350253.
      Citations: 3     
    661. Konda V, Huo D, Hermes G, Liu M, Patel R, Rubin DT. Do patients with inflammatory bowel disease want genetic testing? Inflamm Bowel Dis. 2006 Jun; 12(6):497-502. PMID: 16775494.
      Citations: 6     Fields:    Translation:Humans
    662. Rubin DT, Parekh N. Colorectal cancer in inflammatory bowel disease: molecular and clinical considerations. Curr Treat Options Gastroenterol. 2006 Jun; 9(3):211-20. PMID: 16901385.
      Citations: 9     
    663. Rubin DT. Genetic Testing in IBD Patients. Gastroenterol Hepatol (N Y). 2006 May; 2(5):342-344. PMID: 28289337; PMCID: PMC5338187.
      Citations:    
    664. Rubin DT. The changing face of colorectal cancer in inflammatory bowel disease: progress at last! Gastroenterology. 2006 Apr; 130(4):1350-2. PMID: 16618426.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    665. Jahraus CD, Rubin DT, Scherl EJ, Bettenhausen D. Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide. Gastroenterology. 2005 Aug; 129(2):770-2. PMID: 16083743.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    666. Rubin DT, Lashner BA. Will a 5-ASA a day keep the cancer (and dysplasia) away? Am J Gastroenterol. 2005 Jun; 100(6):1354-6. PMID: 15929769.
      Citations: 4     Fields:    Translation:Humans
    667. Ross AS, Gasparaitis A, Hurst R, Hanauer SB, Rubin DT. Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease. Nat Clin Pract Gastroenterol Hepatol. 2005 Jun; 2(6):281-5; quiz 1 p following 285. PMID: 16265232.
      Citations: 3     Fields:    Translation:Humans
    668. Rubin DT. To test or "NOD-2" test: what are the questions? The balanced viewpoint. Inflamm Bowel Dis. 2005 May; 11(5):510-2. PMID: 15867593.
      Citations: 3     Fields:    Translation:Humans
    669. Rubin DT, Kornblunth A. Role of antibiotics in the management of inflammatory bowel disease: a review. Rev Gastroenterol Disord. 2005; 5 Suppl 3:S10-5. PMID: 17713454.
      Citations: 3     Fields:    Translation:Humans
    670. Rockey DC, Paulson E, Niedzwiecki D, Davis W, Bosworth HB, Sanders L, Yee J, Henderson J, Hatten P, Burdick S, Sanyal A, Rubin DT, Sterling M, Akerkar G, Bhutani MS, Binmoeller K, Garvie J, Bini EJ, McQuaid K, Foster WL, Thompson WM, Dachman A, Halvorsen R. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet. 2005 Jan 22-28; 365(9456):305-11. PMID: 15664225.
      Citations: 123     Fields:    Translation:Humans
    671. Harrell LE, Rubin DT, Hanauer SB. Fever and right upper quadrant pain in a pregnant woman at 30 weeks' gestation. Nat Clin Pract Gastroenterol Hepatol. 2004 Dec; 1(2):113-6; quiz 1 p following 116. PMID: 16265073.
      Citations: 1     Fields:    Translation:Humans
    672. Groeger JS, Weiser MA, Lederberg MS, Rubin DT, Siegler M. The case: can doctors say "enough"? Camb Q Healthc Ethics. 2003; 12(2):215-23. PMID: 12764890.
      Citations:    Fields:    Translation:Humans
    673. Yoshida H, MacEneaney P, Rubin DT, Dachman AH, Näppi J. Computer-aided diagnosis scheme for detection of polyps at CT colonography. Radiographics. 2002 Jul-Aug; 22(4):963-79. PMID: 12110726.
      Citations: 29     Fields:    Translation:Humans
    674. Yoshida H, Masutani Y, MacEneaney P, Rubin DT, Dachman AH. Computerized detection of colonic polyps at CT colonography on the basis of volumetric features: pilot study. Radiology. 2002 Feb; 222(2):327-36. PMID: 11818596.
      Citations: 28     Fields:    Translation:Humans
    675. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery. 2002 Jan; 131(1):6-15. PMID: 11812957.
      Citations: 106     Fields:    Translation:Humans
    676. McConville JF, Rubin DT, Humphrey H, Carson SS. Effects of billing and documentation requirements on the quantity and quality of teaching by attending physicians. Acad Med. 2001 Nov; 76(11):1144-7. PMID: 11704518.
      Citations: 3     Fields:    Translation:Humans
    677. Rubin DT, Dachman AH. Virtual colonoscopy: a novel imaging modality for colorectal cancer. Curr Oncol Rep. 2001 Mar; 3(2):88-93. PMID: 11177739.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    678. Ehrenpreis ED, Rubin DT, Ginsburg PM, Meyers JS. Treatment of anal fissures with topical nitroglycerin. Expert Opin Pharmacother. 2001 Jan; 2(1):41-5. PMID: 11336567.
      Citations: 1     Fields:    Translation:Humans
    679. Ginsburg PM, Janefalkar P, Rubin DT, Ehrenpreis ED. Malabsorption testing: a review. Curr Gastroenterol Rep. 2000 Oct; 2(5):370-7. PMID: 10998664.
      Citations: 1     Fields:    Translation:Humans
    680. Rubin DT, Hanauer SB. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2000 Aug; 12(8):855-62. PMID: 10958212.
      Citations: 35     Fields:    Translation:Humans
    681. San Agustin M, Cohen P, Rubin D, Cleary SD, Erickson CJ, Allen JK. The Montefiore community children's project: a controlled study of cognitive and emotional problems of homeless mothers and children. J Urban Health. 1999 Mar; 76(1):39-50. PMID: 10091189; PMCID: PMC3456713.
      Citations: 10     Fields:    Translation:Humans
    682. Dachman AH, Kuniyoshi JK, Boyle CM, Samara Y, Hoffmann KR, Rubin DT, Hanan I. CT colonography with three-dimensional problem solving for detection of colonic polyps. AJR Am J Roentgenol. 1998 Oct; 171(4):989-95. PMID: 9762982.
      Citations: 25     Fields:    Translation:Humans
    683. Ross LF, Rubin DT, Siegler M, Josephson MA, Thistlethwaite JR, Woodle ES. Ethics of a paired-kidney-exchange program. N Engl J Med. 1997 Jun 12; 336(24):1752-5. PMID: 9180096.
      Citations: 21     Fields:    Translation:Humans
    684. Mooteri S, Rubin D, Leurgans S, Jakate S, Drab E, Saclarides T. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum. 1996 Oct; 39(10):1073-80. PMID: 8831518.
      Citations: 13     Fields:    Translation:Humans
    685. Young SW, Qing F, Rubin D, Balkus KJ, Engel JS, Lang J, Dow WC, Mutch JD, Miller RA. Gadolinium zeolite as an oral contrast agent for magnetic resonance imaging. J Magn Reson Imaging. 1995 Sep-Oct; 5(5):499-508. PMID: 8574032.
      Citations: 7     Fields:    Translation:HumansAnimalsCTClinical Trials
    686. Okuyama S, Rubin D, Woodley M, Peters MG. Regional expression of murine intestinal immune cells in normal and isografted intestine. Cell Immunol. 1995 Jul; 163(2):198-205. PMID: 7606793.
      Citations:    Fields:    Translation:AnimalsCells
    687. Stanley SL, Zhang T, Rubin D, Li E. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect Immun. 1995 Apr; 63(4):1587-90. PMID: 7890426; PMCID: PMC173193.
      Citations: 33     Fields:    Translation:Animals
    688. Dworkin BM, Antonecchia PP, Smith F, Weiss L, Davidian M, Rubin D, Rosenthal WS. Reduced cardiac selenium content in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr. 1989 Nov-Dec; 13(6):644-7. PMID: 2614866.
      Citations: 16     Fields:    Translation:Humans
    Rubin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (1083)
    Explore
    _
    Co-Authors (113)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _